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Abstract
Native arteriovenous fistulas created in the forearm between the radial artery and the 
cephalic vein are currently considered the best vascular access for hemodialysis in terms 
of outcome and safety. However, this type of access is associated with a significant 
failure rate that is generally caused by intimal hyperplasia development and consequent 
stenosis. Computational studies have shown that intimal hyperplasia is preferentially 
localized in regions of the fistula that are exposed to disturbed wall shear stresses. This 
thesis reports the development and testing of a novel, real-time controlled cone-and- 
plate device to assess the role of changes in shear stress induced by fistula creation on 
the activation state of endothelial cells and paracrine signalling in vitro. The selected 
shear stress waveforms were representative of the pulsatile/unidirectional waveforms in 
zones that are generally not affected by hyperplasia or the disturbed/reciprocating 
waveforms present in the high-risk stenosis areas. Experimental results showed that 
after 48 hours of flow exposure, these stimuli elicited differential effects on human 
umbilical vein endothelial cells monolayers. Pulsatile waveforms induced major cellular 
shape remodeling and upregulation of the transcription factor KLF2 mRNA expression. 
On the contrary cells exposed to reciprocating flows showed a lack of cytoskeletal 
remodeling, upregulation of the enzyme PLDl , the integrin subunit ITGA4 and RASA1 
(coding for the protein activator pl20RasGAP) mRNA expression and an increased 
production of chemoattractant cytokines MCP-1 and IL-8. Furthermore, it was observed 
that human smooth muscle cells incubated for 24 hours with medium conditioned by 
endothelial cells exposed to reciprocating shear stress stimuli, had an increased rate of 
proliferation compared to smooth muscle cells cultured in medium conditioned by 
endothelial cells exposed to pulsatile waveforms. These results confirm potential links 
between disturbed wall shear stress and arteriovenous fistula failure.
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Introduction
I.A) Chronic kidney disease and therapies
tiiChronic kidney disease (CKD) has been recently identified as the 18 major 
cause of global mortality with the third highest increase (82.3%) in the last two decades, 
resulting in the recognition of CKD as a public health priority (1). CKD severity is 
defined by five stages based on renal function and assessed by measuring the 
Glomerular Filtration Rate (GFR, table 1) (2, 3).
CKD stage GFR [mL/min/1.73m2]
1 90+
2 60-89
3a 45-59
3b 30-44
4 15-29
5 or ESRD <15
Tab.l: CKD stages defined by GFR according to the Kidney Disease Outcome Quality Initiative
(3).
The fifth and worst CKD stage, also referred as end-stage renal disease (ESRD), 
occurs in- 10% of the population and requires renal replacement therapies (RRT) to 
address the diminished renal function that jeopardizes patient survival (3). RRT 
however, have very high social and economic costs. In developed countries, the 0.1-
0.2% of the population that is affected by ESRD absorbs 2-3% of total health-care 
expenditure (4). In the future the problem will become worse due the increase of the 
older population. The therapies available to treat ESRD patients are transplant, 
peritoneal dialysis (PD) and haemodialysis (HD).
16
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Transplant is considered the best solution in terms of outcomes and impact on 
patient lifestyle. However, the number of donors is not sufficient to provide organs for 
all waiting patients. According to the Italian Health Ministry data for 2014 
transplantation activity, among the 8700 patients recorded in the kidney waiting list 
only 18.25% received a transplant and 1.8% did not survive. The average waiting time 
in the list is more than 3 years (5). In this context, dialysis techniques remain the only 
therapy available for those patients that do not match transplant requirements or are still 
waiting for a donor.
PD consists of a synthetic membrane surgically inserted into the patient 
abdominal cavity. The membrane is filled with dialysis solution that exchanges solutes 
with corporeal fluids and must be replaced periodically. Depending on the PD modality, 
dialysis solution is either replaced manually or by an automatic system that allows 
patients to perform PD during the night. Compared to HD, this dialysis technique 
presents some advantages including the possibility to perform it autonomously, at home, 
according to patient necessities. It also presents disadvantages including less efficient 
solute exchange, the necessity to train patients in PD management and high risks of 
infections such as peritonitis (6, 7).
HD is an RRT performed in specialized centres by dedicated personnel. It 
consists of connecting the patient to an extracorporeal device that provides filtration 
functions. It presents advantages with respect to PD in terms of better filtration 
efficiency. However, HD also has disadvantages as patients are required to go 
frequently and for several hours to a dialysis centre. Finally it requires also the surgical 
creation of a permanent vascular access (VA), able to provide adequate blood flow to 
the filtration system as well as resisting repeated puncture. The VA is both the "lifeline"
17
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and the "Achille's heel" of HD treatment and its dysfunctions are the main causes of 
hospitalization among HD patients (8, 9).
Many studies have reported outcomes and patient satisfaction related to PD and 
HD, but results are controversial. According to very recent studies (10), no major 
differences between the two techniques emerged in long-term outcomes as well as no 
differences in hospitalization or infection rates. However, PD showed a slightly better 
outcome in the short-term (2-3 yrs). The authors proposed the maintenance of a higher 
residual renal function in PD patients compared to HD patients was the reason for 
improved initial PD outcomes (11). In the long-term PD loses this initial advantage, 
possibly due the degradation of the peritoneal membrane and the loss of ultra-filtration 
capacity. Regarding patient satisfaction (12, 13), despite higher symptoms of depression 
and poorer physical health, PD patients were more satisfied compared to HD patients 
due to the higher flexibility and autonomy guaranteed by the PD technique. In 
conclusion the choice between PD and HD should take into account patient lifestyle and 
preferences, together with clinical aspects. Several authors have underlined that the 
limited or partial information currently provided by clinicians to patients should be 
improved in order to define the best dialysis strategy (14, 15).
I.B) V ascular accesses for hem odialysis
Surgical creation of a Vascular Access (VA) is a key aspect of hemodialysis 
(HD) treatment. The VA is necessary to perform efficient HD and it consists of a 
usually permanent access to the bloodstream, that clinicians use to connect patients to 
dialyzer devices. To meet HD requirements, the VA has to ensure an adequate blood 
flow through the dialyzer, to withstand repeated cannulation and to avoid complications
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like infection. Despite the efforts to ameliorate VA complications, no definitive 
solutions are currently available to completely avoid VA-related complications (16, 17).
Nowadays there are three main possibilities to create a VA (table 2). For long­
term dialysis, the preferred techniques are the creation of a native arteriovenous fistula 
(AVF) or an arteriovenous synthetic graft (AVG). These VA require time to mature and 
meet requirements for dialysis thus are generally planned weeks before the 
commencement of dialysis. Alternatively, a central venous catheter (CVC) is a VA 
immediately available for HD and is generally used in patients that commence HD as 
emergency treatment (18).
Permanent vascular 
accesses
Order of preference Type
Arteriovenous fistula Radial-cephalic fistula
Brachial-cephalic fistula
Brachial-basilic transposition  fistula
Arteriovenous graft Biological
Synthetic
Central venous catheter Internal jugular vein
Femoral vein
Subclavian vein
Tab.2: Permanent vascular accesses order of preference (19).
The AVF, introduced by Cimino-Brescia in 1966, consists of the surgical 
anastomosis between an artery and a vein in the arm. There are three basic types of 
AVF, the radial-cephalic, the brachial-cephalic and the brachial-cephalic transposition. 
There are different surgical techniques available to create the anastomosis. The 
possibilities are the end-to-end and the side-to-side anastomosis or the side-to-end of the
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vein-to-artery or artery-to-vein. The radial-cephalic AVF created in the forearm with the 
side-to-end technique is considered the gold standard due its simplicity, low incidence 
of complication and long-term patency rate. Several studies addressed AVF outcomes 
and reported primary failure rates of 18%-28%, a one-year patency rate (including 
primary failure) of 56%-64% and a two-year patency of 44%-58%. Secondary patency 
rates of AVFs treated for primary failure were 64%-78% after one year and 56%-73% at 
two years (20-22). In recent years a major effort has been made to induce clinicians to 
adopt AVF creation in preference to other VA types. This has resulted in an increase in 
AVF placement in USA as reported in figures 1 and 2 (15, 23, 24).
The AVG consists of a high capacity synthetic or biological prosthesis, 
interposed between an artery and a vein, cannulated for HD. It allows clinicians to 
connect vessels that are distant or deep in subcutaneous tissues (25). Several materials 
and surgical techniques are available to create an AVG. Biological allo/heterografts as 
well as polymeric prosthesis (Dacron® or ePTFE) are currently used to obtain straight, 
curved or loop configurations that can be placed in the forearm, arm or thigh (26-28). 
Several studies attempting to determine the best choice between biological or synthetic 
grafts, failed to define a consistent result in terms of outcome or infection rate. AVG 
however, should be considered the second choice for VA creation due its lower patency 
rate, higher risk of infection and ischemia compared to AVF (29). Only in selected cases 
should the AVG be the preferred course of treatment. These cases include patients with 
lack or fragility of autologous vessels, with lack of access to superficial veins due to 
obesity or for short-term pediatric HD (30).
CVCs consist of thin synthetic tubes that are surgically inserted into large veins. 
They can be made from different materials and can have different geometries (31). 
CVCs are recommended for predicted short-term HD treatment or for emergency
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initiation o f HD (32). A non-tunneled CVC is usually used as a temporary (acute) 
access while for long-term HD purposes tunneled CVCs are preferable (33). Moreover 
tunneled CVCs usually also have a cuff that is placed in the subcutaneous tissue to 
provide a fibrotic seal for transcutaneous catheter passage, reducing infection risks. 
CVCs are considered the third choice for VA due to lower patency rates and higher risk 
o f infection and complication related to the access procedure compared to AVF and 
AVG (34-36).
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I.C) Native arteriovenous fistula for hem odialysis
National VA creation guidelines provide slightly different indications about 
preference for VA choice and HD requirements (37). However, in the last two decades 
common features have emerged to define the best practice to perform HD. As 
mentioned before, the radial-cephalic, side-to-end AVF is considered the gold standard 
(16, 17) as it comes closest to the ideal VA compared to other available techniques.
The success of a VA depends on the possibility for clinicians to repeatedly use it 
in order to perform efficient dialysis treatment. This means that a number of 
requirements must be met by the AVF (38). These requirements are reported in table 3.
Arterial requirements Venous requirements
Pressure differences be tw een Patency of vessel and absence  of
arm s < 20 mmHg obstructions
Pa ten t  palm ar arch Straight segm en t  for cannulation
Lumen d iam ete r  a t  point of Lumen d iam ete r  a t  point of anastom osis  >
anastom osis  > 2 mm 2.5 mm
Continuity with proximal central veins
Tab.3: Requirements for vessels eligible for AVF creation that should be evaluated prior to 
surgery (38).
Firstly an AVF must provide an adequate blood flow (350-500 mL/min) to the 
dialyzer. To remain patent during the procedure the AVF blood flow should be slightly 
greater than the demand of dialyzer. On the contrary, insufficient blood flow causes 
recirculation that forces clinicians to decrease the dialyzer demand with an increase of 
the time of treatment. Moreover, low AVF blood flow can negatively affect initial AVF
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development causing early fistula failure due to the impossibility for clinicians to use it 
for adequate treatment.
The second requirement for a functional AVF is appropriate maturation of the 
fistula itself This process needs time, flow and pressure in order to induce a series of 
events that lead to an increase in vein diameter and venous wall thickness (39, 40). A 
correctly matured AVF allows clinicians to undertake repetitive cannulations (3 
sessions of 4 hrs per week) and to perform efficient HD treatment.
Another important AVF requirement relates to the AVF position in the 
surrounding tissues. The AVF must be within 1 cm from the skin surface to allow 
cannulation. A possible solution using deep vessels is called transposition and consists 
of the dissection of the deep vein and in the positioning to a more superficial position. 
To ensure an easy and safe cannulation, the AVF must also have a relatively straight 
segment of several centimeters (17).
A key point of a well functioning AVF is the time of maturation before use (41, 
42). The general opinion is that the optimal time that should elapse between creation 
and first cannulation, is 3-4 months and strictly not less than 1 month (43, 44). A 
clinical study that assessed this problem found that no significant decrease in risk of 
failure was associated with AVFs cannulated 14 days after creation compared to those 
cannulated after 3 months (43, 45).
The timing of AVF placement should be optimised not only to ensure AVF 
maturation, but also to allow time to eventually create a second access in cases of early 
failure of the first VA and to avoid the use of a catheter as an initial dialysis access (16, 
17). Since no disadvantages are related to early AVF creation, the National Kidney 
Foundation - Kidney Disease Outcomes Quality Initiative (NKF - KDOQI) guidelines 
suggest that patient clinical parameters, such as creatine clearance or stage of CKD,
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indicate the anticipated need for AVF placement. A general rule for non-emergency 
dialysis patients is to create an AVF one year before dialysis is required to initiate the 
treatment.
To maximize AVF outcomes it is important to perform initial patient evaluation. 
Previous insertion of a CVC or major thoracic surgery and trauma will affect success of 
the AVF (46). Moreover, a detailed direct evaluation of both artery and vein 
functionality should be assessed to plan the access creation (47, 48). Doppler ultrasound 
is considered the best approach to perform pre-evaluation for AVF placement (49, 50). 
To visualize vessel anatomy angiography is also available. However, this requires the 
use of a radio-contrast liquid that should be avoided in CKD patients. Recent advances 
in medical imaging and in computer-assisted surgical planning have made AVF 
positioning a relatively simple and quick procedure that causes minimal patient 
morbidity, compared to graft insertion (51).
Other aspects that can be evaluated before AVF surgery with non-invasive 
methods are arterial narrowing and the presence of calcifications, usually related to co­
morbidity such as hypertension and diabetes in ESRD patients. Also, the patency of the 
palmar arch should be evaluated with the Allen test together with Doppler 
ultrasonography examination (52). This ensures that the collateral circulation provided 
by the ulnar artery delivers enough blood flow to the hand when the dominant artery is 
used to create an AVF.
Venous evaluation is even more important to create a VA since vascular 
problems affecting AVF patency are more likely to be venous than arterial. The cephalic 
vein is considered the best choice to create an AVF due to its superficial location and 
easy access to the vein when the patient is sitting for dialysis treatment. Non-invasive 
venous assessment enhances the chance to successfully create an AVF rather than a
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graft. Venous mapping also dramatically reduces unsuccessful surgical exploration 
since clinicians can evaluate the existence of vessels available for an AVF prior to 
surgery. Vein mapping is thus very important to increase AVF placement (53) (54).
A newly created AVF experiences large changes in blood flow and mechanical 
loads that induce vessel wall remodeling (55) to restore a more physiological condition. 
Successful vascular remodeling or maturation should end within few months. At this 
time point an experienced clinician should evaluate the maturation level and decide if 
the AVF is suitable for HD access. The protocol for accomplishing this evaluation 
requires a simple, cost-effective, physical examination, as this has been shown to result 
in 80% accuracy in identifying a mature AVF and allows the clinician to diagnose the 
major causes of failure (39).
Several complications can result in early or late failure of the AVF (56). Early 
failure causes can be divided into inflow and outflow problems (57). Since AVF 
maturation requires high blood flow and pressure, insufficient arterial diameter results 
in early failure. Despite pre-operative evaluation, which allows some causes of vessel 
diameter reduction to be identified, an acquired juxta-anastomotic or proximal venous 
stenosis can occur immediately after AVF creation, resulting in failure. Whilst the 
etiology of the stenosis is not clear, damage to the vasa vasorum, vessel manipulation 
during surgery and altered hemodynamics typical of anastomosis curvature may be 
involved in this process. This lesion is usually treated by angioplasty or surgically (58- 
61). However, even successfully treated AVFs have a lower long-term outcome 
compared to those that matured autonomously (62).
Outflow problems are related to abnormal increase of resistance to blood flow 
downstream of the AVF (56). This can be caused by lack of venous diameter increase 
after AVF creation or phenomena such as fibrosis and stenosis caused by trauma.
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Another important aspect that should be evaluated prior to surgery is the presence of 
accessory veins (63, 64). The ideal anatomy for a vein suitable for AVF is the presence 
of a long straight segment and the absence of side branches. The presence of accessory 
veins could result in a drop in blood flow and pressure at the level of the AVF and 
negatively affect the maturation process. Some clinical controversies exist in how to 
avoid complications related to accessory veins (65). A recent study (66) suggests that 
these veins should be ligated or embolized to assist non-maturing AVFs. However, the 
lack of randomized clinical trials does not allow clinicians to confirm these procedures 
as more effective compared to angioplasty.
Successful maturation of the AVF does not prevent long-term failure (67). 
Failures that occur 3 months following AVF creation are referred to as late failure. 
Possible causes of AVF late failure are similar to causes of early failure and consist of 
venous stenosis and arterial lesions that develop progressively over time. Venous 
stenosis is the first cause of AVF late failure and consists mainly in an increase of wall 
thickness due to neointima formation, not adequately compensated for by outward 
remodeling (68). Intimal hyperplasia (IH) consists of an uncontrolled proliferation of 
cellular components of the vessel wall, especially smooth muscle cells (SMCs) and 
fibroblasts (FBs) that acquire an activated phenotype and migrate underneath the 
endothelial layer (69, 70). As shown in figure 3, this pathology develops mainly in 
specific areas of the AVF such as the venous side of the anastomosis or at the more 
proximal area above the juxta-anastomotic curvature between the feeding artery and the 
draining vein. Another high-risk stenosis area is the anastomotic floor of the feeding 
artery (71).
A further AVF dysfunction that leads to late failure is thrombosis (58). It occurs 
mainly on the venous side of the AVF and is identified by clinically undetectable blood
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flow through the AVF. In certain cases, despite the stenosed AVF, the blood flow is 
preserved by the collateral venous branches. The stenotic lesion is commonly treated 
with angioplasty and failure is caused by the impossibility to intervene to reestablish an 
adequate blood flow through the AVF.
Vein
Proximal artery
B Distal artery
Fig.3: AVF anatomy. Blood coming from the proximal artery flows mainly toward the draining 
vein and only a small fraction continues to the distal artery. IH development results 
preferentially localized in specific AVF areas, A) the juxta-anastomotic curvature and B) the 
anastomosis floor of the feeding artery.
Despite the fact that the increase in blood flow is the main purpose o f AVF 
creation, an excessive flow is also considered cause o f AVF late failure (2). Excessive 
flow can result in ischemia o f the hand due to the local high resistance o f the hand 
compared to venous return through the AVF. Excessive flow (> 3-4 L/min) through the 
AVF can also lead to high output cardiac failure and requires ligation o f the fistula 
itself. Finally, aneurysms can result from a continuous increase in vessel size (2). These
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generally occur on the venous side due a downstream venous stenosis although the 
feeding artery can also experience local aneurysm due to repeated punctures.
Many different factors are involved in the development of IH. In common with 
other pathologies that affect vasculature like diabetes and hypertension, CKD seems to 
predispose patients to development of IH. However, the localization of lesions occurs in 
areas where blood flow experiences recirculation, high frequency fluctuations and 
disturbed flow. This association has led to the study of local hemodynamics as a 
potential trigger for IH development (72).
The features of local blood velocities, such as changes in direction and 
magnitude, have been shown to affect vascular function by modulating endothelial cell 
(EC) signalling. Wall shear stress (WSS), the frictional force per unit area exerted by 
the blood due its viscosity, has emerged as a stimulus able to regulate EC phenotype 
(73, 74). Observations focused on atherosclerosis development have reported that 
turbulent, oscillating or reciprocating blood flow induces activation of ECs leading to a 
proliferative, pro-inflammatory and pro-oxidant state (75-77) that can regulate the other 
cellular components of the vessel wall. The role of WSS in AVF maturation and failure 
is the main focus of the present study and will be addressed in the following chapters.
I.D) Aim of the study and structure of the thesis
As there continues to be a high rate of fistula failure despite major efforts of 
recent years (Introduction), this thesis investigates the hypothesis that reciprocating 
WSS waveforms are responsible for development of intimal hyperplasia, resulting in 
low AVF maturation rates and poor outcomes (78). The state-of-the-art in 
understanding of the biology of native AVF development is reviewed in Chapter 1 and 
Chapter 2 reviews the possible role of wall shear stress patterns in determining AVF
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maturation. To examine this hypothesis wall shear stress (WSS) patterns representative 
of those experienced by high and low risk stenosis areas in an idealized model of a side- 
to-end AVF were defined, according to a previous study (79), these results are presented 
in Chapter 2.
To verify the hypothesis the following steps were undertaken, reported as 
indicated:
- Definition of endothelial cell biology relevant to fistula failure and potentially 
modulated by selected WSS waveforms (Chapter 2).
- Design and validation of an in-vitro cell shearing system capable of generating 
controlled, highly unsteady WSS stimulation on an endothelial cell monolayer (Chapter 
3).
- In vitro flow exposure experiments to compare the effects of different WSS 
patterns on endothelial cells derived from human umbilical vein in regard to 
morphology (Chapter 4), gene expression (Chapter 5) and molecule release (Chapter 6) 
elicited by selected WSS waveforms
- Evaluation of proliferation of SMCs incubated with medium conditioned by 
ECs exposed to different flow stimulation (Chapter 7).
- Determination of a possible role of WSS in modulating the expression of genes 
known to be involved in neointimal hyperplasia development (Chapter 8).
Chapter 9 provides a summary and discussion of the outcomes of the study and a 
perspective on future areas for research.
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CHAPTER 1: AVF development
Native Arteriovenous Fistula (AVF) creation is considered the best choice to create a 
vascular access for hemodialysis treatment. Despite many years o f clinical practice and 
major efforts to ameliorate the outcome, AVF failure due to stenosis remains very 
frequent. This chapter reviews the current knowledge regarding AVF biology. 
Maturation o f the A VF is addressed in the first part o f the chapter together with the role 
o f the endothelium in regulating vessel wall remodeling. AVF stenosis biology due to 
intimal hyperplasia (IH) is the topic o f the second part o f the chapter. This section also 
addresses the role o f myofibroblasts in A VF remodeling, the consequences o f chronic 
kidney disease on vascular function and the potential involvement o f TGF-f pathways 
in IH  development.
l .A ) Native arteriovenous fistula maturation biology
1.A1) Biolosy o f  AVF maturation.
After surgical creation, AVFs are exposed to a high flow, high shear stress, low 
pressure arterial environment (80, 81). The surgical trauma and the increased blood flow 
initiate and regulate vessel wall remodeling in order to reestablish physiological 
mechanical stresses within the vessel wall (82-86). Inflammation and vascular tone are 
the two main regulators of this remodeling (68, 87).
Ideally, immediately after the vein is shunted to the artery, the acute blood flow 
increase causes the release of nitric oxide (NO) by the endothelium (88). NO induces 
elevated levels of cyclic guanosine monophosphate levels that cause vasorelaxation (89- 
91). Furthermore a sustained increase in blood flow induces superoxide production, 
which forms peroxynitrite combining with NO (92). Peroxynitrite induces
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metalloproteinase 2 and 9 (MMP-2, -9) production, which leads to vascular dilatation 
by digestion and remodeling of the internal elastic lamina (93). The overall effect is an 
increase in vessel diameter (94-96).
Circumferential stress is defined as the tensile stress that develops within the 
vessel wall as a consequence of blood pressure increase. An increase in vessel tissue 
stretch results in SMC activation, increased cytokine expression and an increase in 
extracellular matrix turnover (97, 98). These pathways lead to vessel wall thickening in 
order to reestablish physiological transmural stress (99). This phenomenon is referred as 
medial hypertrophy (100).
In a successful maturation process (shown in figure 4), the altered blood flow in 
the AVF drives outward vessel remodeling balanced by induction of NO and limited IH 
formation caused by inflammation. This process is termed venous arterialization (101) 
and can be considered optimal to guarantee the success of an AVF. To preserve long­
term patency after a correct maturation, AVF vessel tissues have to down-regulate the 
pro-inflammatory, proliferative activities that were activated by surgical trauma and 
onset of new hemodynamics. Central to this process is the restoration of the endothelial 
integrity, which is damaged by AVF creation.
All vessel layers participate in flow-induced adaptation. Endothelium however, 
due its position, the presence of numerous mechano-sensors (102, 103) and the extreme 
sensitivity (104) to changes in mechanical loading, may be considered the conductor of 
the orchestrated signalling that drives vessel remodeling (105).
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Fig.4: Potential mechanisms of AVF maturation. Pre-existing CKD may lead to vascular 
dysfunction by enhancing oxidative stress and fibrosis in the adventitia and by inducing IH prior 
to AVF creation. Surgical creation of the AVF causes endothelial denudation and increase in 
blood flow, these events induce release of vascular tone active molecules and inflammation. The 
equilibrium of these two aspects is reflected by the extent of vascular wall remodeling, tightly 
controlled by ECs. Unidirectional high WSS leads to endothelial NO release, causing 
vasodilation, promoting functional re-endothelization and suppressing inflammation. The 
overall effect is a structural vessel outward remodeling with limited IH development. This form 
of vessel remodeling is classed as successful fistula maturation and allows clinicians to use the 
AVF as access for HD treatment (68).
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1. A2) Role o f  the endothelium in A VF maturation.
As shown in figure 5, endothelium is the master regulator in inflammation and 
vessel tone due to its ability to produce and control a plethora o f autocrine and paracrine 
signals (106, 107). ECs release mitogens and chemotactic agents, regulators o f 
extracellular matrix (ECM) remodeling, and vasoactive molecules that regulate dilation 
to allow vessel adaptation to flow, shear stress, pressure, and tension (68, 100).
V e sse l to n e  
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c e lls
In f la m m a t io n  
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Fig.5: Endothelial cells control a number of pathways that are potentially involved in AVF 
vessel remodeling and inflammation.
Endothelial trauma caused by AVF creation affects endothelial integrity and 
alters EC signalling. Furthermore the increased blood flow can induce endothelial 
denudation within hours. Denudation leads to barrier dysfunction, exposure o f 
subendothelial collagen, thrombus formation, and inflammatory cell extravasation into 
the vein wall (108, 109).
Endothelium controls the production o f the main vasoactive signals (110). ECs 
produce endothelial nitric oxide synthase (eNOS) that synthesizes NO from L-Arginine
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(111). However, ECs also produce reactive oxygen species (ROS) via the nicotinamide 
adenine dinucleotide phosphate-oxidase (NADPH oxidase) enzyme complex (112). The 
main EC ROS are free radicals such as superoxide anion and non-free radicals such as 
hydrogen peroxide (H2O2). H2O2 plays an important role in mediating vascular 
activation. Low levels of H2O2 induce vascular cell proliferation. Low levels of H2O2 
exert a mitogenic function through the activation of casein-kinase-a-LS (CKla-LS) 
(113), which then phosphorylates the heterogeneous nuclear ribonucleoprotein-C 
(hnRNP-C) (114). It is known that hnRNP-C modulates the expression of several genes 
regulating cell growth and survival, including PDGF-B (115).
In the vascular system, ROS play a physiological role in controlling endothelial 
function, vascular tone, integrity and remodeling (116). ROS production is closely 
linked to NO generation and elevated levels of ROS lead to low NO bioavailability. 
Humoral agents, such as Angiotensin II (Ang-II) and Endothelin 1 (ET1), platelet 
derived growth factor (PDGF) and thrombin can modulate basal superoxide production 
by NADPH oxidase (117). Ang-II and ET1 are inflammatory mediators of 
vasoconstriction and endothelial proliferation that can be produced by ECs as autocrine 
signals (118). PDGF is produced by EC and promotes vascular cell proliferation and 
migration (119). Thrombin modulates platelet activation and vessel permeability (120). 
Furthermore the activation of Phospholipase D (PLD) promotes hydrolyzation of the 
phosphatidylcholine (PC) to phosphatidic acid (PA) that mediates the ROS-induced 
endothelial permeability by modulation of Rho GTPases activity and actin cytoskeleton 
remodleing (121). PA also stimulates the NADPH oxidase system that increases levels 
of ROS and leads PLD and PA to form both positive feedback and feedforward loops 
that amplify and integrate the oxidative signalling pathways (122).
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The equilibrium between NO and ROS production is fundamental in AVF 
maturation and is tightly controlled by ECs (117). A damaged endothelium leads to an 
increase in ROS necessary to promote inflammation and facilitate vessel remodeling. 
However, chronic increase in EC oxidative stress impairs vasodilation and leads to 
vessel inward remodeling (87, 123).
Endothelial integrity is fundamental to control NO/ROS production. The 
endothelium is regenerated 2 weeks after AVF surgery, although EC proliferation 
continues for months (109). Once vessels reestablish tissue continuity and physiological 
mechanical load, ECs should down-regulate their pro-inflammatory signals and acquire 
a quiescent phenotype.
Functional to this phenotype are several biological processes tightly related to 
WSS mechanotransduction (124). Quiescent ECs show sustained up-regulation of 
Kruppel-like factor 2 (KLF2) (125, 126) synthesis induced via the dual specificity 
mitogen-activated protein kinase 5/ Extracellular-Signal-Regulated Kinase 5 pathway 
(MAPK5/ERK5) (127).
KLF2 exerts a protective function by stabilizing EC activity mainly through the 
promotion of eNOS production and cytoskeletal remodeling. NO production controls 
SMC proliferation and migration (128). Communication between ECs and SMCs is 
provided in vivo by physical contact of the myoendothelial junctions (MEJs). MEJs 
regulate NO diffusion and provide a bidirectional cross talk between the two layers 
(129). NO also regulates endothelial barrier function through activation of focal 
adhesion kinase (FAK) and recruitment of additional focal adhesion complexes (FA) to 
the basal EC surface, in order to control barrier permeability during the inflammation 
process that occurs after AVF creation (130). NO/ROS balance is also involved in ECM 
turnover by its ability to activate MMPs that selectively degrade components of the
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extracellular matrix and their inhibitors such as tissue inhibitor of metalloproteinases 
(TIMP) (131).
KLF2 is essential for cytoskeleton remodeling, especially F-actin stress fiber 
formation and cell alignment (132). This cytoskeletal reorganization is promoted by 
alteration in mechanical stresses and regulated by signalling from small Rho-GTPases 
(Ras homolog or Rho, Ras-related C3 substrate or Rac and cell division cycle protein or 
CDC42) (133, 134) to optimize mechanical loading distribution within the cell. The 
remodeling and stabilization of the cytoskeleton is promoted by physiological 
mechanical loading and is essential in EC to form stable junctions with other 
components of the tissue. ECs form different junctions with surrounding EC and with 
the elastic laminae and the medial SMCs below (135-138). The reorganization and 
stabilization of these junctions allows the endothelium to control permeability (139), 
proliferation, and ECM turnover and is ultimately involved in the protective effect 
exerted by re-endothelization after vascular trauma.
KLF-2 exerts a protective function by stabilizing EC autocrine and paracrine 
activity. KLF2 promotes thrombomodulin and inhibits vasoconstrictor agents such as 
ET1 and Ang-II (140). KLF-2 down-regulates the release of pro-inflammatory 
molecules such as the Monocyte Chemoattractant protein 1 (MCP-1) and Interleukin 8 
(IL-8) (141, 142) and expression of adhesive molecules such as Vascular Adhesion 
molecule (VCAM) and Intercellular Adhesion molecule (ICAM) (143).
KLF2 expression inhibits tranforming growth factor (3 (TGF-p) (144) 
proliferative signalling and attenuates activation of several pathways including nuclear 
factor kB (NF-kB) (124), MAPKs dependant transcription of the Activator protein 1 
(AP-1) (144) and the Serine/Threonine-protein kinase 1 (PAK1) (127, 145). Finally
36
Marco Franzoni 2015 Chapter 1
KLF2 has been shown to be involved in antioxidant activity of Nuclear factor-erythroid 
2-like 2 (Nrf-2) translocation to the nucleus (146).
Numerous studies have shown that mechanical loading, especially WSS, have a 
deep impact on EC biology by mediating KLF2 expression (147) and cytoskeletal 
remodeling. The beneficial effect of increase in WSS induced by AVF creation should 
guarantee endothelial quiescence and survival, orientation of EC in the direction of flow 
and the production of anti-inflammatory and anticoagulant mediators (110). On the 
contrary, low and reciprocating WSS prevent the expression of KLF2 and eNOS 
resulting in impaired cytoskeletal remodeling and cellular junction stabilization that 
leads to increased EC pro-inflammatory and procoagulant signalling, a pro-oxidant 
state, sustained cellular proliferation and impaired ECM turnover (148).
The majority of these studies have considered the effect of WSS on arterial 
endothelium while the response of the venous endothelium to WSS is not always the 
same (148). Furthermore, swine venous vessels have been shown to have a lower 
expression of antioxidant genes (eNOS, superoxide dismutases) compared to regionally 
linked arteries (149). This aspect could be detrimental when veins are directly 
connected to the arterial system. However, evidence focused on venous remodeling 
induced by an arterial flow environment in animal models, reported that veins share 
similar features to arteries and that ECs play a fundamental role in both vascular 
districts. Endothelium showed to be intimately connected with the environment and to 
be sensitive to mechanical stresses or oxygen tension that discriminate arterial and 
venous districts (86). ECs exposed to high magnitude arterial WSS presented a loss of 
Ephrin type-B receptor 4 (EphB4), a marker of venous identity but the arterial identity 
marker EphrinB2 was not gained (150-152). EphB4 expression has been shown to
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prevent venous remodeling (153) but the precise role of the Ephrin-Eph pathway in 
controlling WSS-induced endothelial signalling is not known.
Despite the differences between arterial and venous endothelial sensitivity to 
WSS magnitude (154), reciprocating/disturbed WSS has been shown to deeply 
influence ECs independently of the vascular bed of origin, possibly leading to sustained 
inflammation and impaired wall remodeling. Within AVFs the lack of vessel 
stabilization could manifest in vessel diameter reduction and IH development (155). All 
this evidence demonstrates the importance of hemodynamic changes following AVF 
creation and the pivotal role of ECs in controlling the fate of vessel wall remodeling.
l .B )  Native arteriovenous fistula failure biology
1.B1) Failing A VF biology.
Venous stenosis due to IH development is the first cause of failure in AVFs 
created for HD treatment. IH development can be divided into an inflammatory phase 
(hours to days), a granulation or cellular proliferation phase (days to weeks) and a phase 
of remodeling of the ECM and protein synthesis (3-18 months) (156). The 
aggressiveness of these processes is often not adequately compensated for by outward 
vessel remodeling, leading to AVF stenosis and failure (68, 157). Histological studies of 
stenotic tissues from AVFs undergoing early failure are characterized by an aggressive 
IH formed mainly by a-smooth muscle actin-positive, vimentin-positive and desmin- 
negative myofibroblasts (MFs) and some activated SMCs that migrate either from the 
adventitial and medial layers or derived from circulating progenitors (9, 158). They 
participate in neointimal formation due to their high ECM protein synthesis capacity 
and autocrine signalling mainly based on TGF-p (159, 160). The role of MFs in AVF 
failure is addressed in paragraph 1.B2
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High levels of oxidative stress products (161), MMP-2 and MMP-9 were found 
in stenosed fistulas (86, 93, 162). ECM deposition is the major contributor to neointimal 
layer development and MMP-2 and -9 are involved in both beneficial AVF outward 
remodeling and stenosis induced by IH (94). MMP-2 and-9 up-regulation has been 
linked to endothelial denudation (163) while lower levels of MMP-2/TIMP-2 or MMP- 
9/TIMP-4 ratios were found to correlate with AVF stenosis (164). Decreased levels of 
MMP-1 and -3 together with MMP-9 (165) were also correlated with AVF failure. A 
recent study in mice showed that during AVF maturation a distinct temporal pattern 
regulates proteins such as MMP and TIMP and leads to the expression of structural 
proteins that potentially mediate ECM degradation and deposition to control AVF 
remodeling (162).
MMPs control ECM degradation whereas TGF-p is the major promoter of ECM 
protein synthesis and also the main regulator of activation of ECs, SMCs and FBs (166). 
This growth factor plays a central role in many pathways related to vascular 
dysfunction. Interestingly inhibition of TGF-p leads to decreased IH and MCP-1 
expression (167). Due to its complex role in AVF failure this will be addressed in 
paragraph 1.B4.
Stenosed AVF tissue also shows macrophages infiltration (168) and elevated 
levels of VCAM (169), IL-6, IL-8 and MCP-1 (156, 169). These cytokines have 
chemoattractant properties that lead to monocyte recruitment and infiltration through the 
endothelium. Monocytes can also undergo differentiation toward macrophages that 
participate in ECM remodeling and inflammation. MCP-1 binding to chemokine 
receptor 2 (CCR2) appears to be central in the process of monocyte recruitment and 
macrophage accumulation within vascular lesions (170). Beyond MCP-1 chemotaxis of
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monocytes, this cytokine leads to activation and migration of endothelial cells, 
proliferation and migration of SMCs and pro-coagulant signalling (142).
Another important molecule in vessel remodeling and angiogenesis is the 
vascular endothelial growth factor (VEGF) (171). VEGF has a complex, central role in 
many vascular related events. Blocking VEGF-A correlates with a negative regulation 
of IH and positive vessel remodeling, thus has a beneficial effect in AVF maturation 
(172). Finally, preexistent CKD may have a detrimental effect on AVF maturation since 
this condition has many negative effects on vascular tissues. A description of this 
relationship is reported in paragraph 1.B3.
IH occurs in AVF areas that experience oscillating and reciprocating WSS, in 
particular on the venous side of the anastomosis (juxta-anastomotic stenosis) (71, 72, 
173, 174). Endothelial damage and denudation during AVF creation activate the pro- 
inflammatory cascade that should be downregulated within a few weeks in order to 
preserve vessel patency. However, abnormal WSS prevents functional re- 
endothelization and causes an increase in vascular interstitial flow that activates vessel 
cellular components (148). Damaged ECs promote a pro-oxidative environment within 
vessel wall, altering MMP regulation and ECM remodeling. WSS also deeply affects 
endothelial barrier integrity that is central to down-regulation of inflammation after 
AVF creation. Disturbed WSS can also induce up-regulation of adhesive molecules and 
expression of chemoattractant agents by ECs, facilitating monocyte recruitment and 
transendothelial migration, a phenomenon tightly related to vascular dysfunction (175, 
176).
In conclusion, both primary and late AVF failures are related to altered cellular 
proliferation and matrix deposition not compensated for by vessel diameter increase 
(figure 6). Despite pre-existing risk factors, such as CKD, the role of inflammation and
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regulation o f vascular tone in AVF failure suggests EC function is central to successful 
AVF maturation. An environment that promotes MFs activation and impaired re- 
endothelization enhances the risk o f IH development.
i Vascular dysfunction i Vessel remodelingHealthy vessel
AVF failure
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Fig.6: Potential mechanisms of AVF failure. The phases prior to AVF creation are similar to 
figure 4. In the later phases lack of equilibrium between the production of vascular tone active 
molecules and inflammation leads to fistula failure. Reciprocating WSS enhances endothelial 
ROS production that affects vasodilation. Furthermore reciprocating WSS prevents re- 
endothelization leading to a sustained inflammation and cell proliferation. The increased 
adventitial stiffness and sustained pro-inflammatory and chemoattractant signal production 
induced by reciprocating WSS, may cause vessel inward remodeling and sustain IH 
development in order to reduce WSS magnitude. This form of vessel remodeling is classed as 
fistula failure since it does not allow clinicians to use the AVF for HD treatment (68).
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1.B2) Role o f Myofibroblasts in AVF stenosis.
Myofibroblasts (MFs), also defined as "mesenchyme-like interstitia cells", are 
cells that contribute to tissue repair during wound healing by promoting tissue 
contraction. (177) MFs also participate in ECM remodeling, pro-inflammatory and pro- 
angiogenic signalling (178, 179). However, at the end of wound healing these cells 
should undergo massive apoptosis 2-3 days after injury, in order to reestablish 
quiescence in the vascular tissue (178). Despite in-vitro evidence showing the capability 
of MFs to reverse differentiation, in-vivo studies have not detected this phenomenon, 
leading to the assumption that apoptosis is the main process responsible for MF 
deactivation (180).
MFs can have multiple origins since they can derive from trans-differentiated 
SMCs, fibroblasts differentiated to proto-myofibroblasts then to MFs, ECs which have 
undergone a endothelial-mesenchymal transition (EndMT) (181), from circulating 
progenitors (fibrocytes) and others (182-185). The main source of MFs in AVF stenosis 
is still controversial. Furthermore some authors have suggested that MF markers 
identify a cellular functional status and not a specific cell type (182).
Activated MFs share many markers with SMCs, particularly a smooth muscle 
actin (a-SMA) which acts as a mechanosensor and is recruited to form stress fibers 
under mechanical tension (186). MFs form bundles of contractile microfilaments, 
integrin-mediated cell-to-matrix bonds and adherens junctions (AJs) and gap junctions 
(GJs) with surrounding cells (187), these ultrastructural features distinguish MFs from 
FBs and are responsible for wound contraction, cell migration and eventually cellular 
apoptosis.
Several external stimuli can activate MFs, including ECM stiffness, loss of cell- 
ECM interaction caused by surgical trauma and mechanical loading or altered TGF-p
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signalling caused by pre-existing disease and altered hemodynamics (186, 188-190). As 
mentioned before, once recruited and activated, MFs contribute to wound healing by 
forming granulation tissue then disappear (178, 191).
A sustained activation of MF leads to ECM deposition that affects matrix 
stiffness and promotes MF activity (158). In-vivo evidence shows the adventitial layer 
of stenotic vessels exhibits an increased presence of fibrosis probably caused by the 
increase of oxidative stress (192). This increased fibrosis alters vessel stiffness and 
affects AVF maturation by limiting positive vessel remodeling and possibly inducing 
MF proliferation (188, 193, 194).
Sustained pro-inflammatory signalling, unbalanced mechanical loading on 
vessel tissues and lack of ECM stabilization may prevent MF apoptosis and lead to 
fibrosis. The fate of MFs at the end of the healing process may determine stable wall 
remodeling or excessive neointimal growth and negative remodeling leading to AVF 
failure (179, 195). This vicious cycle could be promoted via latent TGF-p mobilized by 
MF activity (196) or flow-induced EC signalling (197) leading to IH development (160, 
172).
1 .B3) CKD as a risk factor in IH  development.
To address the biology of failing AVF due to IH development, it is not possible 
to avoid considerations of preexisting pathologies that affect the vasculature such as 
CKD (198), diabetes and hypertension. The degree of CKD, that is a prerequisite for 
AVF creation, is probably directly related to AVF non-maturation since its effects on 
the vasculature (199) could predispose to inward remodeling and IH development (69, 
200).
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The presence of IH in uremic patients even before AVF creation has been 
reported (201). However, this aspect is controversial since a study of over 50 uremic 
patients showed that IH was not present at the time of AVF creation but developed de- 
novo after surgery (157). Nevertheless it is a matter of fact that CKD induces vascular 
damage and endothelial barrier dysfunction in the earlier stages (199, 202, 203), 
possibly due the activation of the Notch intercellular communication pathway (204).
The Notch pathway is fundamental during embryonic development and is a key 
controller of vascular cell fate (differentiation, proliferation, survival and activation) 
(205-207). In mammals a large number of combinations of four Notch receptors 
(Notchl -4) and five Notch ligands (Jagged 1 -2, Jag and Delta-like 1,3 -4, Dll) are 
possible. In addition other non-canonical ligands provide activation or inhibition of 
Notch activation (208). All vascular cells express specific patterns of Notch receptors 
and ligands, in a composition that depends on cell type and specific vascular locations.
Despite the complex and potentially opposite context-dependent effects, Notch 
signalling has emerged as a potential trigger of IH (209). It is involved in pro- 
inflammatory cytokine and chemokine release by EC or macrophages and it has 
multiple interactions with the main EC pro-inflammatory pathways (NF-kB, MAPK, 
NO/ROS and TGF-P) (210, 211). Some key aspects of Notch activation effects on ECs 
are related to the impairment of the endothelial barrier (209, 212). Notch affects 
Vascular Endothelial cadherin stability and promotes ECs to undergo EndMT (213). In 
contrast, Notch2 has anti-inflammatory effects on ECs by reducing VC AM expression 
and promoting EC apoptosis (214).
Notchl and 3 receptors are also involved in SMC differentiation, probably via 
platelet derived growth factor (PDGF) modulation (206). Notch activation is required to
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induce a-SM A expression in SMC and it has regulatory effects, which can enhance or 
inhibit the phenotypic switch due to Fles/Hey induction (215).
Notch 1 is involved in TGF-p-induced transition o f lung FBs to MFs. Impaired 
Notch signalling has been shown to reduce MF differentiation in an animal model. 
(216)
The emerging concept focuses on tight spatial and temporal regulation o f Notch 
activation pathways in the vasculature (209). Targeting o f downstream Notch effects 
may positively or negatively regulate Notch-induced signalling, with important effects 
on IH development, CKD induced oxidation (217, 218)and Notch activation due to 
TGF-P up-regulation (219, 220). This activation may lead to endothelial dysfunction, 
EndMT, differentiation o f SMCs and FBs, predisposing vessels to IH development 
(figure 7). Interestingly, the knockout o f Recombinant binding protein-Jk (RBP-Jk) 
(221), the major transcription factor associated with Notch activation, in ECs o f uremic 
mice, reduces CKD-dependant IH formation.
I n f l a m m a t i o n
CDK
Calcif icat ion
V ascu la r
d y s f u n c t i o n
Fig.7: CKD relationship to vascular dysfunction.
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1 .B4I TGF-6 role in vascular homeostasis and disease.
TGF-p superfamily signalling is fundamental in vasculogenesis, angiogenesis, 
vascular homeostasis and disease development (166, 222). TGF-p exerts its functions 
through complex pathways involving different small mother against decapentaplegic 
proteins (SMADs). Depending on the context, TGF-P elicits both cellular quiescence 
and proliferation (223).
Several extracellular mediators regulate the extent of the TGF-P binding effect 
(224). Downstream signalling effects depend on the expression level of ligands and 
receptor affinity. Ligand-trapping proteins or release mediators modulate the assembly 
of latent TGF-p and control cytokine availability and gradient formation (196).
The plethora of TGF-P superfamily ligand binding induces assembly of a 
complex composed of two type I (signal-propagating) and two type II (activator 
components) receptors that are serine/threonine-specific protein kinases. Ligand binding 
promotes type II receptors to phosphorylate type I receptors, which propagates the 
signal by phosphorylation of SMADs (225). The combination of receptors and 
accessory receptors (type III receptors) or ligand antagonists, regulate binding. All these 
factors interact to provide a fine tuning mechanism for TGF-P signalling (166, 226).
In addition to SMAD activation (225), TGF-P non-canonical signalling can 
activate other pathways that involve p38/MAPKs, NF-kB, Protein kinase B (AKT), 
ERK and JUN N-terminal kinase (JNK), Rho GTPases. These signals can have direct 
effects on cells or crosstalk with SMADs and mutually influence each other. Molecules 
such as Notch, WNT, Ras, Hedgehog, tumor necrosis factor (TNF) and interferons (IFs) 
can modulate both canonical and non-canonical TGF-p pathways (227).
Despite the complexity of these processes, TGF-P superfamily activity can be 
summarized in two main pathways. TGF-P binding promotes formation of TpRI (i.e.
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activin receptor-like kinase 5, ALK-5), TpRII heteromeric receptor complex and 
induces receptor-regulated SMAD 2/3 (r-SMAD) phosphorylation that, in association 
with common-mediator SMAD 4 (co-SMAD), sustains cell quiescence through 
expression of different transcription factors (i.e. Plasminogen activator inhibitor-1, PAI- 
1) (228). On the contrary bone morphogenic proteins (BMPs) binding to ALK-1/2/3/6, 
BMPR2 complex phosphorylate r-SMAD l/5/9(8) that, in association with co-SMAD 4, 
leads cells to a proliferative state due to synthesis of transcription factors such as DNA- 
binding protein inhibitor (229, 230).
Inhibitory SMAD 6/7 (i-SMAD) also participates in this process through 
blocking signalling induced by TGF-P or BMP (224). Moreover type III receptors like 
betaglycan and endoglin (Eng) control cytokine binding to different receptor complexes 
depending on cell type, senescence and possibly on mechanical loading.
ECs are involved with a distinct TGF-p pathway (231) (figure 8). ALK-1, 
typically involved in BMP signalling, can form a receptor complex with TpRII in ECs, 
becoming responsive to TGF-P induced r-SMAD l/5/9(8) and eliciting ECs 
proliferation, migration and organization (222). In contrast, TGF-P-induced ALK-5 
signalling leads EC to a quiescent state and regulates endothelial permeability. 
Although these receptors have divergent effects on ECs, they do interact. ALK-5 is 
required in ALK-1 activation and ALK-1 can directly antagonize ALK-5-related 
SMADs phosphorylation (232). Eng is considered to be the major regulator of 
preferential TGF-P binding to ALK-1 rather than ALK-5 (233, 234).
Eng exists in long (L-Eng, most expressed) and short (S-Eng) isoforms that are able to 
interact with both ALK-1 and ALK-5. Eng isoforms differ by receptor affinity, inducing 
different levels of phosphorylation and regulating TGF-p-dependent response (235).
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Fig.8: Possible role for endoglin in regulation of TGF-P pathway in ECs. Abbreviations: TGF-P 
transforming growth factor p, TpR transforming growth factor P receptor, ALK activin receptor­
like kinase and SMADs small mother against decapentaplegic proteins (231, 235).
L-Eng have pro-angiogenic effects by inducing NOS expression otherwise S- 
Eng has anti-angiogenic effects. S-Eng is enhanced by EC senescence (236), leading to 
age-related vascular dysfunction (235). A soluble form o f Eng, cleaved by MMP-14, is 
a biomarker for vascular dysfunction (237). However, Eng and ALK-1 function in TGF- 
p signalling are not completely understood (238) and increasingly the cellular context 
(developmental stage, receptor composition) is considered as a key regulator o f TGF-P 
and other signalling in ECs (239-241).
Beyond the dramatic effects on ECs, TGF-p signalling also regulates SMC de­
differentiation via SMAD-3 and p38/MAPK pathways (242). Furthermore, TGF-P 
enhances SMC activation, proliferation and migration and inhibits apoptosis (243).
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TGF-p canonical and non-canonical pathways are also the main regulators of FB to MF 
transition (178). These phenotypic switches play a fundamental role in wound healing 
and vessel remodeling after AVF creation. Due to the synthetic nature and elevated 
motility, MF fate is pivotal in IH development. A clinical study (244) in patients with 
primary AVFs showed that polymorphism in the region encoding for TGF-P 1 affects 
AVF outcome. In particular, patients with increased protein synthesis activity have a 
shorter AVF patency rate compared to those with a low synthesis activity. In conclusion 
the TGF-P pathway deeply affects vasculature biology and the consequent alterations in 
signalling may result in vascular defects and diseases.
l .C ) Summary
After surgical creation of an AVF the vessel wall tissue undergoes a major 
remodeling process orchestrated to reduce WSS and tensile stress to within the 
physiological range (78). The complex cascade of events that involves vessel tone 
regulating molecules and inflammation, determines the balance between beneficial 
outward remodeling and detrimental IH development (as shown in figure 9) (68).
These two processes have some common features such as the role of MMPs in 
facilitating outward remodeling in the early stages of AVF maturation but also 
enhancing IH formation in the later stages. Furthermore, pro-inflammatory signals and 
such as MCP-1 and IL-8 are produced during initial inflammation to reestablish vessel 
continuity, but their sustained upregulation is also involved in the proliferative phase of 
IH (156).
Endothelium is probably the master regulator of these events and its integrity is 
functional to vasodilatation, luminal caliber preservation and thus long-term AVF 
patency since it prevents IH development (245). In the last decades hemodynamics has
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emerged as a potent stimulus in regulating endothelial permeability and signalling. In 
particular, depending on the features of the flow waveform, WSS has been shown to 
induce EC phenotypes that can deeply affect AVF remodeling.
Beyond endothelial activities, to understand AVF biology it is necessary to 
consider pre-existing CKD. Several studies have shown that renal dysfunction can have 
a significant impact on the vasculature by enhancing inflammation and oxidative stress 
(202). Finally, both CKD and WSS have been shown to influence TGF-p signalling 
(246, 247) with potential effects on cellular components of the vessel such as EndMT 
(248) and myofibroblasts activation (223, 228).
In conclusion, CKD patient arteries and, although less investigated, veins have 
an increased stiffness that can predispose to inward remodeling and IH development 
after AVF creation. Despite this pre-existent vascular dysfunction, some fistulas 
adequately mature for HD treatment. Our hypothesis is that hemodynamics plays the 
ultimate role in deciding the fate of AVF remodeling and that EC mechanotransduction 
of WSS could make the difference between failure and maturation. This aspect is 
addressed in the next Chapter.
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Fig.9: General mechanisms of AVF failure due to intimal hyperplasia-induced stenosis. 
Abbreviations: CDK chronic kidney disease, TGF-p transforming growth factor (3, FBs 
fibroblasts, SMCs smooth muscle cells, MMP metalloproteinases, TIMP tissue inhibitor 
metalloproteinases and ECM extracellular matrix (166).
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CHAPTER 2: Wall Shear Stress in AVF failure
This Chapter addresses the biological effects o f Wall Shear Stress (WSS) on the 
endothelium. After a brief definition o f analytical methods to evaluate WSS, a 
previously published idealized computational model o f an End-to-Side Arteriovenous 
Fistula is presented, used to calculate the WSS waveforms investigated in vitro in the 
present work. The second part o f the Chapter focuses on the literature findings related 
to WSS effects on endothelial cells that are potentially involved in Fistula stenosis and 
failure.
2.A) Wall shear stress effects on endothelial function.
2.A1) Wall shear stress definition.
WSS is the frictional force per unit area exerted by blood flow on the surface of 
the endothelium. The average physiological levels of WSS range from 1 to 6 dyn/cm 
and from 10 to 70 dyn/cm2 (76) in the venous and in the arterial vasculature network 
respectively (10 dyn/cm2 = 1 Pa). WSS magnitude and direction depend on blood flow 
rate and vessel geometrical features. According to Poiseuille's law (249) the WSS 
generated by a laminar flow in a straight a cylinder (figure 10) is
6 * Q * u
WSS = r  = ----
TC *  R
n 1
where x is wall shear stress (Pa), Q is the blood flow (m s ' ), p, is blood dynamic 
viscosity (Pa's) and R is the vessel radius (m) (250).
During the cardiac cycle, the endothelium experiences rapid changes in WSS 
magnitude and direction. Features of vascular geometry such as branches and curvature
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force the blood to create zones of recirculation and flow separation. Studies by Caro and 
colleagues (251) on atherosclerosis localization identified a correspondence between 
low WSS and areas of the vasculature most exposed to lesion development. Ku and 
Giddens (259) proposed in addition that marked oscillations in the direction of WSS 
may lead to atherogenesis. Subsequent studies have shown how shear stress deeply 
affects EC morphology, gene expression and biochemical signal productions depending 
on the features of the WSS waveform.
Despite the fact that Poiseuille's law is widely used to provide a simple method 
to calculate WSS, this formula assumes a steady, fully developed flow in a rigid 
cylinder. However, the AVF physiological conditions differ from these assumptions, 
since blood flow is unsteady and the vessels are elastic and present curvatures.
In 1955, Womersley considered the unsteady blood flow components by 
introducing a non-dimensional parameter that is the ratio between the transient inertial 
effect and the viscous effect of blood according the following definition
Wo = R0 ^ co/ v
where Wo is the Womersley number, Ro is the vessel radius, co is a frequency 
component of the blood flow ( co = 2‘n /T where T is typically the fundamental period of 
the unsteady flow) and v is the kinematic viscosity of blood (252, 253). Physiological 
values of Wo vary from ~ 20 at the aorta level to values ~ 1 at the terminal part of 
arteries, and became <1 in arterioles, capillaries and veins (254). Using this parameter it 
is possible to determine the blood velocity profile within vessels and to estimate the 
phase lag between the oscillating pressure and the correspondent flow. Furthermore, for 
higher values of a, several authors found dramatic differences in blood flow profiles
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with respect to those calculated with Poisenille's law. In particular the blood inertia 
effect causes zones o f backward flows near the vessel wall despite an overall forward 
flow within the vessel (figure 10). Many previous studies have shown that considering 
Womersley number in calculating blood velocity and WSS, increases the accuracy of 
results compared to those obtained with non-linear numerical approaches (255, 256).
Parabolic P oiseuille’s flow W om ersley 's  flow
Blood f lo w  
Vessel radius 
Blood viscosity
Blood velocity along blood/endothelium interface 
Height a b o ve  endothelium  surface
Shear ra te
= A v / &  d
Wall shear stress = WSS
v / A d * u
Fig. 10: Wall Shear Stress (WSS) in a cylinder according Poiseuille's law or corrected with 
Womersely number.
An even better estimation o f WSS generated by unsteady blood flows in realistic 
vessel geometries (i.e. tapered or stenosed vessels) can be achieved by considering the 
Strouhal number (also referred as reduced velocity) defined as
1 2 W o2
St = ----------- = -----------------
U re d  TC R e £)
where St is the Strouhal number, Ured is the reduced velocity, Re is Reynolds number o f 
the characteristic diameter D and Wo is the W omersley number (257).
Furthermore, to take into account vessel curvatures and branches, the Dean 
number can be used together with other parameters, while to model vessel elasticity
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numerical approaches based on the fluid-structure interactions are required (257, 258). 
A detailed description of the above mentioned approaches is beyond the purpose of this 
study.
2.A2) Wall shear stress in side-to-end A VFs.
CFD simulations were performed in an idealized side-to-end AVF geometry, 
created between the radial artery and the cephalic vein, by Ene-Iordache et al. (79). 
Flow simulations were performed with an 8 core, 64 bit computer using the 
OpenFOAM 2.3.1. code, a multipurpose CFD tool based on the finite volume method 
(OpenFOAM team, 2014, The OpenFOAM Foundation, http://www.openfoam.org). A 
three-dimensional parametric model (figure 11) of the volume inside the AVF geometry 
was built using the GAMBIT 2.3 mesh generator software (Fluent Inc., Lebanon, NH, 
USA). The internal volume, corresponding to the fluid domain, was meshed with a 
structured grid consisting of 131,443 hexaedral cells (figure 12). Blood density was 
assumed constant (1.045 g/cm3) and blood viscosity was considered non-Newtonian. 
The result of simulation was post-processed and visualized using ParaView 4.2 software 
(Kitware Inc. Sandia National Laboratories, Albuquerque, NM, USA). For the purpose 
of this study only the WSS vector components parallel to the mean flow direction were 
considered.
55
Chapter 2 2015 Marco Franzoni
0 A =  0.37 cm
Fig.l 1: Parametric model of AVF used in flow simulations. oA is the arterial diameter and 0 V is 
the venous diameter(79).
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Fig. 12: Structured mesh of AVF model (79).
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In the present work, four WSS patterns have been tested (table 6, figures 13 and
14):
The radial artery WSS calculated before the AVF surgical creation (PUL_A).
S  The cephalic vein WSS calculated far from the disturbed area (PULV).
S  The distal radial artery WSS, downstream of the AVF on the anastomosis floor 
(RECA).
S  The venous side of the anastomosis WSS (REC_B).
PUL_A represents the lower WSS measured in the radial artery before the AVF 
creation. PUL_V derived from the cephalic vein, downstream the anastomosis, where 
the flow re-acquires a laminar and unidirectional waveform, after the disturbances 
introduced by the anastomosis curvature. Both these waveforms demonstrate pulsatile 
behavior and are distinguished by the suffix PUL.
REC_A and R E C B  were calculated downstream of the AVF on the 
anastomosis floor and at the anastomosis on the inner side of vein curvature 
respectively. These two areas have been previously identified as common sites for IH 
development (71).
Waveforms PUL_A PUL_V REC_A REC_B
Mean [dyn/cm2] 3.35 15.78 0.08 0.07
STD [dyn/cm2] 6.58 3.16 7.53 9.55
Max absolute WSS [dyn/cm2] 26.67 22.76 16.51 26.03
WSS step [dyn/cm2] 30.03 10.32 29.67 37.08
OSI 0.06 0 0.49 0.49
Tab.4: Main features of investigated WSS waveforms. Mean is the mean value of WSS during 
the 1 second cycle, STD is the standard deviation of WSS values during the cycle, Max absolute 
WSS is the highest value of WSS modulus, WSS step is defined as the difference between the 
maximum and minimum WSS values and OSI is the Oscillatory shear index (259).
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Fig. 14: Origin and profile of WSS waveforms selected for the present study (79). This image 
has been published in "Am. J. Physiol. Heart Circ. Physiol. 2015 Oct 23. doi: 
10.1152/ajpheart.00098.2015".
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2.B) Endothelial WSS mechanotransduction.
2.B1) Endothelial wall shear stress mechanotransduction.
Evidence emerging in the last three decades of in-vivo and in-vitro experimental 
studies focused on atherosclerosis, has shown that WSS waveforms can be divided into 
two classes named "Atheroprone" or "Atheroprotective", depending on their capacity to 
elicit or prevent vascular dysfunction (260). According to this classification, the WSS 
waveforms calculated from the A W  CFD model were divided into two groups. As 
shown in figure 15, unidirectional and pulsatile waveforms with a relatively high 
magnitude and low frequency oscillations have been shown to be protective for 
endothelium (261) by eliciting a quiescent ECs phenotype that results in vessel 
homeostasis and antioxidant effects (262). On the contrary, as shown in figure 16, 
reciprocating or disturbed WSS, characterized by a relative low magnitude and/or 
important reverse flow phases with high frequency oscillations, elicits an activated state 
in ECs that results in an overall pro-inflammatory, proliferative paracrine signalling and 
in pro-oxidant state (263). Continuous exposure to oscillating WSS stimuli deeply 
affects EC morphology, gene expression and biochemical signals and results in an 
endothelial loss of continuity and altered permeability (77).
Mechanotransduction of WSS in ECs is exerted by a plethora of sensors (102). 
Immediately after WSS onset, activation of surface potassium channels leads to 
membrane hyperpolarization (264). Subsequent recovery and membrane depolarization 
depend on chloride channel activation. Moreover the WSS onset leads to a net influx of 
Ca (265, 266) and causes NO production (267, 268). Other membrane structures such 
as G-coupled protein receptors (269) and tyrosine kinase receptors are also activated by
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WSS (110). Finally, WSS affects the balance between caveolae-mediated NO release 
and ROS (270, 271).
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Fig. 15: Schematic representation of unidirectional WSS signalling in ECs. Abbreviations: ROS 
reactive oxygen species, MAPKs mitogen activated protein kinases, KLF Krtippel like factor, 
Nrf2 nuclear factor-erythroid 2-like 2, eNOS endothelial nitric oxide synthase, NO nitric oxide, 
PI3K phosphatidylinositol-3-kinases, AKT protein kinase B, ECM extracellular matrix, 
NADPH nicotinamide adenine dinucleotide phosphate, FAs focal adhesions, AJs adhems 
junctions (263).
62
Marco Franzoni 2015 Chapter 2
Reciprocating 
shear stress
Endothelial
permeabilityNF-kB, AP-1, p38, JNK
ROS
ERK/MAPK
NO, TGF-p, TIMPs, 
CGX and cytoskeleton 
remodeling
MMPs, MCP-1, IL-8, 
VCAM, ICAM, BMP4, 
ET-1, VEGF and PDGF
ECM
l ' l
Vessel tone, cell shape
FT
Apoptosis, proliferation, migration, inflammation
Sustained ECM remodeling, SMCs and MFs 
proliferation, migration
Legend
Integrin
NADPH
oxidase
Tyrosin kinase 
receptor
V
u
FAS
CGX
Caveolae
G protein 
receptor
AJs
Enhancement
Inhibition
Impairment/damage
Fig. 16: Schematic representation of reciprocating WSS signalling in ECs. Abbreviations: ROS 
reactive oxygen species, NF-kB nuclear factor kB, AP-1 activator protein 1, JNK jun n-terminal 
kinase, ERK extracellular-signal-regulated kinase, MAPKs mitogen activated protein kinases, 
NO nitric oxide, TGF-P tumor growth factor P, TIMPs tissue inhibitor metelloproteinases, GCX
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glycocalyx, MMPs metalloproteinases, MCP-1 monocyte chemoattractant protein 1, IL-8 
interleukin 8, VCAM vascular adhesion molecule, ICAM intracellular adhesion molecule, 
BMP-4 bone morphogenic protein 4, ET-1 endothelin 1, VEGF vascular growth factor, PDGF 
platelet derived growth factor, ECM extracellular matrix, NADPH nicotinamide adenine 
dinucleotide phosphate, FAs focal adhesions, AJs adhems junctions (75).
Depending on WSS waveform features, flow-induced transcription factors elicit 
gene expression on a time scale of 24-72 (125) hours controlling EC morphology, 
proliferation, migration, inflammation and apoptosis, thus promoting wall remodeling 
induced by mechanical stress. These pathways synergistically act to modulate EC 
transcription factors including NF-kB, AP-1 (75).
Activation of EC surface receptor molecules induces activation of several 
downstream pathways within seconds to hours (104). Key molecules regulating these 
pathways are MAPKs (ERKs, JNKs), kinases involved in the cell cycle and 
proliferation (272).
EC activation is only transitional if elicited by physiological/unidirectional WSS 
onset (273). On the contrary sustained signalling is generated by disturbed/reciprocating 
WSS stimuli (274, 275). The temporal regulation of these pathways is mainly exerted 
by functional ECs morphological adaptation to flow that involves structures such as the 
glycocalyx (GCX) and cytoskeleton (135, 276).
WSS-induced cytoskeleton remodeling is related to EC quiescence or activation 
by transmitting and producing intracellular forces with direct effects on several EC 
structures. The structural tensegrity (277, 278) model provides a description for the 
mechanical properties of ECs. In this model the cell is considered as a prestressed
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tensegrity structure due to the ability o f the cytoskeleton to absorb the mechanical 
loading applied to its surface.
The cytoskeleton elements are very flexible and can adapt to variations in 
mechanical stress. The interconnected structures o f the cytoskeleton balance the internal 
forces o f tension originated by microfilaments and compression forces exerted on 
microtubules in order to reach equilibrium (figure 17). Changes in mechanical loading, 
such as those elicited by AVF creation, induce EC cytoskeleton remodeling as described 
by the "bumper-car" model (279).
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Fig. 17: Schematic representation of endothelial cytoskeleton and its connections with 
mechanosensitive structures. Abbreviations: WSS wall shear stress, EC endothelial cell, ACW 
actin cortical web, SMC smooth muscle cell, ECM extracellular matrix, adherens junctions AJs, 
tight junctions TJs, focal adhesions FAs, glycosaminoglycans GAGs, glycocalyx GCX (279).
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2.B2) "Bumver-car" model o f endothelial cells mechanotransduction.
The "bumper-car" model (279) provides a hierarchical description of mechanical 
downstream events induced by WSS that result in signalling transfer from the cell apical 
surface to the cytoskeleton, then to junction complexes, to basement integrins and to the 
cell nucleus.
The normal endothelial surface is covered by a thick (0.5 -10 pm) (293) 
structure called the glycocalyx. This is composed of several transmembrane (syndecans) 
and membrane bonded (glypicans) core proteglycans carrying a complex network of 
glycosaminoglycan (GAG) chains that can bind to circulating molecules such as growth 
factors to form the endothelial surface layer (ESL) (280-282). Under physiological 
conditions, an extended endothelial CGX arises from endothelial surface and, by 
forming the ESL, provides a filter at the blood/EC interface, both steric and 
electrochemical due the net negative charges conferred to endothelial surface (283). A 
fully formed CGX may be able to completely shield the EC surface from WSS stimuli, 
preventing direct WSS activation of EC surface structures (284).
The GCX structure has a quasi-periodic highly dynamic structure (276). Several 
factors including the surrounding microenvironment, diseases such as CDK (285, 286) 
and local hemodynamics (276), regulate GCX composition and extent. Furthermore, 
ECs can provide active regulation of physicochemical properties and content of GAGs 
as a result of a continuous metabolic turnover orchestrated in order to adapt the CGX to 
changes in the local environment (287).
The most abundant GAG in human endothelium is heparan sulfate (HS, 50- 
90%), the rest is composed by chondroitin/dermatan sulfate and hyaluronic acid or 
hyaluronan. GAGs chains are covalently attached to specific sites on proteoglycans 
(288).
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Human ECs express different proteoglycans. Transmembrane syndecan-1, -2 
and -3, emerge from the cell surface with a very regular pattern and provide 3 to 5 
attachment sites for GAGs in the extracellular domain, which bind preferentially, but 
not exclusively, to HS (289). The syndecan cytoplasmic domain is associated with the 
cytoskeleton via a hexagonally arranged actin filament cortical web (ACW) and 
participates in its organization through molecules such as a-actinin and tubulin. 
Simultaneously, syndecan-binding properties can be modulated by intracellular signals 
(290,291).
Glypican-1 is also expressed by human ECs and localized to lipid rafts at the 
caveolae level that are involved in NO release. Glypican-1 is directly bound to the cell 
membrane through a C-terminal glycosylphosphatidylinositol anchor and presents 3 to 4 
attachemnt sites for HS (292).
Recent studies have revealed the structure of the GCX (293) participates in EC 
mechatransduction of WSS (294). Alternatively, knockout of sydecan-1 or glypican-1 
causes lack of cytoskeletal remodeling and a reduction in NOS synthesis respectively in 
ECs exposed to fluid flow (295). Similar effects were observed after enzymatic removal 
of HS (296).
WSS exposure causes torsion of GCX core proteins and initiates an integrated 
signalling in which cytoskeletal elements, such as ACW, transduce apical forces at 
basement attachment sites and at junction complexes (297). WSS also induces major 
cytoskeletal remodeling that affects the type and structure of connections and can lead 
to changes of a specific ECs phenotype (289, 298).
Actin filaments (F-actin) are the most abundant and proximal to cell membrane, 
among the three polymers that compose cytoskeleton (299). They are directly connected 
to p-integrin tails, by talin and fllamin, and to cadherins, by vinculin and catenins. In EC
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cultures under static conditions, F-actin is organized in dense peripheral bands (DAPBs) 
localized at the cell border and connected to neighborhood cells DAPBs by weak VE- 
cadherin linkages (279). As soon as ECs are exposed to unidirectional WSS, DAPBs 
disassemble and F-actin fibers undergo remodeling to form stress fibers connecting the 
cell basement and apical surface, several hours later (24-46 hrs) (300).
The Ras superfamily of GTPases and in particular, the GTPases RhoA, Racl, 
and Cdc42 are known to regulate cell shape changes through effects on the 
cytoskeleton, cell polarity and transcription factor activity, in response to WSS (134). 
The primary regulation of GTPase operates similar to GEFs, GAPs control binding to 
GDP/GTP (139).
The first effect of WSS onset is probably the conversion of Ras-GDP to Ras- 
GTP that induces the activation of ERK and JNK pathways (301, 302). Flow onset 
induces immediately a structurally identifiable Rac-1 mediated formation of 
ruffies/lamellipodia in the direction of flow (303). WSS-induced activation of Rac-1 
and its effector Serine/threonine-protein kinase (PAK) is required at the front of the cell 
to regulate actin polymerization and membrane protrusion (304). The activation of Rac- 
1 has to be spatially restricted in order for cells to polarize and align and/or migrate in 
the direction of flow. Localization of activated Rac-1 is induced by WSS through a 
PKA-dependent alpha4 integrin phosphorylation at the downstream edge of ECs and 
directs cytoskeletal alignment in response to shear stress (305, 306). Rac-1 is also 
required to induce NF-Kp transcription and nuclear translocation in response to WSS 
(307).
Rho activity regulates stress fibers and focal adhesions via the Rho-associated 
protein kinase (ROCK) pathway (308). Rho activity is also required for the initial 
alignment of EC and for WSS-induced polarization and (309) migration (310). It has
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also been proposed that subcellular localizations of RhoA activation is linked to 
endothelial barrier integrity and barrier function. Indeed Rho participates to AJs, TJs 
and FAs regulation and is necessary to induce WSS-mediated increase of endothelial 
permeability (309). A potential inhibitor of RhoA activity is the tyrosine 
phosphorylation of pl90RhoGAP GTPase activating protein (311-313). In ECs, 
integrin-mediated adhesion provides a binding site for pl20RasGAP (314), displacing it 
from the complex with pl90RhoGAP and hence contributes to the decrease in RhoA 
activity (315, 316). CDC42 is known to promote formation of filopodia and controls 
cell polarity (317, 318). Despite the fact that CDC42 is not required in ECs to control 
stress fibers formation or permeability (309), its fundamental role has been established 
in the polarization of the microtubule-organizing centre (MTOC) to a position on the 
downstream side of the nucleus relative to the direction of flow (319). A correct spatial 
activation of CDC42 rather than activity per-se is essential for localization of the 
MTOC after shear stress.
A tight spatial and temporal regulation is essential in GTPase orchestrated 
activation and deactivation of cytoskeletal activities and can be modulated by external 
agents such as thrombin, VEGF or WSS (133, 320). The hallmark of these processes is 
the elongation of ECs in the flow direction in order to distribute the mechanical loading 
and to control endothelial barrier function. The optimization of stress fibers architecture 
and cell shape orientation in the flow direction, rather than merely an increased amount 
of polymerized F-actin, are necessary in ECs to maintain adhesion to the substrate when 
chronically stimulated with WSS (321).
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2.B3) Adherens junctions in endothelial mechanotransduction.
Remodeling and stabilization of the cytoskeleton promotes formation of AJ 
complexes with several downstream effects on ECs. AJs, along with TJs, directly 
control endothelial permeability and intracellular signals (322). Many molecules with 
different functions form AJs (323, 324). VE-cadherin is the regulator of complex 
formation and provides the link between neighbouring cells (325). Platelet-endothelial 
cell adhesion molecule (PECAM) is a mechanosensor situated at the cell-to-cell 
interface and it may be responsible for the signalling that controls AJ formation in 
response to the pulling force transmitted by the cytoskeleton after WSS onset (326). A 
main AJs component is vascular endothelial growth factor receptor 2 (VEGFR-2) (327), 
a receptor tyrosine kinase that mediates the angiogenic effect of VEGF. VEGFR 
downstream effects strongly depend on AJ complex formation and context. VEGFR- 
VEGF binding in an intact endothelial monolayer controls proliferation contact 
inhibition by promoting pro-survival AKT signalling (328). On the contrary VEGFR- 
VEGF binding in damaged endothelium promotes proliferation via ERK/MAPK 
signalling. Many other molecules have functional interactions with AJ complexes (329). 
p i20 p-catenin is the link between AJs and the cytoskeleton and promotes VE-cadherin 
stabilization (330). AJs also interact with TGF-p, hepatocyte growth factor (HGF or 
MET), VEGF, epithelial growth factor and fibroblast growth factor (FGF) possibly 
leading to signalling dysfunction (331).
2.B4) Tight and Gap junctions in endothelial mechanotransduction.
Similar to AJs, TJs are also junctional complexes that regulate endothelial 
permeability and leukocyte trafficking (332, 333). TJs consist in protein complexes 
where occludins, claudins and junctional adhesion molecules are connected to F-actin
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fibers through zonula occludens (ZO-1, 2, 3) (334). Upon VEGF, MCP-1 or WSS 
stimulation, occludin is phosphorylated on multiple serine and threonine residues 
leading to increased endothelial permeability (335). Furthermore ZO-1 expression is 
also modulated by WSS with important effects on EC signalling and leukocyte 
transmigration (336).
Gap junctions (GJs) provide passage for ions and small molecules between 
adjacent cells (337). GJs are formed by connexin proteins and even if they may have a 
secondary role in mechanotransduction, they do participate in WSS-induced signalling 
(338-341).
2.B5) Focal adhesion complexes in endothelial mechanotransduction.
As mentioned above, the cytoskeleton transmits mechanical stress from the 
apical membrane to ECs basal laminae. At this level, the mechanical stress is equal and 
opposite in direction to the stimulus at apical level. This is necessary to avoid 
catastrophic endothelial delamination (279). Beyond cell-to-cell adhesion complexes, 
WSS causes major redistribution of proteins involved in FA formation (342). These 
complexes provide anchorage for ECs to the elastic laminae underneath the endothelium 
and promote linkage of F-actin to extracellular matrix via transmembrane integrins such 
as avP3 and transmembrane syndecan-4 (343-345). A short time after WSS onset, FAK 
are recruited to form complexes involving, among others, vinculin, paxilin and talin 
(346). According to the "bumper car" model (279), ECs assume an unstable 
configuration during the transitional remodeling phase. To avoid EC delamination, new 
FAs are formed together with actin stress fibers at the basal EC margin due to vinculin 
migration. Once the new configuration is stable, DAPBs are reformed and vinculin is 
dispersed.
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Phosphorylation and relocalization of FAs caused by mechanical stimuli are 
deeply involved in ECs mechanotransduction. Modulation of FA activity is involved in 
EC migration, proliferation and apoptosis. FAs are also involved in the regulation of 
endothelial permeability and inflammation (347-349). Conformational activation of 
integrins, caused by activated VEGFR-2 recruitment and activation of PI3K, induce 
formation of new binding sites on the ECM that promote activation of small GTPases, 
such as Rho and Rac (272). Furthermore, downstream effects of integrin activation 
involve up-regulation of proinflammatory transcription factors such as NF-kB, MAPK 
or adhesion molecules that affect vascular permeability (350, 351). Interestingly, 
blocking integrins with specific antibodies inhibits WSS-induced EC remodeling (352).
The tension exerted on integrins by physiological flows however, is lower than 
that necessary for direct activation and it is more likely that the force generated by the 
cytoskeleton (272) causes integrin activation. Latent TGF-p (353, 354), possibly 
activated by integrin signalling (355), plays the most important role in matrix deposition 
due to its ability to induce synthetic phenotypes in vascular cells, regulating IH 
development.
2.B6) Primary cilia in endothelium mechanotransduction.
The primary cilium is a non-motile apical membrane structure involved in 
mechanotransduction (356, 357). It protrudes from the EC membrane as a single 
structure with functions of an antenna able to transduce both mechanical (WSS, 
pressure) and chemical (PDGF) signals within the cell (358). Primary cilia are involved 
in Ca2+influx induced by WSS and cilia defects are related to several pathologies. (359) 
A recent study showed that lack of primary cilium induce ECs to undergo EndMT due
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to TGF-p signalling and repression of KLF-4, while cilium rescue or KLF-4 
overexpression prevent the transition (360).
2.B7) Nucleus transmembrane comvlexes in endothelial mechanotransduction.
The EC cytoskeleton structure can directly bind to the cell nucleus membrane 
and nuclear laminin (361). Actin filaments form a nesprin/SUN/laminin complex that 
binds nuclear chromatin and can transmit mechanical forces to the nucleus 
karyoskeleton. This evidence suggests that, beyond biochemical pathways activation, 
WSS can directly control gene expression through cytoskeletal mechanotransduction 
(362).
2.B8) Hemodynamics in AVF maturation and failure.
Previous studies have shown that low/reciprocating WSS has many detrimental 
effects on ECs leading to pathologies such as atherosclerosis and aneurysms. 
Low/reciproeating WSS waveforms have been defined as athero-prone due their ability 
to lead to atherosclerotic lesion development (274). WSS waveforms in the high risk 
stenosis area of AVFs have a generally higher magnitude with higher frequency 
oscillations and possibly several reverse flow phases compared to those investigated in 
atherosclerosis development (260). Since atherosclerosis development is a major focus 
of research interest, the affect of AVF-specific WSS waveforms on ECs has been poorly 
addressed.
As mentioned before, AVF creation induces a significant increase in blood flow 
while the rise in WSS acting on the endothelium is limited by the vessel diameter 
increase induced by NO release. The high sensitivity of endothelium to WSS is further 
confirmed in-vivo. A previous study showed that radial artery remodeling after AVF
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creation is able to provide an increased blood flow maintaining an almost constant peak 
WSS during the cardiac cycle (82).
An effective remodeling process provides an increased blood flow through the 
AVF with limited effects on WSS. In high risk AVF areas, WSS has been shown to be 
reciprocating with non-physiological high frequency oscillations. Since physiological 
unidirectional WSS is a determinant in inducing EC quiescence (figure 9), reciprocating 
WSS in the AVF may lead to altered EC permeability and chemoattractant signalling, 
responsible for IH development.
As described above, many upstream events may be responsible for IH 
development and lack of positive remodeling, such as surgical handling, damage to the 
adventitia and other vessel layers, increased oxidative stress levels and inflammation. 
Since these events affect all the areas of AVF vessels but ffl-induced stenosis occurs in 
those areas exposed to reciprocating WSS, it is reasonable to hypothesis this force is the 
ultimate regulator of IH development.
This hypothesis is strongly supported by further experimental evidence focused 
on atherogenesis, which have emerged in the last three decades (figure 10) (110). 
Reciprocating flows cause a down-regulation of KLF-2 expression (140). KLF2 is 
highly expressed in-vivo by endothelium but not in areas of the vasculature 
characterized by curvature and branches that are exposed to reciprocating WSS (363). 
ECs exposed to reciprocating WSS show a lack of cytoskeletal remodeling and 
elongation, related to cell quiescence (364). Reciprocating WSS affects vascular 
remodeling mainly by the down-regulation of NO release and up-regulation of the 
vasoconstrictor ET1 (365). Disturbed WSS also prevents CGX formation (366) and 
affects cytoskeleton remodeling and stabilization. The unstable cytoskeleton promotes 
AJ destabilization that prevents contact inhibition and induces EC proliferation. Also
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FA formation and distribution is affected by cytoskeletal remodeling (279). Disturbed 
WSS also affects integrin interaction with ECM and EC nuclei (361).
Furthermore, WSS has been shown to control EC adhesion molecule expression 
such as VC AM and ICAM. The expression of these molecules along with 
overexpression of IL-8 and MCP-1 is fundamental in promoting monocyte adhesion and 
infiltration (75, 76). Reciprocating WSS also causes an increase in MMP-2 and 9 
syntheses that, along with impaired TIMP expression, sustains ECM remodeling 
inducing SMC migration and proliferation (367). ECM remodeling can also activate 
latent TGF-P complex inducing vascular cells activation and IH (354).
2.C) Summary
Wall Shear Stress is a fundamental mechanical stimulus in vascular biology. 
Several analytical and computational approaches have been developed in order to 
calculate in-vivo WSS profiles during the cardiac cycle in the different areas of 
vasculature. To address this problem in the Arteriovenous Fistula for hemodialysis 
vascular access, our group have developed an idealized model to calculate WSS 
waveforms in AVF areas more frequently affected by neointimal hyperplasia (72). From 
previously published simulations, four WSS profiles are reported here to be used in the 
present in vitro study (79). These profiles were classified according their temporal 
behaviour as Pulsatile or Reciprocating. Pulsatile WSS was computed in AVF areas 
relatively protected from IH development while Reciprocating WSS was computed in 
areas that previous studies identified as more exposed to IH and stenosis. This 
classification is similar to that proposed by several authors to define the atherogenicity 
of WSS that develops in the carotid bifurcation (260).
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To explore the hypothesis that local disturbed hemodynamic, and the consequent 
reciprocating WSS, in the AVF affects EC phenotype and signalling, enhancing IH 
development, an experimental set-up, based on a cone-and-plate geometry was designed 
as described in the next chapter.
To investigate the cellular effects generated by these AVF-specific WSS 
waveforms, later chapters describe observation of EC morphology after flow exposure 
and quantification of F-actin fiber distribution to assess cytoskeletal remodeling. This is 
complemented with further evaluation of KLF-2 m-RNA differential expression elicited 
by WSS stimuli and the expression of genes involved in RhoGTPase downstream 
effects. Measurement of the flow-induced production of IL-6, IL-8 and MCP-1 is also 
reported along with the evaluation of the paracrine proliferative effect on SMCs of 
medium conditioned by HUVECs during flow exposure experiments. Finally, flow- 
induced CCR2 and CKl-a mRNA expression was quantified.
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CHAPTER 3: Cone-and-Plate device
This Chapter provides a review o f the currently available cell shearing devices used in 
biomedical research and the design and construction o f the real-time controlled Cone- 
and-Plate device used in the present work. In the second part o f the Chapter, results 
obtained with analytical and numerical methods to evaluate the capability o f the device 
to generate tightly controlled, highly unsteady Wall Shear Stress stimulations over the 
cell monolayer culture are reported.
3.A) In-vitro exposure to WSS
3.A1) Cell shearing: devices.
The last thirty years have seen an enormous increase of interest towards in-vitro 
models to evaluate the effect of mechanical stimulation on different tissue and cell 
types. Despite the attempt to reproduce the complex in-vivo environment, the 
reductionist approach implicit in in-vitro models was introduced to study the effects of a 
single mechanical parameter. To investigate the effect of in-vitro shear stress on cell 
cultures many devices have been developed (figure 18), these include;
• Square Capillary tube (A);
• Parallel plates flow chamber (B);
• Parallel plates viscometer (C);
• Cone-and-plate viscometer (D).
Each of the systems has both positive and negative aspects (368). The capillary 
tube (Fig. 18A) presents difficulties in cell seeding, it does not allow observation of
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seeded cells under the microscope and it also requires a system to generate the flow 
inside the tube (e.g. constant pressure head, syringe or peristaltic pump). Indeed, it 
offers a simple geometry, similar to physiological conditions.
The parallel plates chamber (figure 18B) is capable of providing a wide range of 
WSS stimuli, however it does not allow control of WSS magnitude and waveform over 
a continuous range. Flow is usually produced with a pressure generating system similar 
to those reported for the capillary tube. WSS rise time depends on chamber geometrical 
parameters and fluid viscosity, thus a time delay occurs between a change of inlet 
pressure and consequent WSS variation. Among the advantages are the easiness of cell 
seeding and the opportunity to observe cell behaviour under a microscope during the 
experiment.
e r r "  - — i
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D
Fig. 18: Examples of cell shearing systems. A) Capillary tube, B) parallel plates 
chamber, C) parallel plate viscometer and D) cone and plate viscometer.
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The two viscometer configurations were originally developed to measure fluid 
viscosity. Basically they consist in an element rotating over a fixed plate. The test fluid 
fills the gap and it is dragged by the rotating element. The fluid viscosity is evaluated 
from measurements of torque necessary to maintain a constant rotation.
The two viscometers have been used to stimulate cell monolayer cultures since 
the 1980's and present similar advantages. The main improvement over other devices 
relates to the fluid drive system. The flow is regulated by rotation of the viscometer 
upper element provided by an electrical engine. This system allows a continuous control 
of WSS delivered to the culture surface and no pumping system is required. Similarly, 
both systems require a time of development necessary to achieve the new shear stress 
value on the culture surface due a change of rotation velocity. This aspect limits the 
maximum acceleration and deceleration, which can be correctly transferred across the
gap-
The main difference between these systems relates to the rotating element and 
the geometry of the surface that moves the fluid. Due to the geometrical configuration, 
the parallel plates apparatus (figure 18C) fails to create a uniform shear stress stimulus 
on the entire culture surface. The fluid tangential velocities generated by a certain cone 
angular velocity increase along the radius from the plate centre to the periphery. This 
limitation was overcome by introducing the cone-and-plate geometry (figure 18D) that 
compensates for the radial increase in velocity with the increase of gap between the two 
elements due to the cone angle. A detailed description of cone-and-plate geometry 
(cone-and-plate device, CPD) and fluid dynamics is provided in next paragraphs.
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3.A2) Cone-and-vlate device.
Introduced by Mooney and Ewart in 1934 (369) as a tool to measure fluid 
viscosity, the device was firstly used by Dewey and colleagues (1981) (370) as device 
for cell shear loading (371). Since then many groups have used devices analogous to the 
cone-and-plate viscometer to study in-vitro effects of shear stress on monolayer cell 
culture, platelet adhesion or red blood cell mechanical damage.
For applications in cell biology, the CPD is usually operated to obtain laminar 
flow (termed primary flow), which generates concentric fluid streamlines, thus a 
uniform shear stress field on the entire culture surface. To match such conditions, the 
cone angle must be small (0.5°-3°) and the cone rotation velocity has to be low. 
However, different studies have addressed the CPD problem for larger cone angles as 
well as higher velocities
Using dye visualization techniques, Cox and others in 1962 (372), observed the 
development of circulatory secondary flows when the centrifugal forces become 
significant. Pelech and Shapiro in 1964 (373), proposed the ratio between fluid 
centrifugal forces and inertial forces (the so-called modified Reynolds number, Re, very 
similar to the Reynolds number used to evaluate turbulence inside pipes) as the 
parameter which governs the secondary flow onset in CPD geometry.
Fewell and Heliums in 1977 (374), provided a complete theoretical description 
of CPD internal flows. They reported how secondary flows are always present within 
the fluid, but are negligible for low angular velocities.
Bussolari in 1982 (375) and Sdougos in 1984 (371), proposed a simple 
formulation, based on CPD geometry simplifications, to calculate WSS on the plate 
surface. This approach is accurate only when CPD flow is primary. The authors 
successfully used Re as a threshold to avoid secondary flows within the CPD (371). For
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Re—>0, (Re<0.5) it is possible to consider the CPD internal flow as primary with fully 
developed concentric streamlines (figure 19). For higher Re values (0.5<Re<l) the 
secondary flows increase but remain negligible. Secondary flows start to disturb CPD 
internal flow for Reynolds number greater than 1 (l<Re<4), in this condition the fluid 
streamlines deviate from their concentric path by an angle which is a function o f Re 
itself, forming a helix around the plate centre (figure 19). Finally for Re>4 the flow 
becomes fully turbulent and numerical methods are necessary to evaluate the shear 
stress field inside the CPD.
Fig. 19: Effect of secondary flows within a cone-and-plate viscometer. Azimuthal (v) and radial 
(u) components of velocity near the plate surface, showing the angle cj). The dotted line 
represents the surface streamline and the angle between azimuthal and the surface directions 
(371).
Although numerical evaluations are necessary to calculate WSS on the plate for 
high Re values, macroscopic observations have reported recirculation o f fluid along the 
radial direction. In this condition the fluid at the cone surface experiences outward
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centrifugal forces, while an inward motion due to the recirculation forces characterizes 
fluid motion at the plate level.
Together with the increase of Reynolds number, other aspects ignored under 
primary flow conditions, become relevant. The formation of transient eddies, caused by 
fluid turbulence and the irregularities of the cell coated plate surface, affect the CPD 
internal fluid dynamics. Nevertheless, Couette flow is observed in the peripheral fluid 
volume present in the outer plate region, outside the cone area. These aspects however, 
were not addressed for the present study purpose.
The Sdougos' formulation (371) provides a valuable tool to estimate shear stress 
values on the plate surface. However, it is based on an idealized CPD geometry with no 
gap between the cone apex and the plate centre. Real experimental set-ups maintain a 
certain distance between the two elements of the device, which strongly affects the 
shear stress field underneath the cone, at the plate level.
Buschmann and his group (376) proposed a new formulation to overcome this 
limitation. The new approach introduces gap height as a parameter to calculate WSS 
delivered to the cell monolayer. The WSS evaluated with this method varies with 
radius, losing shear stress field uniformity. The proposed formula is accurate for 
realistic CPD configurations and agrees with CFD simulations performed by Spuell at 
al. (377).
The majority of reported experiments apply steady flow to stimulate the cell 
culture. However many cellular events rely on transient signals following the onset of 
unsteady flows. Several groups have reported the important role played by the form of 
the shear stress waveform in inducing disease progression. Together with the emerging 
importance of unsteady flows, research interest has moved to waveform features such as 
the level of mean shear stress, the magnitude and the frequency content.
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These studies require dynamic control of cone rotation through a motor 
connected to a programmable interface. Blackman and colleagues (378) have proposed 
such a device that enabled the group to accurately handle complex shear stress 
stimulation. However, to accurately apply a realistic shear stress waveform it is 
necessary to evaluate the effect of inertial forces on CPD internal flow and the resulting 
effect on WSS delivered to the plate surface.
The steady flow condition provides an easy control for cell loading after the 
transitional phase at the beginning of a stimulus. In contrast, time-dependant 
stimulations require the evaluation of the time lag between variation in cone rotation 
speed and the subsequent change of WSS magnitude at the plate level. The goal is to 
avoid undesired loss of stimulus frequency components.
According to Malek and others (379), the analytical solution for a suddenly 
accelerated plane wall in a semi-infinite Newtonian fluid allows evaluation of the 
development time necessary to obtain a deviation of the velocity profile from the 
asymptotic linear distribution less than 1%. A frequency threshold is introduced to 
achieve an accurate replication of shear stress waveform on the culture plate. The next 
section describes the CPD developed for the present study and the evaluation of the 
internal flows for the experimental test conditions.
3.B) CPD development
3.B1) Design o f a compact cone-and-vlate device.
The project aim was to test in-vitro effects of realistic fluid shear stress stimuli 
on HUVEC monolayers. Computational studies of in-vivo wall shear stress reported a 
wide range of physiological values and patterns depending on the vessel tree area 
examined. WSS values range from 0 to 70 dyn/cm2 with either unidirectional or
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reversing patterns (76), while oscillations at frequencies much higher than heart rate 
resulted from CFD simulations.
To deliver such highly unsteady flows, the cell shearing device had to match two 
main requirements: the capability to accurately generate both unidirectional and 
oscillating/reversing flow patterns, in a time dependant manner and to ensure a wide 
range of almost uniform stimulation on the entire culture surface at any given instant.
Among the different in-vitro systems currently available to expose cell 
monolayers to fluid shear stress, only the cone-and-plate device meets the project 
requirements. To achieve the study aims, a compact CPD, suitable for use in a standard 
cell incubator, was designed and constructed together with the Mechatronic Laboratory 
o f Bergamo University (figure 20).
The system is composed of an AISI-316 stainless steel cone with a radius, r, of 
67 mm and an angle, a, of 0.5° deg, coupled with a standard tissue culture Petri dish 
(disposable P-150, Falcon, BD Biosciences, Franklin Lakes, NJ, USA) used as a plate 
(figure 21).
The cone apex and plate are very close to each other, but they are not in contact, 
maintaining a gap h0 of 0.1 mm (figure 22). The basement of the device is aluminium 
coated to prevent any corrosion phenomena. The base is shaped to provide a lodge for 
the plate. A vacuum was created underneath the plate through a pipe connected to a 
pump to ensure the correct position of the plate. This solution provides a strong bond to 
the plate that remains fixed in position. At the end of experiment however the bond is 
easily removed by turning off the pump. The cone is connected to a gear that is moved 
by a pinion (figure 23A) driven by a brushless electrical engine (Mavilor, Barcelona, 
Spain) operated by a dedicated programmable driver. The cone and gear rotate on a
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circular guide thanks to three runners (figure 23B). By changing the rectified spacers 
between the cone and the plate it is possible to modify the gap ho (figure 23C).
The described system ensures quick and simple assembly/disassembly processes. 
By removing the engine from the CPD base (figure 24), the system is compact and easy 
to handle. Cell culture plates loading and unloading, culture medium change, are 
performed under a laminar flow hood, ensuring sterile and quick procedures. 
Furthermore, the CPD size and the reduced engine heat production, make the system 
suitable for use in a regular cell incubator chamber, ensuring proper culture conditions 
for long-term experiments. Finally a dedicated electrical circuit in compliance with legal 
electrical safety requirements provides the CPD power supply.
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C o n e
D r i v e n  g e a r
C ell  c u l t u r e  
p l a t e
E n g i n e C o n e
Fig.20: A) A picture of the CPD system within the cell incubator. B) Exploded view of the CPD 
system. This image has been partially published in "Am. J. Physiol. Heart Circ. Physiol. 2015 
Oct 23. doi: 10.1152/ajpheart.00098.2015".
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Fig.21: Images of the cone and its angle a and the plate with its radius r.
E n g i n eP l a s t i c  c o v e r
D r i v e n  g e a r
/  . /  /  
C o n e  x
P l a t e  s u p p o r t C u l t u r e  p l a t e
V a c u u m  p u m p
Fig.22: Schematic representation of the CPD geometrical features. Abbreviations: co cone 
angular velocity, r radius, hO gap between cone apex and plate and a cone angle. This image has 
been published in "Am. J. Physiol. Heart Circ. Physiol. 2015 Oct 23. doi: 
10.1152/ajpheart.00098.2015".
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Fig.23: A) Schematic representation of the operating principle of the CPD. B) The circular 
guide (red arrow), the space for the engine (green arrow), the vacuum line (yellow arrow) and 
the runners (orange circle). C) The driven gear (red arrow) the lodge (orange circle) of the 
rectified spacers (in the box).
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Fig.24: Sequence describe in the
experimental set-up. A) The body of the 
CDP without the engine under a laminar flow 
hood. B) The plate is inserted within its 
lodge. C) The sterile cone is coupled with the 
plate. D) The CPD is closed with a plastic 
cover. E) The CPD is positioned within the 
incubator and mounted with the engine. F) 
An overview of the set-up.
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The motion control of the cone is provided by a PC-based platform, equipped 
with a Linux-based Real-Time Application Interface that enables the control loop to be 
closed with a 1 kHz sample frequency through a hard-real time thread. An acquisition 
data board or NIB (NI-6229, National Instruments Corp, Austin, TX, USA) supporting 
the COMEDI collection of drivers for data acquisition is used as the interface between 
the device and the control unit (figure 25A). An encoder embedded with the engine (E) 
produces a signal based on engine angular velocity cop (t). This signal is acquired by the 
control unit that generates a torque control voltage signal (V) to pilot the engine and two 
digital signals that enable power and logic driver switches. A graphical user interface, 
developed with Linux IDE (Qt Creator), allows the user to upload the motion law that 
sets the cone rotation velocity set-point cos (t) and the cone acceleration, each 
millisecond. Furthermore the user interface provides a real-time visualization of cone 
rotation velocity, engine torque and cone position. The user can easily create motion 
laws since they are based on ASCII text files
In order to perform highly unsteady WSS stimulations, a proportional-integral 
controller (PID) with an anti wind-up element for the integral component, closed on the 
cone velocity, provides tight control and fast cone rotation dynamics (Figure 25B). The 
PID is a low-pass filter that reduces high frequency noise while the integral component 
guarantees the tracking of steady state conditions. To compensate for cone and gear 
inertial effects during fast acceleration, important for realistic WSS waveforms, a feed­
forward block (FF) was introduced to compensate for such effects and to increase the 
dynamic behavior of the system. Finally, the device performance was evaluated for 
reproduction of highly unsteady waveforms. Different waveforms were replicated in the
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laboratory and the correspondence of engine angular velocity G)p (t) to velocity set-point 
cos (t) was verified.
A
PID
B
0)s
NIB NIBPID DRIVER
ii)p
Fig.25: Schematic representations of the CPD control system. A) The set-point velocity (cos) is 
coupled with the engine velocity (cop) and the difference (et) is used by the proportional-integral 
controller (PID) together with the correction generate by the feed-forward component (FF) to 
generate the torque signal (te) to pilot the engine. B) The signal generated by PID is transformed 
into a voltage signal (V) by the acquisition data board (NIB) and transferred to the engine 
driver. The driver generates also the voltage signal that is used as feedback for the PID control 
loop.
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3.B2) Analytical evaluation o f cone-and-plate fluid dynamics.
The main advantage in choosing the cone-and-plate geometry consists in an 
almost uniform shear stress filed over the entire culture surface due to the linear 
increase of both gap width hr and azimuthal cone surface velocity vr, thus a radius 
independent shear rate 8V / 5Z = Vo / h = const. Despite the complexity of the device 
internal fluid dynamics, a simple formulation is commonly used to estimate shear stress 
values generated on the plate surface. By assuming low velocities, small cone angle a < 
5°, thus tan a  « a, and considering the axial-symmetry of the device geometry, it is 
possible to calculate the WSS on the plate surface (371)
r  =  i i *  d v /  d z  =  p. * 0 0  =  [i * t a n a j  =  A* * ”  1]
where t  is wall shear stress on the plate, p is dynamic viscosity of the fluid in the gap, 
and 5V / 5Z is the variation of velocity v  in the z  direction, 0) is cone angular velocity, r  
is the radius and a is the cone angle in radians. This formula has been validated with 
computational and experimental studies and shown to be accurate when negligible 
secondary flow exists and the gap ho is negligible.
To ensure negligible secondary flows, it is necessary to respect the threshold for 
the modified Reynolds number specific for the cone-and-plate geometry, proposed in 
(371) , where u is kinematic viscosity
r 2o)a2
R e  = --------- . [2]12v L J
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Similar to the traditional Reynolds number, this formula evaluates the ratio 
between centrifugal forces and viscous forces acting on the fluid at any radius from the 
cone centre. Low Reynolds value (Re < 0.5) ensures optimal conditions for cell shear 
loading. Below this threshold the viscous forces dominate, the centrifugal forces are 
negligible and secondary flows are small over the entire plate surface
Although good agreement of this approach has been shown with experimental 
results, this formulation considers an ideal configuration with no gap between the plate 
and the cone apex. Realistic experimental set-ups maintain a certain gap, thus to 
calculate WSS on the plate it is necessary to consider a formulation which takes into 
account this parameter.
Sucosky et al. (380) addressed this issue and proposed the following formula 
where ho is the gap between cone and plate at the centre
r  =  ( f i  * o j )  * ( r / ( / i 0 +  r a ) ) .  [3]
This approach introduces a radius dependence for the WSS value over the plate
(figure 26A), which goes from 0 at the plate centre and increases along the radial
direction up to approximately 85% of WSS value obtained with the previous
formulation (figure 26B). The approach differences for WSS patterns tested in the 
present work will be discussed in the next paragraph.
Although many studies used Sdougous approach, considering a constant WSS on 
the entire plate surface, Dardik et al. (381) measured differences in WSS generated at 
the centre and the periphery of a cone-and-plate device, which affect both cell 
proliferation and morphology. Bovine aortic ECs (BAEC) seeded at the two different 
locations after 24 hrs and 5 days of exposure to laminar shear stress (210 rpm cone
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rotation velocity, resulting in a stimulation of 4.8 dyn/cm2 at the centre and 11.1 
dyn/cm2 at the periphery) revealed significant cellular alignment at the periphery but 
cells at the centre showed a polygonal shape, increased proliferation and apoptosis, 
similar to effects observed after reciprocating flow exposure.
The gap ho together with the cone angle a, are fundamental parameters to 
minimize the radius dependence of WSS on the plate. Spruell and Baker (377) 
simulated the effect of different device configurations by changing angle a from 0.5° to 
2° and gap ho from 1 to 100 pm. The effect of different angles and gaps on WSS, 
reported by other authors, are similar to those obtained by the Sucosky analytical 
approach [3] (380). Increasing cone angle increases the non-uniformity of WSS 
delivered at plate level (figure 27A). By increasing the gap ho, the WSS generated at 
plate level decreases dramatically (Figure 27B).
Even though a gap of 100 pm strongly affects the shear stress field uniformity, 
this was adopted in the experiments of this thesis in order to preserve the integrity of the 
EC monolayer. The adherent EC thickness in the central perinuclear region is 
approximately 3 pm while the covering glycocalyx layer (measured in-vitro for BAEC) 
was found to be thicker than 10 pm (293). From these considerations it is possible that 
irregularities in the cultured monolayer alters the flow field and influence WSS at the 
plate level.
According to these considerations we considered the plate outer ring (from 2 cm 
radius to the external edge at 6.7 cm radius) as exposed to a controlled and rather 
uniform shear stress. We defined this area of the plate region of interest since WSS 
calculated with [3] varies from 65% to 85% with respect to that calculated with [1].
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Fig.26: Comparison of WSS at plate level calculated by eq. [1] and eq. [3], A) The effect of the 
gap of 0.1mm on WSS (continuous line) calculated by eq. [3] for an angular velocity to of 2.46 
rad/s. Eq. [1] (dotted line) does not consider the gap and the result is a constant WSS along the 
plate radius. B) The comparison of WSS calculated by eq. [1] and eq. [3] in the plate region of 
interest were HUVECs are seeded.
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The second device requirement was to perform highly unsteady WSS 
stimulation, requiring rapid change of cone rotation velocity or even change in rotation 
direction. Despite fine control of cone rotation velocity, a time delay occurs between 
cone rotation and WSS generated on the plate (376). According to Sutera and 
colleagues (382), it is possible to estimate the wave development time in the gap 
between the cone and the plate with the suddenly accelerated plate formula,
t d <  0 . 2 5 * ^  [4]
where hr is the gap along the plate radius, u is the fluid dynamic viscosity and td is the 
time required to get a difference between cone velocity and it's asymptotic value less 
than 1%. This approach limits the cone maximum acceleration to ensure complete 
motion transmission across the gap, achieving precise WSS stimulus at the plate level. 
The time lag of the device used in this study is < 50 ms at any radius (figure 27C), 
ensuring full WSS development for any WSS waveform with frequency components up 
to 10 Hz.
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Fig-27: A) The effect of different cone angle (0.5°, 1°, 2°) on WSS at plate level for co of 2.46 
rad/s and a gap of 0.1mm. B) The effect of different gaps (1, 10, 100 pm) on WSS at plate level 
for ct) of 2.46 rad/s and cone angle of 0.5°. C) The time delay between cone accelerations and 
the 99% development of correspondent WSS at plate level, estimated by eq. [4].
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3.B3) Computational evaluation o f CPD fluid dynamics.
To evaluate the accuracy of these analytical methods in describing CPD fluid 
dynamics, numerical simulations of CPD transient flows were performed using the 
OpenFOAM code (383). BlockMesh is a mesh generator tool included in OpenFOAM 
v. 2.3.1 suite. The mesh represents the fluid domain inside the CPD and consists of the 
upper conical surface and a bottom plane surface representing the cells, connected with 
an exterior vertical wall. After a mesh sensitivity test (see appendix A), the volume was 
meshed using a structured grid consisting of 138,000 hexahedral cells (figure 28).
Newtonian fluid with a dynamic viscosity, p, of 3.54 cP and a density p of 
0.9544 g/cm3 was considered. Geometrical parameters were the same as the 
experimental set up (cone angle, a, of 0.5°, cone radius, r, of 67 mm and a central gap, 
ho, of 0.1 mm). The variable angular velocity oo(t) in rad/s during the cycle was imposed 
as the boundary condition on the upper conical surface according to the CPD motion 
laws of the different WSS profiles. No-slip (i.e., zero velocity) conditions were imposed 
on the bottom surface (the cell monolayer) and on the vertical wall. The unsteady 
Navier-Stokes equations were solved using pimpleFoam, a transient solver for 
incompressible flows employing the PIMPLE (merged PISO-SIMPLE) algorithm and 
first order Euler time integration scheme. One period of the cycle (T = 1 s) was divided 
in 1,000 fixed time steps (dt = 1 ms) and the results were saved for post-processing in 
1,000 time steps for each cycle. Four complete cardiac cycles were solved in order to 
damp the initial transients of the fluid and only the results of the fourth cycle were 
considered for data processing. The results of simulations were post-processed and 
visualized with ParaView software. In the next section the results are compared between 
the CFD model and analytical approaches [1] and [3].
98
Marco Franzoni 2015 Chapter 3
Fig.28: 138 '000 elements structured grid created to mesh internal fluid volume of CPD and used 
to simulate the different flows.
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3.C) Comparison of different methods to evaluate WSS at plate level
The effect of gap ho on WSS generated at plate level was computed. Using 
equation [3] a difference of WSS peak value with respect to that calculated with [1] 
ranged from 68.3% to 84.8% from radius 2.5 to 6.5 cm (figures 29A, 32A, 35A, 38A). 
This result is independent of the velocities and accelerations of the single WSS 
waveform since it depends uniquely on the medium viscosity and on the gap dimension.
According to the results of CFD simulations (figures 29B, 32B, 35B, 38B), the 
Sucosky approach accurately describes the gap effect on WSS generated at plate level 
(figures 30, 33, 36, 39). The WSS peak values calculated with equation [3] with respect 
to that calculated using CFD methods, in the region of interest, ranges from 96.2 to 
100.2% in PUL A waveforms, from 95.5 to 95.8% in PUL_V, from 96.3 to 99.8% in 
REC A and from 96.2 to 99.6% in REC B (figure 31 A, 34A, 37A, 40A).
A significant difference emerged from the comparison of the results obtained at 
the outer edge of the plate. At a radius of 6.7cm the WSS peak calculated with equation 
[3] is 85.4% of that calculated with [1]. In the CFD model the presence of the fixed 
plate outer edge introduces border effects that strongly reduce WSS magnitude in all the 
waveforms. WSS peaks calculated with equation [3] are the 138.1, 133.6, 144.3 and 
137.3% of those reported by the simulation for PUL_A, PUL_V, REC_A and REC_B 
waveforms respectively (figure 31 A, 34A, 37A, 40A).
The td for WSS peak with equation [1] and CFD simulations was also computed. 
Equation [1] depends exclusively on medium viscosity and the distance between the 
rotating cone surface and the plate, td ranges from 9 to 37 ms for radii 2.5 and 6.7cm 
respectively (figures 3 IB, 34B, 37B, 40B). As expected the simulations showed a 
reduced delay with respect to that evaluated for the instantaneously accelerated plane. 
The td of PUL_A and PUL_V was 5 ms at radius 2.5cm and 20 ms at 6.5cm. REC_A
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had td increasing from 5 to 18 ms. REC_B td ranged from 4 to 17 ms (figures 3 IB, 34B, 
37B, 40B). Maximal td was found at radius 6.5cm. On the outer edge the lowest WSS 
magnitude calculated by simulations was reached 1 ms earlier.
These results make the selected limit of 10 Hz a reasonable threshold for 
frequency components of WSS waveforms. A 10 Hz oscillation completes its cycle in 
100 ms, one order of magnitude higher that the td found in the tested cases.
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Fig.29: PUL_A WSS stimuli at plate level. A) WSS calculated by eq. [3] and eq. [1] (Sdougos).
B) WSS calculated by CFD methods and eq. [1] (Sdougos).
102
Marco Franzoni
A
30 -i
c>•T3
B
30
25
20
?  15 
E
2 ,
i/)oo
2015
Comparison of different approaches to evaluate WSS
Chapter 3
25
20
Sdougos [1]
15
Analytical [3] r = 25 mm
10
CFD model r = 25 mm
5
0
5
0,2 0,4 0,6 0,8
t [s]
Comparison of different approaches to evaluate WSS
-5
Fig.30: PUL A WSS stimuli at plate level. A) WSS calculated by eq. [1] (Sdougos), eq. [3] and
CFD method at 2.5 cm radial position. B) WSS calculated by eq. [1] (Sdougos), eq. [3] and
CFD method at 6.5 cm radial position.
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Sucosky [3] vs CFD m odel
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Fig .31: A) Comparison o f WSS calculated by eq. [3] vs. eq. [1] in the plate region o f interest. B)
Time delay estimated by eq. [4] and calculated by CFD in the plate region o f interest.
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Fig.32: PUL V WSS stimuli at plate level. A) WSS calculated by eq. [3] and eq. [1] (Sdougos).
B) WSS calculated by CFD methods and eq. [1] (Sdougos).
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Fig.33: PUL_V WSS stimuli at plate level. A) WSS calculated by eq. [1] (Sdougos), eq. [3] and 
CFD method at 2.5 cm radial position. B) WSS calculated by eq. [1] (Sdougos), eq. [3] and 
CFD method at 6.5 cm radial position.
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Fig.34: A) Comparison o f WSS calculated by eq. [3] vs. eq. [1] in the plate region o f  interest. B)
Time delay estimated by eq. [4] and calculated by CFD in the plate region o f interest.
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Fig.35: REC_A WSS stimuli at plate level. A) WSS calculated by eq. [3] and eq. [1] (Sdougos).
B) WSS calculated by CFD methods and eq. [1] (Sdougos).
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Com parison o f d ifferent approaches to  eva lu ate  WSS at r = 25 mm
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Comparison of different approaches to evaluate WSS at r = 65 mm
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Fig.36: REC A WSS stimuli at plate level. A) WSS calculated by eq. [1] (Sdougos), eq. [3] and
CFD method at 2.5 cm radial position. B) WSS calculated by eq. [1] (Sdougos), eq. [3] and
CFD method at 6.5 cm radial position.
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WSS peak, Sucosky [3] vs CFD sim ulation
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Fig.37: A) Comparison o f WSS calculated by eq. [3] vs. eq. [1] in the plate region o f interest. B)
Time delay estimated by eq. [4] and calculated by CFD in the plate region o f interest.
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3.C4) Anastomosis angle Reciprocating flow ( R E C B )
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Fig.38: REC B WSS stimuli at plate level. A) WSS calculated by eq. [3] and eq. [1] (Sdougos).
B) WSS calculated by CFD methods and eq. [1] (Sdougos).
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Comparison o f d ifferent approaches to  eva lu ate  WSS
15
fN<
E
c>-
10
5
0
5
Sdougos [1]-10
-15 Analytical [3] r = 25 mm
-20 CFD m odel r = 25 mm
-25
0,2 0,4 0,6
t [s]
0,8
B
Comparison of different approaches to evaluate WSS
15
10
5
0(N
5
Sdougos [1]
Analytical [3] r = 65 mm
CFD m odel r = 65 mm-25
-30
10,6 0,80,40,20
t[s]
Fig.39: REC_B WSS stimuli at plate level. A) WSS calculated by eq. [1] (Sdougos), eq. [3] and
CFD method at 2.5 cm radial position. B) WSS calculated by eq. [1] (Sdougos), eq. [3] and
CFD method at 6.5 cm radial position.
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WSS peak, Sucosky [3] vs CFD m odel
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Fig.40: A) Comparison of WSS calculated by eq. [3] vs. eq. [1] in the plate region of interest. B)
Time delay estimated by eq. [4] and calculated by CFD in the plate region of interest.
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3.D) Summary
Due to the fundamental importance of Wall Shear Stress in endothelial biology, 
several systems have been developed and used in biomedical research to reproduce 
flows over cell cultures. Despite the fact that each system presents some advantages, in 
order to obtain controlled, highly unsteady WSS stimulation over a cell monolayer 
culture a compact, real-time controlled Cone-and-Plate device was designed and 
constructed, suitable for use within a standard cell incubator. The device is controlled 
by dedicated software and a proportional-integral controller able to accurately pilot the 
cone rotation in a time dependant manner. In order to verify the correspondence 
between cone velocity and WSS at plate level, published analytical methods and a 
computational model were used. In line with previous studies, the results showed that 
the device produces a WSS stimulus that increases from the centre to the periphery and 
that the vertical edge of the plate strongly reduces the magnitude at the border. 
Furthermore, to guarantee a coherent stimulus over the entire plate, it is necessary to 
introduce a threshold for the frequency components of WSS waveforms since medium 
inertial effects cause a time lag between cone accelerations and the correspondent WSS 
variations. In conclusion, the stimulus was considered to be uniform in the outer ring of 
the plate (for radius > 20mm, referred as region of interest) and for WSS waveforms 
with frequency components < 10Hz.
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CHAPTER 4: Endothelial cell culture and exposure to AVF- 
specific transient WSS
This Chapter addresses the methods used to isolate Human Umbilical Endothelial Vein 
Cells (HUVECs) and to culture them in order to obtain the cell monolayers used in the 
flow exposure experiments. Isolated cells were characterized and the content o f smooth 
muscle cells was quantified to ensure that these cultures were composed o f HUVECs. 
Further evaluation is reported o f the cell culture plate coating and the experimental set­
up o f the Cone-and-Plate device. The investigations performed to evaluate HUVECs 
morphological adaptation to flow are reported in the second part o f  the Chapter. After 
a qualitative analysis based on contrast phase microscopy and scanning electron 
microscopy images, specific structural features were stained, F-actin fibers and tight 
junctions ZO-1 protein, fo r  cells exposed to different culture conditions and these 
features were quantified with a software-based image analyzer tool.
4.A) HUVEC isolation and characterization
4.A1) HUVECs isolation.
HUVEC were freshly isolated from the umbilical cord according to (384). 
Briefly, cords were carefully washed with warm physiologic solution twice to remove 
blood from the vein. The cords, filled with collagenase solution or COLLS composed 
by 47,6 mg of collagenase (Sigma-Aldrich, St. Louis, USA) in 100 mL of Phosphate 
Buffered solution (DPBS, refers to Dulbecco's phosphate buffered solution. The 
solution is composed by distilled filtered water added with 132 mg/L of CaC12 (Merck 
KGaA, Darmstadt, Germany), 100 mg/L MgC12 (Carlo Erba reagents, Milan, Italy), 440 
mg/L Na2HP04 (Carlo Erba), 200 mg/L KH2P04 (Sigma), 8 g/Ml NaCl (Sigma), 200
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mg/L KC1 (Carlo Erba) warmed to 37°C, were incubated for 13 minutes at 37°C. 
COLLS containing isolated HUVECs plus red blood cells, was collected in a backer 
with New Bom Calf Semm (NBCS, Life Technologies, Milan, Italy), to block 
collagenase activity. The cell suspension was centrifuged for 8 minutes at 1200 rpm. 
The pellet was re-suspended with growth medium (GM), composed by culture medium 
(M l99 Biowest, Nauille, France) added with 10% of NBCS, 10% of Human Semm 
(HS, directly separated in our laboratory from human plasma), 1% Penicillin and 
Streptomycin (PenStrep, Life Technologies), 1% Amphotericin B (Fungizone, Life 
Technologies) and 0.1% Heparin (TEVA, Petah Tikva, Israel) and seeded in a cell 
culture plate (disposable P55, Falcon) coated with bovine gelatine at 1% (Sigma).
After cell adhesion, the medium was removed and the dish surface was washed 
twice with warm physiologic solution to remove red blood cells. Finally GM added with 
and 0.02% endothelial cell growth supplement (ECGS, Tebu-Bio, Offenbach, Germany, 
referred also as complete GM) was added to the dish. HUVEC were expanded until 3rd 
passage and then frozen in GM added with 5% Dimethyl Sulfoxide (DMSO, Sigma).
Six days before the experiment, the HUVEC were thawed in GM, then seeded 
on a Petri dish P I50 (BD Bioscience, Franklin Lakes, NJ, USA), coated with bovine 
gelatine at 0.2% (Sigma) grown until confluence and used in flow exposure experiments 
at 4th or 5th passage.
4.A2) Isolated HUVEC characterization.
To characterize cells collected from umbilical cords, we incubated samples of 
isolated cells with rabbit anti human von Willebrand factor (vWF, 1:100, Sigma) 
primary antibody for two hours at room temperature, and with Fluorescein 
isothiocyanate-labeled (FITC) goat anti-rabbit secondary antibody (1:25, Jackson
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Immunoresearch) for 45 minutes at 37°C. Counterstaining with 4,,6-diamidin-2- 
fenilindolo (DAPI) (lpg/ml, Sigma) for 10 minutes at 37°C was performed for cell 
nuclear staining.
To further evaluate contaminations of isolated HUVECs with SMCs we 
performed FACS analysis to evaluate percentage of cells positive for a smooth muscle 
actin (a-SMA). Cells were detached from the culture plate after 3 minutes incubation 
with trypsin (EDTA trypsin 0.05%, Sigma) at 37°C. Cells were then fixed with 2% 
solution of paraformaldehyde (Societa Italiana Chimici, Rome, Italy). The cells were 
washed twice with PBS buffer solution then permeabilized with 0.1% triton X-100 
(Fluka) for 3 minutes and incubated in 3% BSA (Sigma) for 10 minutes at room 
temperature. The sample was incubated with Cy3-labeled anti-human a-SMA antibody 
(1:250, Sigma) for 30 minutes at room temperature, suspended in 500 pL of PBS 
solution and analyzed with FACSCanto II system (BD Biosciences).
4.A3) Results.
Cells collected after collagenase digestion of the umbilical cord vein endothelial 
layer may be contaminated with SMCs. In order to evaluate this contamination and the 
effective phenotype of isolated cells we performed imunofluorescence staining for 
endothelial marker vWF (figure 41 A). Images showed that almost all isolated cells were 
positive for this marker. We further confirmed this result by counting the SMC specific 
marker a-SMA positive cells with Fluorescence-activated cell sorting (FACS). The 
result confirmed a low contamination of 4.6% a-SMA positive cells within the pool that 
was then used in flow exposure experiments (figure 4 IB).
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Fig.41: A) HUVECs stained for vWf (green) and counterstained for nuclei (blue). Magnification 
20x, scale bar 20pm. B) FACS result for HUVECs incubated with anti-a-SMA antibody.
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4.B) Culture plate gelatine coating evaluation
4.B1) Cell cultures time-lavse.
A well of a 6-well plate (Falcon) was coated with different percentage bovine 
gelatine (Sigma) solutions, 0.2%, 0.6%, 1% respectively, for one hour at 37°C. After the 
coating process, the well was seeded with 3* 105 /cm2 HUVEC and 2mL of complete 
growth medium was added to each well. HUVEC motility and proliferation was 
observed for 24 hours using an Axio Observer.Zl microscope equipped with a Slide-in 
module standard XLMultiSl, a heating module and a C02 module (Carl Zeiss, Jena, 
Germany). Images were taken at a rate of one frame per minute. Cell movement 
analysis was performed using Axio Vision software (Carl Zeiss). Each percentage 
solution was tested three times. Motility was reported as the average cell velocity in 
um/s and proliferation was reported as the % of cells, which underwent mitosis during 
the 24 hours period.
4.B2) Results.
Gelatine coating evaluation did not show statistically significant differences in 
HUVECs motility (figure 42A). Furthermore a slight increase in the number of mitotic 
cells (figure 42B), from 15% to 25%, was observed in plates coated with decreasing 
concentration of gelatine. Based on these results plates for the flow exposure 
experiment were coated with 0.2% gelatine solution.
4.B3) Statistic methods
To evaluate the statistic significance of results obtained during the research 
activities, we performed one-way ANOVA test and the post-hoc Bonferroni multiple
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comparisons test was used to establishe differences among groups. Tests were 
performed using PRISM 6.Of software (GraphPad Software Inc., La Jolla, CA, USA).
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Fig.42: A) Mean velocity of HUVEC seeded on different gelatine percentage (1%, 0.6%, 0.2%) 
coated plates. B) Percentage of mitotic cells counted in plates coated with different percentage 
gelatine solutions.
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4.C) Flow exposure experiments
4. C l) Exverimental set-uv.
Confluent EC monolayers were exposed to four different WSS patterns, derived 
from previous CFD analysis of an idealized A W  (79) as reported in chapter 2. The day 
of the experiment, under a laminar flow hood, the GM was changed with experimental 
medium (EM, composed by GM, added with 4% of high molecular weight Dextran 
(Dextran from Leuconostoc spp, 450-650 kDa, Sigma) (385). The plate was fixed in 
position with a vacuum pump and closed with the cone. The CPD, described in chapter
3, was then transferred to the incubator and mounted with the engine. The cone rotation 
speed was slowly increased to the desired value over approximately 1 hour, 
experimental medium was changed twice a day and stored at -80°C for further analysis. 
Contrast phase microscopy images where taken at the beginning, during and at the end 
of each experiment. Each condition was tested ten times. A control cell sample 
underwent the same process as the cells exposed to flow, without transfer to the CPD 
device.
4.C2) SEMsample preparation.
Since contrast phase microscopy images provide only limited information on 
cells morphology and are not indicated to evaluate the three dimensional shape, we 
wanted to develop a protocol to be able to perform SEM images of cells attached to the 
plate of our system. Thus after 48 hrs of flow exposure, the cell culture plate was 
removed from the device. Using a circular hollow punch (0.6 mm of diameter), we 
removed pieces of the plate from the area of interest of the dish. These samples were 
fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodilate for 1 hour, then postfixed with 
osmium tetroxide and dehydrated with a series of passage in increasing ethanol baths.
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Cell monolayers on samples were dried in pure hexamethyldisilazane (HDMS, Fluka 
Chemie AG, Buchs, Switzerland), sputter-coated with gold and examined using 
scanning electron microscope (SEM, 1540 EsB, Carl Zeiss GmbH, Oberkochen, 
Germany).
4.C3) Results.
Contrast phase microscopy images showed that HUVECs exposed to 
unidirectional stimuli have deep morphological changes compared to the static control 
(figure 43). As shown in figures 44 and 45, cells exposed to PUL_A and PUL_V 
waveforms were elongated and aligned in the flow direction. A major alignment was 
observed in HUVEC exposed to P U L V  (figure 45) WSS waveform while cells 
exposed to PUL_A (figure 44) presented a lower rate of alignment especially in the 
outer part of the plate. HUVECs exposed to both REC_A (figure 46) and REC_B 
(figure 47) WSS waveforms did not elongated or aligned and presented a cobblestone 
shape similar to that observed in HUVECs maintained in static condition (figure 48).
Finally, in order to evaluate the three dimensional shape of HUVECS, we 
developed a SEM sample preparation protocol that allowed us to obtain images of the 
cell culture monolayers after 48 hours of exposure to PUL_V WSS waveforms and after 
48 hours of static culture, as shown in figure 49.
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Static 30 mm radius 50 mm radius
Fig.43: Contrast phase microscopy images of FlUVECs at different plate radial positions, 
maintained in static conditions. A) HUVECs at the beginning of experiment, magnification lOx, 
scale bar 50pm. B) HUVECs after 48 hours, magnification lOx, scale bar 50pm. C) HUVECs 
after 48 hours, magnification 20x, scale bar 50pm.
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Fig.44: Contrast phase microscopy images of HUVECs at different plate radial positions, 
exposed to PUL_A waveform. A) HUVECs at the beginning of experiment, magnification 1 Ox, 
scale bar 50pm. B) HUVECs after 48 hours, magnification lOx, scale bar 50pm. C) HUVECs 
after 48 hours, magnification 20x, scale bar 50pm.
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Fig.45: Contrast phase microscopy images oh HUVECs at different plate radial positions, 
exposed to PUL V waveform. A) HUVECs at the beginning of experiment, magnification lOx, 
scale bar 50pm. B) HUVECs after 48 hours, magnification lOx, scale bar 50pm. C) FIUVECs 
after 48 hours, magnification 20x, scale bar 50pm.
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Fig.46: Contrast phase microscopy images of HUVECs at different plate radial positions, 
exposed to R E C B  waveform. A) HUVECs at the beginning of experiment, magnification lOx, 
scale bar 50pm. B) HUVECs after 48 hours, magnification lOx, scale bar 50pm. C) HUVECs 
after 48 hours, magnification 20x, scale bar 50pm.
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Fig.47: Contrast phase microscopy images of HUVECs at different plate radial positions, 
exposed to REC B waveform. A) HUVECs at the beginning of experiment, magnification 1 Ox, 
scale bar 50pm. B) HUVECs after 48 hours, magnification lOx, scale bar 50pm. C) HUVECs 
after 48 hours, magnification 20x, scale bar 50pm.
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Fig.48: Contrast phase microscopy images oh HUVECs kept static (S) or exposed to different 
WSS conditions for 48 hours. Magnification 20x, scale bar 50pm.
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48 hours
Fig.49: SEM images of FIUVEC exposed to 48 hours of PUL V WSS stimulation or kept static.
4.D) HUVEC morphology evaluat ion
4.D1) Immunofluorescence staining.
At the end o f each experiment the cell monolayer on the Petri dish P I 50, was 
fixed in 2% paraformaldehyde (Societa Italiana Chimici) in 4% sucrose (Sigma) 
solution, for 10 minutes at room temperature. Cells were then permeabilised in 0.1% 
triton X-100 (Fluka) for 3 minutes and incubated in 3% BSA (Sigma) for 30 minutes at 
room temperature. HUVEC were incubated with rabbit anti-ZO-1, 1 pg/m L (Sigma) 
overnight at 4°C as a primary antibody. HUVEC were then incubated with a FITC- 
conjugated goat anti-rabbit (1:25) antibody (Jackson Immunoresearch, W est Grove, PA) 
for 45 minutes at 37°C followed by incubation with rhodamine-labeled phalloidin
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(Invitrogen, Paisley, UK) (1:40) for 45 minutes at room temperature. Counterstaining 
with DAPI (1 mg/ml, Sigma) for 20 minutes at 37°C was performed for cell nuclear 
staining. The slides were finally mounted with a fluorescent mounting medium (Dako 
Cytomation, Carpinteria, CA) and examined by ApoTome microscopy (Axio 
Imager.Z2, Carl Zeiss). Each condition was tested three times.
4.D2) Immunofluorescence imase analysis.
To quantify F-actin fibers distribution the ImageJ plug-in OrientationJ (EPFL, 
Lausanne, Switzerland) was used, as described in a previous study (386). Briefly, 
immunofluorescence images were acquired and split into RGB components. The R (red) 
channel image was then transformed to an 8-bit image and processed by the plug-in to 
return the distribution of fibers according their direction. The complete procedures and 
settings are reported in Appendix Bl.
To evaluate the elongation of HUVECs exposed to different WSS waveforms, 
the open source software CellProfiler (v2.1.0, Broad Institute, Cambridge, USA) was 
used to perform automatic recognition of cells in immunofluorescence images obtained 
after ZO-1 protein staining. The software allows the user to define a sequence of 
modules, or pipeline, that processes images and identifies single cells. After nuclei 
(primary objects) and cell (secondary objects) recognition an additional module allow 
manual correction of mismatched objects. Finally, a dedicated module quantifies 
geometrical parameters of cells, returning axes dimensions and orientation of the major 
axis. Two pipelines, reported in appendix B2, were defined to differentiate between 
elongated and polygonal cell shapes.
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4.D3) Statistic methods
To evaluate the statistic significance of results obtained during the research 
activities, we performed one-way ANOVA test and the post-hoc Bonferroni multiple 
comparisons test was used to establish differences among groups. Tests were performed 
using PRISM 6.0f software (GraphPad Software Inc., La Jolla, CA, USA).
4.D4) Results.
As shown in figure 5OB, HUVEC monolayers maintained in static condition 
showed random distribution of F-actin fibers, mostly organized in dense peripheral actin 
bands, with a few fibers crossing the cellular body. HUVECs exposed to the PUL_A 
WSS waveform showed a loss of peripheral actin bands and greatly increased number 
and thickness of F-actin stress fibers across the cell body (figure 5 IB). This flow- 
dependant organization was even more evident in EC exposed to the PUL_V WSS 
waveform (figure 52B). In HUVECs exposed to REC_A (figure 53B) and REC_B 
(figure 54B) WSS waveforms, F-actin fibers remained mostly peripheral with fibers not 
oriented in the flow direction, showing a pattern similar to that of cells maintained in 
static condition (figure 50).
Automatic cell shape evaluation performed on tight junction-associated ZO-1 
protein staining images (figure 50C, 51C, 52C, 53C, 54C), allowed computation of the 
mean ratio of the major/minor axis for cells exposed to different WSS waveforms. In 
figure 55 is provided the comparison of immunofluorescence images obtained from cell 
monolayers exposed to different flow conditions.
Automatic detection of the direction of F-actin fibers using digital image 
processing was carried out as described in Appendix B. As shown in figure 56A, in 
HUVECs exposed to the PUL_V waveform, 59.5% of F-actin fibers were aligned with
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the flow (within ±15° of flow direction) with only 3.6% of fibers perpendicular to flow 
(± 15°). Interestingly HUVEC exposed to the PUL A waveform did not show a similar 
orientation of F-actin distribution since only 23.2% of fibers were aligned with the flow 
(± 15°), with 13.6% of fibers perpendicular to flow (± 15°). In HUVEC exposed to the 
REC_A and REC_B waveforms, 21.3% and 28.7% of F-actin fibers were aligned with 
the flow (± 15°) and 17.9% and 9.9% of F-actin fibers were perpendicular to flow (± 
15°), respectively. In conclusion only the PUL_V WSS waveform elicited a strong 
alignment of F-actin stress fibers with the flow direction (figure 56B).
HUVEC exposed to PUL_A and PUL_V stimuli have a ratio of 2.5 6± 1.3 2 and 
5.10±1.67 respectively, significantly (figure 57, p <0.01 PUL A and PUL_V vs. Static, 
REC_A and RE CB ,  n=3) higher than that calculated in cells exposed to the REC_A 
and REC B waveforms, in which the elongation ratio averaged only 1.58 ±0.36 and 
1.57±0.37, respectively. These values were comparable to those calculated for cells 
maintained in static conditions (1.54 ±0.37). Cell alignment was also quantified by 
measurement of cell major axis direction (figures 58). 35.1 % of cells exposed to 
PUL_A and 73.4% of HUVEC exposed to the PUL_V waveform had major axes 
oriented between ±20° of the flow direction. Only 21.2% and 22% of cells exposed to 
the REC_A and REC_B WSS waveforms respectively were aligned between ±20° of 
the flow direction, similar to the 28.8% of HUVEC maintained static which had this 
orientation.
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S tatic
A
Fig.50: Images of HUVECs maintained in static conditions for 48 hours. A) Contrast phase 
microscopy image, magnification 20x, scale bar 50pm. B, C) Immunofluorescence images of 
HUVECs stained for F-actin (red), ZO-1 (green) and nuclei (blue), magnification 20x, scale bar 
50pm.
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Fig.51: Images of HUVECs exposed to PUL A WSS waveform (the yellow arrows indicate the 
flow direction) conditions for 48 hours. A) Contrast phase microscopy image, magnification 
20x, scale bar 50pm. B, C) Immunofluorescence images of HUVECs stained for F-actin (red), 
ZO-1 (green) and nuclei (blue), magnification 20x, scale bar 50pm. D) WSS profile PUL_A.
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Fig.52: Images of HUVECs exposed to PUL_V WSS waveform (the yellow arrows indicate the 
flow direction) conditions for 48 hours. A) Contrast phase microscopy image, magnification 
20x, scale bar 50pm. B, C) Immunofluorescence images of HUVECs stained for F-actin (red), 
ZO-1 (green) and nuclei (blue), magnification 20x, scale bar 50pm. D) WSS profile PUL_V.
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Fig.53: Images of HUVECs exposed to REC A WSS waveform (the yellow arrows indicate the 
flow direction) conditions for 48 hours. A) Contrast phase microscopy image, magnification 
20x, scale bar 50pm. B, C) Immunofluorescence images of HUVECs stained for F-actin (red), 
ZO-1 (green) and nuclei (blue), magnification 20x, scale bar 50pm. D) WSS profile REC_A.
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Fig.54: Images of HUVECs exposed to REC B WSS waveform (the yellow arrows indicate the 
flow direction) conditions for 48 hours. A) Contrast phase microscopy image, magnification 
20x, scale bar 50pm. B, C) Immunofluorescence images of HUVECs stained for F-actin (red), 
ZO-1 (green) and nuclei (blue), magnification 20x, scale bar 50pm. D) WSS profile REC_B.
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Fig.55: Immunofluorescence images of HUVECs after 48 hours of different culture conditions. 
Staining for ZO-1 (green), F-actin (red) and nuclei (blue). Magnification 20x, scale bar 50pm. 
This image has been published in "Am. J. Physiol. Heart Circ. Physiol. 2015 Oct 23. doi: 
10.1152/ajpheart.00098.2015".
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Fig.56: F-actin fibers distribution after 48 hours of exposure to flows or static conditions. A) 
Percentage of fibers aligned to the flow (0°±15°) or perpendicular to it (90°±15°). ** p<0.01 
PUL_V vs. all, # p<0.05 PUL A vs. Static and RECA,  ## p<0.01 PUL A vs. REC B and ° 
p<0.05 REC B vs. static and REC A, n =3. B) Percentage of fibers oriented to any angle. This 
image has been partially published in "Am. J. Physiol. Heart Circ. Physiol. 2015 Oct 23. doi: 
10.1152/ajpheart.00098.2015".
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Fig.57: Ratio of major and minor axes of FlUVECs exposed to different conditions of WSS. ** 
p < 0.01 vs. static, REC A and REC B, n=3. This image has been published in "Am. J. Physiol. 
Heart Circ. Physiol. 2015 Oct 23. doi: 10.1152/ajpheart.00098.2015".
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Fig.58: Distribution of HUVEC major axes respect to flow direction (90°) after 48 hours of 
exposure to different WSS waveforms compared to static.
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4.E) Discussion
HUVECs derived freshly from umbilical cord are widely used and investigated. 
However if the collagenase digestion of endothelial layer is too long or if the tissues are 
damaged, the cord basement membrane may be dissolved and the endothelial cells 
suspension will be contaminated with smooth muscle cells or fibroblasts (387). The 
described HUVECs isolation procedure allowed us to obtain homogenous endothelial 
cells culture as showed by vWF staining and a-SMA FACS analysis.
Furthermore it is known that HUVECs growth substrate have deep effects on 
cell growth and cell culture plate coatings are considered necessary for ECs cultures 
(388, 389). Based on previous experiences of our laboratory (365, 390, 391), the use of 
different percentage gelatine solutions coating on cell motility and proliferation has 
been evaluated. No major statistical differences were found in the investigated 
conditions and according to these results we used a 0 .2 % gelatine solution for flow 
exposure experiments.
The previously described experimental set-up ensured adherent HUVECs after 
48 hours of flow exposure. The strength of the procedure relies on the easiness of Cone- 
and-Plate handling in sterile conditions and on the disposable and removable culture 
plate that provides a cost-effective solution and allows the user to remove the plate at 
the end of experiment for further analysis. Furthermore the device is sized to be placed 
within a standard cell incubator in order to avoid the use of other components to control 
temperature and gas composition of CPD environment.
The cells morphological adaptations to different flow conditions were evaluated 
with different techniques. As expected (260, 392) HUVECs morphology was diversely 
affected by the WSS waveforms calculated in AVF high or low stenosis risk areas 
(figures 48 and 55), in line with previous works (260). ECs exposed to PUL_V WSS
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waveform aligned and elongated in the flow direction. PUL_A waveform induced a 
reduced elongation and orientation respect to PUL_V. On the contrary, exposure of 
HUVECs to REC A and REC B profiles did not elongate nor aligned, and maintained 
cobblestone shape similar to cells in static condition.
The cell elongation induced by PUL_V was also visualized by SEM imaging. 
Even though this technique was not further explored, the developed protocol may 
provide information on the three dimensional shape of cells after flow exposure thus 
allows investigating the force acting on cells with different morphology.
HUVEC monolayers maintained in static condition showed a random 
distribution of F-actin fibers, mostly organized in DPABs, with a few fibers crossing the 
cellular body. HUVECs exposed to PUL_V WSS waveform showed a loss of peripheral 
actin bands and greatly increased number and thickness of F-actin stress fibers across 
the cell body. These fibers were markedly orientated towards the flow direction. PUL_A 
waveform again induced a less tightly spatial organized distribution of stress fibers. In 
HUVECs exposed to REC-1 and REC-2 WSS waveform F-actin fibers remained mostly 
peripheral with fibers not oriented in the flow direction, showing a pattern similar to 
that of cells maintained in static condition.
The HUVECs dramatic changes in shape and reorganization of cytoskeletal 
structure, induced by PUL A and PU L V , is involved in several protective effects of 
unidirectional WSS. Cytoskeleton reorganization and optimization is involved in 
endothelial barrier functions as well as in ECs quiescence due its tight relation with 
expression of transcription factors involved in cell proliferation (322).
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4.F) Summary
After HUVEC isolation and characterization, the experimental conditions 
necessary to maintain cells adherent to the system plate in long term flow exposure 
experiments have been evaluated. Thus the culture plate coating, the timing of flow 
onset and the medium change frequency have been tested. The described set-up allowed 
us to perform 48 hours of exposure to different WSS waveforms, maintaining an 
adequate number of cell attached to the plate thus enabled us to perform further 
investigations on the exposed HUVEC monolayers.
The results of cell morphology evaluation were in line with previous 
investigations and showed a significant elongation and alignment of cells exposed to 
pulsatile WSS waveforms as compared to those exposed to reciprocating WSS or 
maintained in static conditions. F-actin fibers showed a dramatic reorganization in the 
flow direction in HUVECs exposed to PUL_V profile, while cell exposed to PUL_A 
presented a less markedly reorganization. HUVECs exposed to reciprocating WSS 
profiles showed randomly distributed F-actin fibers, similar to those observed in cell 
maintained in static conditions.
These morphological adaptations of cells are involved in the beneficial effect 
induced by unidirectional WSS on endothelium. To further demonstrate this effect, the 
HUVECs flow-induced gene expression has been evaluated, methods and results are 
provided in the next Chapter.
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CHAPTER 5: Quantification of endothelial cell gene 
expression following exposure to AVF-specific WSS 
waveforms
This Chapter addresses the mRNA expression elicited in endothelial cells exposed to 
different flow conditions as described in Chapter 4. We initially evaluated the 
expression o f KLF2, a very well known WSS-related transcription factor, deeply 
involved in cell quiescence as described in Chapter 2. Furthermore, since WSS-induced 
cytoskeleton reorganization is involved in cell shape changes, in endothelium barrier 
function as well as in forces transmission necessary to resist to WSS increase after 
fistula creation, we performed a gene array analysis to evaluate the differential 
expression o f more than 80 genes involved in cell motility, induced by the tested flow  
conditions. mRNA o f genes that resulted differentially expressed was further quantified 
by traditional RT-PCR in order to confirm the data o f the assay and to provide the 
statistical significance o f this altered expression.
5.A) KLF-2 mRNA expression.
5.A1) RT-PCR.
Following exposure of the HUVEC to the four WSS waveforms described in 
chapter 2, total RNA was extracted from HUVECs using Trizol reagent 
(LifeTechnologies) according to the manufacturer’s instruction. Contaminating genomic 
DNA was removed by RNase-free DNase (Promega) for lh  at 37°C. Two pg of purified 
RNA was reverse transcribed using a mix of random-examers/oligoT and 200U of 
Superscript II RT (Invitrogen) for lh  at 42°C. No enzyme was added for reverse 
transcriptase-negative controls.
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To amplify cDNA, we used TaqMan Universal PCR Master Mix (Applied 
Biosystems) according to the manufacturer’s instructions and inventoried TaqMan 
assays of Kruppel-like factor2 (KLF2 Hs00360439_gl FAM/MBG probe), and an 
endogenous control (hHPRTl Hs99999909_ml FAM/MBG probe). The PCR was 
performed on a 7300 Real Time PCR System (Applied Biosystems). The amplification 
profile consisted of 2 min at 50°C for and 10 min at 95°C, the samples were cycled 40 
times at 95°C for 15 s and 60°C for 60 s. We used the DDCt technique to calculate 
cDNA content in each sample using the cDNA expression in static control HUVEC as 
calibrator. Each condition was tested five times.
5.A2) Results.
HUVEC exposed to unidirectional PUL A and PUL_V WSS stimulation 
showed an increased expression of KLF2 compared to the static control (figure 59). 
KLF2 mRNA showed a 4.7±2.4 and 3.7±2.2 fold increase in the two conditions 
respectively. It was further observed that both REC_A and REC B WSS waveforms did 
not affect KLF2 expression, resulting in a 1±0.3 and 1.5±0.3 fold increase respectively 
over the level expressed by HUVECs maintained in static conditions.
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Fig.59: KLF2 mRNA expression elicited by different WSS waveforms relative to the static 
control. ** p < 0.01 vs. static, REC_A and REC_B, n=5. This image has been published in 
"Am. J. Physiol. Heart Circ. Physiol. 2015 Oct 23. doi: 10.1152/ajpheart.00098.2015".
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5.B) Rho GTPase effectors mRNA analysis.
5.B1) Gene array.
To study the differentially expressed genes in HUVEC exposed to different 
WSS, the Human Cell Motility RT2 Profiler PCR Array (PAHS-128ZC; SABioscience, 
Qiagen, Frederick, MD, USA) was used. Since PUL_V induced a more elongated and 
organized HUVECs structure, the effect of this stimulus was compared to that induced 
by REC_A and REC_B. Total RNA was extracted using Trizol (LifeTechnologies) and 
was cleaned by RNeasy MinElute Cleanup kit according to the manufacturer’s protocol 
(Qiagen). RNA from three experiments of each group was pooled and quantified 
spectrophotometrically (NanoDrop ND-1000, Thermo Scientific, Wilmington, DE, 
USA). The first-strand cDNA (lpg) was synthesized with RT2 First Strand Kit and was 
analyzed by quantitative Real-Time PCR. Data analysis was performed using the online 
SABioscience software. The boundary (fold regulation cut off) was set to 2-fold change 
between the different groups compared to static control. Those genes that were found to 
have a 2  or more fold increase relative to the static control were considered to be 
positively regulated and those that were found to have a 0.5 or less fold increase relative 
to the static control, negatively regulated.
5.B2) Results.
The PCR array allowed investigation of the expression of 84 genes involved in 
cytoskeletal remodeling and cell movement, which may be modulated by different 
conditions of WSS (tables 5a and 5b). Three different WSS waveforms were considered 
(PUL_V, REC_A and REC B) as well as on HUVEC maintained static as control. 
Among these, 23 genes were identified as regulated by WSS. Some of these genes code 
for proteins that have been related to vascular dysfunction. Another 30 genes were
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identified to be regulated below the 2-fold threshold. It is worthy of note that Rho 
GTPases RhoA and Racl resulted not regulated by the tested conditions. On the 
contrary we observed that other gene expression, deeply involved in IH development 
such as ROCK1, MMP-14 and -9 were downregulated by PUL_V if compared to 
REC_A.TIMP-2 expression was mostly down-regulated by REC_A while VEGFA was 
slightly up-regulated by PUL_V.
In conclusion we found that PUL_V caused the downregulation of mRNA 
expression of genes involved in Rho GTPases downstream pathways and in cell 
motility. On the contrary reciprocating flows and especially REC_A caused a 
generalized upregulation of these genes.
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ACTR2 0.66 1.52 1.41 X X
ACTR3 0.55 1.49 1.41 X X
ARHGDI 1.61 1.84 1.79 X
BAIAP2 3.85 1.71 1.69 X X
CDC42 1.44 3.32 1.31 X X
CFL1 0.84 1.27 1.09 X X
CRK 0.59 1.13 0.69 X
MSN 1.01 2.01 1.65 X
PLCG1 2.97 2.39 1.44 X
LYM 0.41 1.71 0.48 X
MYL9 0.48 0.95 0.56 X
PAK1 0.34 0.76 0.53 X
PLD1 0.24 1.33 1.04 X X X
PRKCA 1.84 1.8 1.74 X
PTEN 0.17 0.50 0.42 X X
PTPN1 0.61 1.52 1.42 X
RAC1 0.83 0.96 0.72 X X
RHOA 0.86 0.84 0.93 X X X
ROCK1 0.75 1.71 0.93 X X X
STAT3 0.96 1.36 1.12 X
VIM 0.44 0.49 0.50 X
WASF1 0.31 0.55 0.42 X X
WASF2 0.67 0.60 0.85 X X X
WASL 0.5 0.58 0.72 X X
ARF6 1.46 1.97 1.38 X
CAPN1 2.16 1.54 0.84 X X
DPP4 1.51 1.38 0.64 X X
Tab.5a: Gene array analysis result. In the table are reported those genes that were expressed by 
HUVECs afetr 48 hours of exposure to different flow conditions. Gees that were downregulated 
beyond the 2-fold threshold as compared to static control are highlighted in green, gene that 
resulted upregulated are highlighted in red. Red boxes indicate those genes that were selected 
for RT-PCR. This table has been published in "Am. J. Physiol. Heart Circ. Physiol. 2015 Oct 
23. doi: 10.1152/ajpheart.00098.2015".
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ENAH 0.59 1.48 0.86 X X
EZR 2.85 2.11 1.69 X X
DIAPH1 1.6 1.73 2.03 X
MYH9 0.77 1.47 1.13 X X X X
MYL10 0.21 0.76 0.45 X X
MMP2 0.66 0.98 0.85 X
MMP14 0.63 1.06 0.62 X X
MSN 1.01 2.01 1.65 X X
PTK2 2.43 1.73 1.3 X X X
PXN 0.72 1.08 0.62 X X
RASA1 0.43 0.78 0.7 X X
RDX 0.59 1.49 1.03 X
TLN1 0.79 1.67 1.16 X X
VCL 0.50 1.16 0.81 X X
VEGFA 1.21 0.82 0.88 X X
WIPF1 1.20 0.65 0.75 X X
TGFB1 0.78 1.45 1.71 X X
CAPN2 1.73 1.47 1.66 X
CAV1 1.04 1.85 1.04 X
CSF1 0.58 0.85 0.56 X
ILK 0.98 1.75 0.91 X X
ITGA4 0.23 1.38 0.83 X X
ITGB1 0.34 1.28 0.66 X X
ITGB3 0.72 1.25 1.04 X X
MET 0.41 2.61 1.47 X
TIMP2 0.71 0.57 0.82 X
Tab.5b: Gene array analysis result. In the table are reported those genes that were expressed by 
HUVECs afetr 48 hours of exposure to different flow conditions. Gees that were downregulated 
beyond the 2-fold threshold as compared to static control are highlighted in green, gene that 
resulted upregulated are highlighted in red. Red boxes indicate those genes that were selected 
for RT-PCR. This table has been published in "Am. J. Physiol. Heart Circ. Physiol. 2015 Oct 
23. doi: 10.1152/ajpheart.00098.2015".
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5.C) Selected genes RT-PCR
5.C1) RT-PCR
Following exposure to flow or static control, total RNA was extracted from 
HUVECs using Trizol reagent (LifeTechnologies) according to the manufacturer’s 
instructions. Contaminating genomic DNA was removed by RNase-free DNase 
(Promega, Milan, Italy) for lh at 37°C. Two jug of purified RNA was reverse 
transcribed using a mix of random-examers/oligoT and 200U of Superscript II RT 
(Invitrogen) for lh  at 42°C. No enzyme was added for reverse transcriptase-negative 
controls. To amplify cDNA, TaqMan Universal PCR Master Mix (Applied Biosystems, 
Monza, Italy) was used according to the manufacturer’s instruction and inventoried 
TaqMan assays of hCDC42 (Hs00918044_gl), hITGA4 (Hs00168433_ml), hPLDl 
(Hs00160118_ml) and hRASAl (Hs00963554_ml) probe and an endogenous control 
(hHPRTl Hs99999909_ml FAM/MBG) probe. The PCR was performed on a 7300 
Real Time PCR System (Applied Biosystems), as previously described (393, 394). 
After initial hold for 2 min at 50°C and for 10 min at 95°C, the samples were cycled 40 
times at 95°C for 15 s and 60°C for 60 s to reach the plateau. The AACt technique was 
used to calculate cDNA content in each sample using the cDNA expression in static 
HUVECs as a calibrator.
5. C2) Results.
Among the four genes that were selected, expression of three of them was found 
to be significantly increased by the REC_A and REC_B WSS waveforms. In particular, 
PLD1 mRNA expression was 0.69±0.32, 1.71±1.16 and 2.17±0.54 in HUVECs exposed 
to PUL_V, REC_A and REC_B respectively compared to HUVEC kept in static 
conditions 1±0.1 (figure 60A). ITGA4 levels were 0.43±0.3, 2.36±0.71 and 1.51±0.48
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in HUVEC exposed to PUL V, REC_A and REC_B respectively compared to the static 
control 1±0.3 (figure 60B). RASA1 mRNA expression levels were 0.66±0.31, 
1.63=1=1.11 and 2.1 ±0.51 in HUVEC exposed to PUL_V, REC_A and REC_B 
respectively as compared to the static control 1±0.31 (figure 61 A). Finally CDC42 
mRNA expression levels were 1.28±0.29, 1.75±0.87 and 0.98±0.14 fold increased in 
HUVEC exposed PUL_V, REC A and REC_B respectively compared to the static 
control 1±0.35. These levels were not statistically different (figure 6 IB).
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Fig.60: A) PLD1 mRNA expression elicited by different culture conditions. § p <0.01 vs. 
REC_B, * p <0.05 vs. PUL V and ** p <0.01 vs. PUL_V. B) ITGA4 mRNA expression
elicited by different culture conditions. ## p <0.01 vs. REC_A, ** p <0.01 vs. PUL V and p 
<0.01 vs. REC A. This image has been published in "Am. J. Physiol. Heart Circ. Physiol. 2015 
Oct 23. doi: 10.1152/ajpheart.00098.2015".
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Fig.61: A) RASA1 mRNA expression elicited by different culture conditions. * p <0.05 vs. 
PUL V and ** p <0.01 vs. PUL V. B) CDC42 mRNA expression elicited by different culture 
conditions. No statistical differences were found. This image has been published in "Am. J. 
Physiol. Heart Circ. Physiol. 2015 Oct 23. doi: 10.1152/ajpheart.00098.2015".
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5.D)Discussion
KLF2 mRNA expression of HUVECs was differently elicited by tested flow 
conditions. As expected (260, 395), both PUL_A and PUL_V waveforms induced 
HUVECs up-regulation of KLF2 mRNA expression after 48 hours of flow exposure 
(figure 59). PUL_A KLF2 levels where even higher despite a reduced spatial 
organization. This up-regulation was significant respect to REC_A, REC_B and static 
conditions that showed similar KLF2 expression. KLF2 has been deeply investigated by 
several authors and its protective function in ECs relies on the anti-inflammatory, 
antithrombotic, antioxidant and anti-fibrotic effects (396) (146) (397).
We further performed the gene assay analysis in order to quantify the mRNA 
expression of genes involved in cytoskeletal remodeling and cell motility that were 
potentially regulated by different WSS waveforms (tables 5a and 5b). Rho GTPases 
(RhoA, Racl) mRNA resulted not differentially expressed by HUVECs exposed to 48 
hours of different stimuli. The downregulation of these proteins, after the initial 
transitional activation, is consistent with previous studies and may indicate that the 
long-term effect of WSS-induced cytoskeletal conformation could rely others signals 
(398).
Despite no statistical significance can be derived from this evaluation, it 
provides much information in a time/cost effective manner. To further verify these 
results and to provide the statistical significance, we quantified the selected genes with 
traditional RT-PCR. With this aim we further selected 4 genes involved in cell motility 
and differentially expressed by HUVECs exposed to different stimuli. We verified that 
PLD1, RASA1 (coding for p i20 RasGAP), ITGA4 but not CDC42 levels were 
statistically increased after 48 hours of exposure to REC_A and REC_B stimuli (figures 
60 and 61). This up regulation has potential detrimental effects on ECs.
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PLD1 gene codes for phospholipase D l, an enzyme known to mediate 
phosphatidylcholine (PC) to the second messenger signalling lipid phosphatidic acid 
(PA) (399). The physiological significance of PLD activation is not well understood, 
but, as shown in figure 62, it has been implicated in mitogenesis, cytoskeletal 
reorganization, chemotaxis, protein trafficking and secretion (462). Despite some 
controversies linked to the strategy used to block PLD activity, a differential role has 
emerged for PLD1 and PLD2 the two most common mammalian isoforms of PLD 
(400). PLD2 shows a higher activity and it localized at the cell membrane while PLD1 
has a lower activity and is generally localized to intracellular compartments (401). 
PLD1 however can be activated depending on the several stimuli and participates in 
vWF secretion (402). vWF is a potent pro-coagulant agent and an inducer of SMCs 
non-canonical activities (403).
ITGA4 gene codes for integrin a4 or CD49d, a protein that, together with 
integrin pi forms the Integrin alpha4betal (Very Late Antigen-4, VLA4) dimer (404). 
VLA4 is expressed in monocytes and causes adhesion to adhesive molecule VC AM 
expressed by the endothelium promoting monocyte arrest and transendothelial 
migration. CD49d however can be expressed also in ECs. Localization of CD49d 
phosphorylation inhibits the assembly of CD49d-paxillin-Arf-GAP complex at the 
driving edge of migrating cells imposing a spatial restriction on Rac activation and 
leading to an adhesion-dependent activation of Rac. As shown in Figure 63, a previous 
study showed that localized phosphorylation of CD49d control WSS-induced EC 
alignment (405). Within 5 minutes of exposure to physiological level of WSS a PKA- 
dependant phosphorylation of CD49d in the downstream edge of microvascular EC 
promotes localized activation of Racl and cytoskeletal alignment and cell elongation. 
According to the authors CD49d informs the cell about the direction of the flow (406).
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We observed no alignment or elongation in EC exposed to both REC_A and R E C B  
WSS profiles and that elongated EC exposed to PUL_V have significant lower level of 
ITGA m-RNA. The upregulation of this gene could be related to a continuous attempt 
of the cell to establish a preferential direction for elongation and alignment that is 
prevented by reciprocating flows.
RASA1 is the gene coding for Ras GTPase activating protein 1 (pl20-RasGAP). 
This protein is traditionally considered protective for endothelium since it showed to 
inhibit Ras activity by hydrolysis of GTP to GDP, and to couple with pl90-RhoGAP to 
form an integrin-activated membrane bound complex that can block Rho activity 
(Figure 64) (314). These two functions seem to be opposed to detrimental effects 
induced by oscillating WSS in EC. However, since persistent RASA1 upregulation was 
not elicited by PUL_V, we hypothesis that ECs up-regulate this gene to limit RhoA 
activity despite a lack in cytoskeletal reorganization and cell elongation. A possible 
upstream event that can cause EC RASA1 regulation is MET signalling. MET 
alternatively induces both activation and quiescence in EC. Physically associate 
amplifier and co-receptor such as GRB2-associated-binding protein 1 (GAB1) can 
modulate MET signalling strength, duration and versatility (407). GAB1 deactivation 
involves the tyrosine phosphatase SHP2, which dephosphorylates the pl20-RasGAP 
binding site on GAB1 and prevents the recruitment of p i20 RasGAP (Figure 64). 
Interestingly we found that MET was upregulated by REC_A and REC_B. Finally, 
miRNA-221/222 and miRNA-132 have been shown to be shear stress sensitive and to 
limit RASA1 and pl20-RasGAP function respectively (463-466). To our knowledge, 
no previous data are available on the WSS-induced modulation of RASA1 expression. 
Further studies on the spatial and temporal regulation of flow-induced RASA1 and p i20
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RasGAP regulation are required to elucidate the role of this protein in EC WSS 
transduction.
In conclusion we verified that reciprocating flows elicited a sustained expression 
of genes involved in cytoskeleton remodeling and cell motility as compared to that 
caused by PUL_V. This up-regulation together with the not upregulated KLF2 
expression indicate that cells exposed to reciprocating flows fails to functionally 
stabilize the morphology. The lack of stabilization may cause an altered endothelial 
permeability and reendothelization after AVF creation, leading to IH development.
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Fig. 62: Possible mechanism of flow-induced IH development induced by PLDl upregulation. 
Abbreviations: ROS reactive oxygen species, GTPase guanosine triphosphate hydrolase 
enzyme, PLDl phospholipase Dl, PC phosphatidylcoline, PA phosphatidic acid, vWf von 
Willebrand factor, MAPK mitogen activated protein kinase, VCAM vascular cell adhesion 
molecule, ECs endothelial cells, SMCs smooth muscle cells and IH intimal hyperplasia (399, 
402,461,462).
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Fig. 63: Possible mechanism of flow-induced IH development induced by ITGA4 upregulation. 
Abbreviations: WSS wall shear stress, ITGA4 Integrin-alpha 4, ITGB1 Integrin-beta 1, EC 
endothelial cell and VLA-4 very late antigen 4 (404-406).
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Fig. 64: The possible roles of Oscillating WSS in RASA1 pathway. Abbreviations: ROS 
reactive oxygen species, CDC42cell division control protein 42, RASA1 gene coding for 
RasGAP Ras GTPase activating protein, RhoGAP Rho GTPase activating protein, Rho A Ras 
homolog A, ECs endothelial cells, WSS wall shear stress, MET hepatocyte growth factor 
receptor, PI3K phosphatidylinositol-3-kinase, Rac Ras-related C3 substrate, ERK extracellular- 
signal-regulated-kinase, MAPK mitogen activated protein kinase, JNK JUN n-terminal kinase 
and mRNA micro-RNA (314, 407, 463-466).
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5.E)Summary
Differential gene expression elicited by different WSS waveforms in HUVECs 
after 48 hours of exposure was quantified. The results showed that PUL_V and PUL A 
elicited an upregulation of the protective gene KLF2. On the contrary reciprocating 
flows and especially REC_A did not affect KLF2 expression as compared to static 
conditions but caused an upregulation of mRNA expression of genes involved in 
cytoskeletal remodeling and cell motility. In addition, Rho GTPases (RhoA, Racl and 
CDC42) ECs expression resulted not affected by WSS after 48 hours of exposure. This 
further confirms that WSS onset induced a transient activation of these proteins. All 
these evidences indicate that reciprocating flows-induced morphological adaptations are 
not functional to ECs quiescence and that this sustained cell activation may be involved 
in vascular dysfunctions. A consequence of this different activation state induced by 
WSS may be an alteration of ECs paracrine signalling. Thus the production of cytokines 
known to be involved in the proliferative phase of IH, has been quantified. Methods and 
results are addressed in the next Chapter.
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CHAPTER 6: Quantification of cytokine release in response 
to AVF-specific WSS waveforms
This Chapter addresses the production o f cytokines involved in intimal hyperplasia 
development caused by different wall shear stress waveforms. As reported in Chapter 2, 
IL-6, IL-8 and MCP-1 showed to be involved in arteriovenous fistula stenosis possibly 
due their pro-inflammatory and chemoattractant properties. Here it is reported the 
average production o f these cytokines and the production time course o f those 
differently induced by the tested conditions.
6.A) Cytokines production elicited by WSS
6.A1) Milliplex assay
The production of MCP-1, IL-8 , 11-6, IL-10 and IL-ip was compared between 
HUVECs exposed to flow or in a static control group by measuring concentration in 
samples of conditioned medium using a Milliplex Map Human kit (Millipore, Billerica, 
MA, USA), according to the manufacturer’s instructions. Briefly, test samples were 
incubated with beads coated with specific antibodies overnight at 4°C, and with a 
biotinylated detection antibody for one hour at room temperature. The resulting mixture 
was finally incubated with a streptavidin phycoerythrin solution for 30 minutes at room 
temperature. A Bio-Plex 200 plate reader (Bio-Rad, Milan, Italy) was used to detect the 
fluorescence signal. All specimens were tested in duplicate to assess inter-assay 
variability. Cytokine concentration in the multiplex assay was calculated from 
calibration curves using recombinant protein as a reference and expressed as 
ng/h/106cells. Each condition was tested five times.
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6.A2) ELISA
ELISA to evaluate MCP-1 and IL- 8  produced by HUVEC was performed to 
investigate the time course of cytokine production in cells exposed to PUL_V, REC_A 
and REC_B or kept in static condition, during Ti (0-12 hrs), T2 (12-24 hrs), T3 (24-36 
hrs) and T4 (36-48 hrs) periods of flow exposure. MCP-1 concentration was determined 
using a commercially available kit (Booster Technology Ltd, Fremont, CA, USA) 
according to manufacturer's instructions. IL- 8  concentration was determined using a 
specific kit (Thermo Scientific) according to manufacturer's instructions. Infinite m200- 
pro (Tecan Group Ltd, Mannedorf, Switzerland) was used to measure absorbance. All 
specimens were tested in duplicate to assess inter-assay variability. Cytokine 
concentrations in the multiplex assay were calculated from calibration curves using 
recombinant protein as a standard and expressed as ng/h/106cells. Each condition was 
tested five times.
6.A3) Results
The Milliplex assay results showed differential production of MCP-1 and IL- 8  
cytokines induced by different flow conditions (as shown in figure 65). In particular, 
MCP-1 production was 2.25±1.75, 2.49±1.14, 2.3±1.21, 3.37±1.6 and 4.72±1.88 
ng/h/106cells under static conditions or by PUL A, PUL_V, REC_A and REC B WSS 
waveforms respectively. MCP-1 production elicited by REC_A was higher compared to 
PUL_A and PUL V stimuli while production elicited by REC_B was statistically 
higher than PUL_A, PUL_V and static stimuli (figure 65 A).
IL- 8  production was 0.51±0.13, 0.73±0.49, 0.68±0.44, 1.26±0.76 and 1.31±0.7 
ng/h/ 106cells under static conditions or by PUL_A, PUL_V, REC_A and REC_B WSS
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waveforms, respectively. Both REC_A and REC_B waveforms induced a statistically 
significant increase in IL- 8  production (figure 65B).
IL- 6  production was 0.09±0.03, 0.08±0.05, 0.1±0.03, 0.1±0.04 and 0.12±0.04 
ng/h/ 106cells under static conditions or by PUL_A, PUL_V, REC_A and REC_B WSS 
waveforms, respectively (figure 65C). None of the different conditions induced 
statistically significant differences in IL- 6  production. Finally, production of IL-10 and 
IL-lp was undetectable in the medium for all conditions.
ELISA was performed on medium conditioned during the flow exposure 
experiments to evaluate the time course of cytokine production. Experiments included 
three different conditions (PUL V, REC_A and REC_B) as well as a static control. The 
results showed a time-dependent production of both MCP-1 and IL-8 .
HUVECs MCP-1 production (figure 6 6 ) elicited by the PUL_V WSS stimulus 
(0.87±0.61, 1.16±0.6, 1.26±0.63 ng/h/106 cells during Ti, T2 and T4 periods 
respectively) or under static conditions (0.83±0.61, 1.08±0.35, 2.44±0.94 ng/h/106 cells) 
was lower than those elicited by both REC_A (2.80±1.71, 2.30±0.6, 2.82±1.03 ng/h/106 
cells) and REC_B (4.99±1.65, 3.07±2.74, 3.71±1.74 ng/h/106 cells) waveforms (figures 
6 6 A and B). MCP_1 production elicited by reciprocating WSS was higher compared to 
that induced by PUL V. In particular the initial (Ti) increase elicited by the REC_B 
WSS waveform was statistically significant compared to that elicited by the PUL_V 
waveform or static conditions (REC_B vs. PUL_V and Static, p<0.01, n=5). It is of 
interest that MCP-1 production elicited under static culture conditions showed a 
tendency to increase at T4 .
HUVECs IL- 8  production (figure 67) elicited by the PUL_V WSS stimulus 
(0.91±0.39, 1.2±0.66, 0.8±0.4, 0.63±0.31 ng/h/106 cells during Ti, T2 , T3 and T4 periods 
respectively) or under static conditions (0.67±0.26, 0.7±0.27, 0.92±0.47, 0.72±0.3
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ng/h/106 cells) was lower than hat elicited by both REC_A (1.1±0.6, 1.61±0.95, 
1.75±0.68, 1.88±1.17 ng/h/106 cells) and REC_B (1.45±0.79, 1.53±0.92, 1.78±0.6, 
1.68±0.9 ng/h/10 cells) waveforms (figures 67A and B). In particular after an initial 
increase elicited by all WSS stimuli compared to the static control, R E C A  and REC_B 
sustained long-term HUVEC IL- 8  production compared to that measured in medium 
conditioned by HUVEC exposed to PUL_V waveform or maintained in static condition. 
The increase became statistically significant in medium collected during the T4 period 
of flow exposure (REC_A and REC B vs. PUL V or Static, p<0.01 and p<0.05 
respectively, n=5).
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Fig.65: A) MCP-1 production induced by different culture conditions. ** p <0.01 vs. static, 
PUL A and PUL_B. B) IL-8 production induced by different culture conditions. ** p <0.01 vs.
REC A and REC B, # p <0.05 vs. PUL V and * p <0.05 vs. PUL A and PUL V. C) IL-6
production induced by different culture conditions.
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Fig.66: A, B) Time course of MCP-1 production during T\, T2 and T4 periods of HUVECs flow 
exposure. ** p <0.01 vs. static and PUL_V. This image has been partially published in "Am. J. 
Physiol. Heart Circ. Physiol. 2015 Oct 23. doi: 10.1152/ajpheart.00098.2015".
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6.B) Discussion
Cytokines are deeply involved in vascular remodeling and inflammation. In 
particular we focused on cytokines known to be involved in vascular dysfunctions such 
as IL-6 , IL-8 , MCP-1, IL-ip and IL10.
Previous studies showed that IL-6 , IL- 8  and MCP-1 are produced during the 
proliferative phase of IH development (156). IL- 6  is a pro-inflammatory cytokine that 
induce other inflammatory cytokines and matrix metalloproteinases. Studies focused on 
the atherosclerosis development have shown that IL- 6  promotes endothelial 
dysfunction, the proliferation and migration of SMCs, the recruitment of inflammatory 
cells and the atherosclerotic plaques destabilization (408, 409).
MCP-1 and IL- 8  exert their pro-inflammatory functions mainly by inducing 
monocytes adhesion to the endothelium and by promoting the transmigration of immune 
cells underneath the endothelium into the intima (142, 410).
Furthermore IL-lp is a potent vascular pro-inflammatory signals induced by 
infection, trauma or immunological challenge. The downstream effects of this protein 
include the modulation of endothelial inflammatory response (411,412).
IL-10 is an anti-inflammatory cytokine and it is considered vasculo-protective 
since it attenuates vessel superoxide levels during inflammation and attenuates 
expression and/or production of pro-inflammatory cytokines, which impair endothelial 
functions (413,414).
In line with previous studies (260, 415), we found that WSS elicited an increased 
production of IL- 8  and MCP-1 in a time dependant manner (figure 6 6  and 67). In 
particular MCP-1 levels resulted higher in culture medium conditioned by HUVECs 
exposed to reciprocating WSS. Both REC_A and REC_B caused an increased 
production of MCP-1 during the first 12 hours of exposure that resulted statistical
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significant for REC_B. After this initial increase, MCP-1 levels return to values similar 
to those observed in medium conditioned by HUVECs exposed to PUL_V or 
maintained static. Furthermore, MCP-1 concentrations measured in medium derived 
from the last period, from 36 to 48 hours of flow exposure, showed a increasing 
tendency in medium derived from reciprocating flow exposure experiments as 
compared to that derived from PUL_V experiments, that again resulted significant for 
REC_B condition. It is worth to note that also HUVECs maintained in static conditions, 
displayed increased levels of MCP-1 respect to those measured in previous periods of 
flow exposure.
IL- 8  showed a time course production very similar to that reported by Dai and 
colleagues, who investigated the effects of realistic WSS waveforms derived by carotid 
bifurcation areas differentially exposed to atherosclerosis. In particular all WSS 
waveforms onset caused the upregulation of IL- 8  levels into culture medium. However, 
PUL V elicited IL- 8  production decreased in the last 24 hours of flow exposure, on the 
contrary, reciprocating flows sustained the increased production that was found even 
higher in the last 48 hours of HUVECs flow exposure. Finally IL- 8  levels were 
statistically higher in the 36-48 hours period of the experiment.
Finally we found that IL- 6  produced by HUVECs exposed to different culture 
conditions was similar and that neither IL-ip nor IL-10 was detectable in conditioned 
mediums. These results are probably caused by the limitations of our system, thus the 
lack of leukocytes and the absence of surrounding tissues, since in-vivo studies showed 
that these cytokines do participate to WSS- induced vessel remodeling and intimal 
thickening (408, 409, 416).
In conclusion our results clearly demonstrate that reciprocating flows sustained 
the ECs pro-inflammatory signals involved in IH development.
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6.C) Summary
As reported in Chapter 2, ECs produce a plethora of signals that modulate 
inflammation and vascular tone after AVF creation. Based on these evidences we 
wondered if WSS, calculated in areas of AVF differentially exposed to IH development, 
diversely modulate ECs IL-1 (3, IL-6 , IL-8 , IL-10 and MCP-1 productions into the 
culture medium. Our results have shown that reciprocating flows elicited an increased 
production of IL- 8  and MCP-1. IL- 6  resulted not affected by different WSS stimuli and 
IL-1 (3 and IL-10 production resulted below detection level in any conditions.
IL- 8  and MCP-1 production time course showed that WSS onset induced an 
increase of these cytokines production that resulted higher in ECs exposed to 
reciprocating flows, as compared to static control. Furthermore reciprocating WSS 
sustained this higher cytokines production while pulsatile WSS-induced cytokine 
production is only transiently increased and returns to basal levels within 48 hours.
Beyond the chemoattractant functions, IL- 8  and MCP-1 may be involved in the 
ECs paracrine proliferative signalling. To evaluate this aspect we cultured human 
smooth muscle cells with medium conditioned by HUVECs during flow exposure 
experiments as described in Chapter 4. The methods and results are reported in Chapter
7.
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CHAPTER 7: Quantification of smooth muscle cell 
proliferation induced by HUVECs exposed to WSS stimuli.
In the previous Chapter it has been shown that reciprocating WSS stimuli caused an 
increased production o f pro-inflammatory cytokines known to be involved in intimal 
hyperplasia development. Beyond the proinflammatory effects o f these cytokines, they 
may also be involved in cell proliferation. In this Chapter the potential WSS-induced 
proliferative paracrine effect o f ECs was evaluated by incubating human aortic smooth 
muscle cells with medium conditioned by HUVECs exposed to different flow  waveforms 
as described in Chapter 4.
7.A) Smooth muscle cell proliferation
7.A1) Cell proliferation assay.
Human aortic smooth muscle cells (HAOSMCs, Cell Applications Inc. San 
Diego, CA) were grown in culture flasks in smooth muscle cell growth medium 
specifically designed by the manufacturer (Cell Applications) to promote attachment, 
spreading and proliferation. The cells were incubated at 37°C in a humidified 5% CO2 
atmosphere. HAOSMC were subcultured when the cells reached approximately 80% 
confluence. Cells at the fifth passage were used for proliferation experiments. Cell 
proliferation was measured by a 3-(4,5-dimethylthiazol-2-yl)-5-(3- 
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. HAOSMC 
were seeded at a density of 8xl03 cells/well on 96-well plates. The cells were incubated 
for 24h with 100 pi of Ti (0 - 1 2  hrs), T2 (12-24 hrs), T3 (24-36 hrs) and T4 (36-48 hrs) 
conditioned medium collected from experiments of HUVEC exposure to PUL_V, 
REC_A and REC_B WSS waveforms as well as from HUVEC kept as static control. 
After incubation, 20 pi of MTS (1.9 mg/ml, Promega Italia S.r.l, Milano, Italy) were 
added into each well and incubated for 90 minutes at 37°C. HUVEC testing medium,
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HAOSMC growth medium and HAOSMC basal medium were used as controls. Four 
wells per treatment were used for the assay. The plate was read spectrophotometrically 
by measuring the absorbance of the dye at a wavelength of 490 nm using Infinite m200- 
pro (Tecan Group Ltd, Mannedorf, Switzerland). Spectrophotometric readings were 
normalized using HAOSMC cell-free media as a blank. Results were normalized with 
respect to absorbance of cells exposed to the medium from HUVEC static control and 
expressed in arbitrary units. Each condition was tested three times.
7.A2) Results
The MTS assay showed that medium conditioned after Ti, T2 , T3 and T4 periods 
of HUVECs maintained under static conditions induced no significant differences in 
proliferation of HAOSMCs after 24 hours of incubation (figure 6 8 ). HAOSMC 
proliferation induced by medium collected following PUL V stimulation of HUVECs 
was significantly higher for the Ti and T2 periods compared to the T3 (p <0.01 vs. Ti and 
p<0.05 V S . T 2 , n=3) and T 4  (p <0.01 vs. Ti and T2) periods of flow exposure. Medium 
conditioned by HUVECs exposed to the REC_A waveform showed a statistically 
significant increase in HAOSMC proliferation at T2 (p <0.01 vs. all). Medium derived 
following the T2 period of HUVEC exposure to the REC B waveform resulted in 
proliferation that was higher but not statistically significant (figure 6 8 ).
Comparing proliferation induced by medium collected following the same 
period of exposure to different waveforms (figure 69) verified that the proliferation of 
HAOSMCs incubated with medium collected following the Ti period of flow exposure 
was statistically lower only for SMCs exposed to medium derived from REC_A 
experiments compared to the static control. Medium collected following the T2 period 
of REC_A and REC_B flows exposure and of static control, induced a significant
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increase in SMC proliferation compared to PUL_V condition (p <0.01 REC_A and 
REC_B vs. PUL_V, and p<0.05 static vs. PUL V). T3 medium elicited proliferation is 
statistically lower in those conditioned by HUVECs exposed to PUL_V and REC_A 
conditions as compared to static control (p <0.01 PUL_V vs. static, p <0.05 REC_A vs. 
static). T4 medium derived from REC_A and REC B flow experiments and from static 
control, elicited much proliferation similar to that observed following exposure for 
period T2 (p<0.01 REC A and REC_B vs. PUL_V, and p<0.01 REC_A and PUL_V vs. 
static). Finally, the controls showed strong effects of medium serum content on SMC 
proliferation. HAOSMC medium without serum elicited decreased proliferation 
compared to other controls (p <0 . 0 1  vs. all).
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Fig.68: Comparison of HAOSMC proliferation elicited by medium conditioned by HUVEC 
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Fig.69: Comparison of HAOSMC proliferation elicited by medium conditioned by HUVEC 
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7.B) Discussion
Several studies have shown that ECs convert hemodynamic stimuli into 
biochemical signals that modulate vascular cell components functions (275, 417-419). 
After AVF creation, ECs synthesize and secrete many molecules that control 
proliferation, migration, phenotypic transformation and apoptosis of SMCs and 
fibroblasts that participate in wall remodeling in order to re-establish tissue integrity and 
physiological mechanical stress. In particular reciprocating or disturbed WSS has been 
shown to induce ECs to produce signals such as MCP-1, that have been related to SMC 
proliferation (420).
This chapter investigated the potential proliferative paracrine effects of ECs 
exposed to different WSS waveforms using an experimental set-up that is much more 
idealized than in-vivo (421, 422) or coculture models (423-425). However, despite the 
simplicity of the system, the results show that medium conditioned by HUVECs 
exposed to different flows has different effects on SMC proliferation. As expected 
(Figure 6 8 ), medium derived from the T3 and T4 periods of PUL_V experiments, 
elicited a lower SMCs proliferation compared to the previous periods. On the contrary, 
reciprocating WSS derived mediums elicited a different trend in SMCs proliferation 
respect to that induced by PUL_V derived mediums. SMCs proliferation induced by 
incubation with mediums collected following T3 and T4 periods of HUVEC exposure to 
reciprocating flows remained similar to that induced by medium collected following Ti 
period. Interestingly, medium collected during the T2 period of REC_A and REC B 
flow exposure had an increased effect on proliferation that was statistically significant 
in SMCs incubated with medium derived from REC_A T2 period (Figure 6 8 ).
By comparing the effects of medium collected during the same time periods for 
different experiments (Figure 69), the proliferation of SMCs incubated with REC_A
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and REC_B medium collected during T2 and T4 periods, was significantly higher than 
proliferation elicited by medium conditioned during PUL_V flow exposure. 
Furthermore, medium conditioned by HUVECs maintained in static conditions and 
collected after the different periods, induced similar levels of SMC proliferation. It 
should be noted that, despite the lower content of MCP-1, the medium derived from T3 
and T4 periods of static HUVEC cultures showed a higher proliferative potential 
compared to medium derived from flow exposure experiments and collected following 
the same periods (Figure 69). Finally, the increase in SMC proliferation induced by 
medium collected after static cultures, resulted statistically higher as compared to T2 , T3 
and T4 periods of PUL V flow exposure (Figure 69).
These results are in line with previous studies but are only partially consistent 
with the observed concentration of MCP-1, shown in Chapter 6 . This indicates that the 
WSS waveforms modulated other proliferative molecules beyond MCP-1. Further 
studies are required to evaluate the production of other molecules, potentially induced 
by WSS and involved in SMC proliferation, such as platelet-derived growth factors, 
insulin growth factor and transforming growth factor.
In conclusion, despite the experimental conditions of SMCs culture are very 
different from the physiological environment, it was found that reciprocating flows 
induced HUVECs to produce paracrine signals that elicited a limited but statistically 
significant higher proliferation rate in SMCs.
7.C) Summary
In this chapter it has been shown that reciprocating flows elicited HUVEC 
production of paracrine signals that caused SMCs to proliferate more than their 
counterparts incubated with medium conditioned during PUL_V exposure. The increase
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in proliferation resulted in a limited but statistically significant change for medium 
collected at the end of T2 and T4 periods of flow exposure. Furthermore, HUVECs 
maintained in static conditions showed even higher proliferative paracrine signal 
production that should be further investigated. This evidence further confirms the role 
of reciprocating WSS in inducing vascular cell proliferation and thus intimal 
hyperplasia.
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CHAPTER 8: CK la and CCR2 expression following 
exposure to AVF-specific WSS waveforms
Several pathways have been related to intimal hyperplasia development but their 
possible WSS-induced modulation has not been investigated. Casein kinase alpha-LS 
has been shown to participate in vascular cell proliferation by inducing the hydrogen 
peroxide mitogenic pathway. Furthermore, despite the fact that the MCP-1/CCR2 axis 
is central to inflammation and monocyte recruitment, adhesion and transmigration at 
endothelial level, the possible endothelial autocrine role o f CCR2 and its relationship 
with WSS remain largely unknown. This Chapter addresses this by focussing on the 
possible differential induction o f the casein kinase alpha family and CCR2 mRNA 
expression induced by different WSS waveforms in HUVECs, as described in Chapter 4.
8.A) C K la  and CCR2 mRNA expression
8.A1) HUVEC flow exvosure and II-IB stimulation.
HUVEC were seeded as described in paragraph 4.C1 and exposed to different 
WSS stimuli as described in 4.E1 paragraph. A single HUVEC culture was also 
incubated with EM added with 20ng/mL IL-ip (Sigma). This culture was maintained in 
static conditions and medium was replaced every 12 hours.
8.A2) RT-PCR.
Total RNA was extracted from HUVEC using Trizol reagent (LifeTechnologies) 
according to the manufacturer’s instructions. Contaminating genomic DNA was 
removed by RNase-free DNase (Promega) for lh at 37°C. Two jug of purified RNA was 
reverse transcribed using a mix of random-examers/oligoT and 200U of Superscript II 
RT (Invitrogen) for lh at 42°C. No enzyme was added for reverse transcriptase-negative 
controls.
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The TaqMan Universal PCR Master Mix (Applied Biosystems) was used to 
amplify cDNA according to the manufacturer’s instruction and inventoried TaqMan 
assays of Casein Kinasel alphal (CSNK1A1 Hs00793391_ml) C-C chemokine 
receptor type 2 (CCR2 Hs00356601_ml), and a endogenous control (hHPRTl 
Hs99999909_ml FAM/MBG probe). The PCR was performed on a 7300 Real Time 
PCR System (Applied Biosystems). The amplification profile consisted of 2 min at 
50°C for and 10 min at 95°C, the samples were cycled 40 times at 95°C for 15 s and 
60°C for 60 s. The AACt technique was used to calculate cDNA content in each sample 
using the cDNA expression of control HUVECs as calibrator. Each condition was tested 
5 times with the exception of CCR2 expression by HUVEC incubated with II-1(3 that 
was tested once.
8.A3) Results.
RT-PCR data showed that CK l-a was not up-regulated by reciprocating WSS. 
Surprisingly only PUL A induced a significant up-regulation with respect to other 
conditions (figure 70A, ** p <0.01 vs. static, PUL_V and REC_A).
CCR2 mRNA levels were at the lower limit of detectability with no differential 
expression in HUVECs exposed to different flow conditions or maintained static (figure 
70B). Adding IL-lp to culture medium was also shown to increase the level of HUVEC 
CCR2. However, this test was performed only once and thus no statistical analysis data 
are available.
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Fig.70: A) CK la mRNA expression elicited by different flow conditions, ** p <0.01 vs. static, 
PUL_V and REC_A. B) CCR2 mRNA expression elicited by different flow conditions or by 
incubation with 20 ng/mL of IL-1 j3 .
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8.B) CCR2 visualization and quantification
8.B1) IL-13 incubation and flow exposure experiments
HUVECs were seeded as described in paragraph 4.C1. In the first experiment 
two HUVECs cultures were incubated in EM with or without addition of 20ng/mL of 
IL-lp (Sigma). This culture was maintained under static conditions and medium was 
replaced every 12 hours.
A second experiment incubated two samples of HUVECs with 20ng/ml of IL- 
1 p, one was kept under static conditions, the other was exposed to the REC_B WSS 
waveform as described in paragraph 4.E1. A third cell culture was maintained under 
static conditions and no IL-lp was added. Culture medium was replaced every 12 hours.
A third experiment reduced the time of HUVEC incubation with IL-ip and the 
time of flow exposure. Three cell culture monolayers were seeded. One culture was 
maintained under static conditions without the addition of IL-ip and used as negative 
control, the second was maintained static but culture medium was added with 20ng/mL 
of IL-lp and the third was incubated with 20ng/mL of IL-lp and exposed to the REC_B 
waveform as described in paragraph 4.E1. Culture medium of all cultures was replaced 
after 8 hours with EM without IL-ip. The experiment was ended after 24 hours. 
Contrast phase microscopy images were taken at the beginning and at the end of the 
experiment.
8.B2) Immunofluorescence stainins
At the end the experiment the cell monolayer was fixed in 2% paraformaldehyde 
(Societa Italiana Chimici) in 4% sucrose (Sigma) solution, for 10 minutes at room 
temperature. Cells were then permeabilized in 0.1% triton X-100 (Fluka) for 3 minutes 
and incubated in 3% BSA (Sigma) for 30 minutes at room temperature. HUVEC were 
incubated with goat anti-human CCR2 FITC (1:50 in 3% solution of BSA) overnight at
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4°C. Counterstaining with DAPI (1 mg/ml, Sigma) for 20 minutes at 37°C was 
performed for cell nuclear staining. The slides were finally mounted with a fluorescent 
mounting medium (Dako Cytomation) and examined by ApoTome microscopy (Axio 
Imager.Z2, Carl Zeiss).
8.B3) CCR2 positive  cells FACS analysis
Cells were detached from the culture plate by 3 minutes incubation with trypsin 
(EDTA trypsin 0.05%, Sigma) at 37°C and washed twice. Cells were then fixed with 
2% solution of paraformaldehyde (Societa Italiana Chimici, Rome, Italy) at 4°C. Cells 
were then permeabilized in 0.1% triton X-100 (Fluka) for 3 minutes and incubated in 
0.5% BSA (Sigma) for 10 minutes at 4°C. Cell were washed twice with PBS buffer 
solution. Samples were incubated with FITC rabbit anti-human CCR2 (1:50, Santa Cruz 
Biotechnology, Inc, Dallas, TX, USA) for 30 minutes at 4°C. The sample was then 
suspended in 500 pL of PBS solution and analyzed with FACSCanto II system (BD 
Biosciences).
8.B4) Results.
In the first experiment we verified that high dose IL-lp induced an increased 
number of HUVECs positive for CCR2 (figure 71) compared to those not incubated 
with the cytokine (66% vs. 52%, figure 72). Furthermore, the presence of the stimulus 
induced also changed the HUVECs shape, which appears more elongated after 24 and 
48 hours of stimulation (figure 73).
The presence of IL-lp affects also the HUVECs adhesion to the plate. In the 
REC_B flow exposure experiment, the repeated addition of the stimulus induced 
significant cell detachment at 24 hours with complete detachment after 48 hours (figure 
74).
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To overcome this problem the time of incubation of HUVECs with IL-lp was 
reduced to 8 hours (figure 75). This ensures the permanence of cells over the plate. 
After 24 hours of exposure to the REC_B WSS waveform the number of cells positive 
for CCR2 was the same as the static control (29.8% vs. 29.4%) and only slightly 
increased with respect to the negative control (20.6%) (figure 76). Interestingly, the 
intensity of the mean fluorescence was higher in the positive control respect to other 
conditions.
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Fig.71: A) Contrast phase microscopy images of HUVECs treated with or without 20 ng/mL of 
IL-ip for 48 hours. Magnification 20x, scale bar 10pm. B) Immunofluorescence images of 
HUVECS treated with or without 20 ng/mL of IL-1(3 for 48 hours. HUVECs were stained for 
CCR2 (green) and nuclei (blue). Magnification 20x, scale bar 10pm.
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Fig.72: FACS analysis of CCR2 positive HUVECs. A) Basal level of CCR2 positive cells. B) 
Positive cells after treatment with 20 ng/mL of IL-1J3 for 48 hours.
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Fig.73: Contrast phase microscopy images of HUVECs treated with or without 20 ng/mL of IL- 
lp at 0, 24 and 48 hours of incubation. Magnification lOx, scale bar 20pm.
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Fig.74: Experimental design and contrast phase microscopy images of HUVECs treated with or 
without 20 ng/mL of IL-1(3 and exposed to REC B WSS profiles or maintained static for 48 
hours.
188
Marco Franzoni 2015 Chapter 8
24 h Medium change 
Static -i------------------ 1--------------------------------------- 0 ng/mLi i  i
Static |  j--------------------------------------- 20 ng/mL
REC B--------\---------  |--------------------------------------- 20nR/mL
I i
Oh 24 h 24h
Fig.75: Experimental design and contrast phase microscopy images of HUVECs treated with or 
without 20 ng/mL of IL-1(3 for 8 hours and exposed to REC B WSS profiles or maintained 
static for 24 hours.
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Fig.76: FACS analysis of CCR2 positive HUVECs. A) Basal level of CCR2 positive cells after 
24 hours. B) Positive cells after treatment with medium added 20 ng/mL of IL-ip for 8 hours 
then incubated with medium not added with IL-ip. C) Positive cells exposed to 24 hours of 
REC B WSS, cells were treated with 20 ng/mL of IL-lp for 8 hours, and then medium was 
replaced with medium not added with IL-ip.
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8.C) Discussion
Despite their role in IH development (114,426), these results confirm that neither 
CK la nor CCR2 mRNA levels were upregulated by reciprocating WSS (figure 70). The 
CK1 family is involved in numerous ECs stress-activated pathways. CKlaLS 
phosphorylation may promote E^Ch-stimulated cell growth (113, 427). However 
cytosolic forms of CK la (CKla and CKlaS) play important roles in the inhibition of 
key proliferative signalling (428). Future studies could reveal a role for WSS in 
modulating CK la isoforms (429, 430).
CCR2 is mostly investigated for its role as a MCP-1 receptor in monocytes
(431). Its potential role in the EC autocrine pathway is generally addressed in cancer
(432). ECs produce low levels of CCR2 mRNA that can be increased by incubation 
with IL-lp (433). The treatment however had dramatic effects on HUVECs resistance to 
WSS. To solve this issue we implemented a new protocol that successfully combined 
the effects of chemical and mechanical stimuli.
8.D) Summary
To assess the influence of different WSS waveforms in inducing C K la  and 
CCR2 in HUVECs, the mRNA expression of genes coding for these proteins was 
evaluated after 48 hours of exposure to different flow conditions as reported in Chapter 
4. The results confirm that mRNA levels were not affected by different culture 
conditions compared to the static control. In particular CCR2 basal levels were very low 
and almost undetectable, in line with the literature. Furthermore, since IL-lp is known 
to induce CCR2 expression in HUVECs, a protocol was developed to successfully 
investigate the combined effects of this cytokine and WSS stimuli. However,
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preliminary results showed that the REC_B profile did not change the expression of 
CCR2 elicited by stimulation with IL-lp.
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CHAPTER 9: Conclusion and discussion
Chapter 9
9.A) General conclusion
In order to stimulate ECs with highly unsteady WSS waveforms, a real-time 
controlled CPD system was designed and constructed. The system resulted in 
reproducible unsteady WSS stimulation of cell monolayer cultures. The compact design 
of the system and the removable engine allow the user to easily handle the CPD base 
under a laminar flow hood ensuring the sterility of cell cultures when inserted into the 
device or during culture medium changes. Furthermore, the device is sized to allow 
placement within a standard cell incubator to avoid the use of other components to 
control temperature and gas composition of the CPD environment.
The distribution of WSS generated by cone rotation on the culture monolayer 
surface was assessed by comparing results obtained with analytical and computational 
methods. The results showed a very good agreement between different approaches. The 
maximum time delay that occurs between the cone acceleration and the WSS variation 
in the tested waveforms was determined. These results led to definition of a threshold of 
10 Hz for WSS frequencies correctly delivered at plate level in the CPD. Below this 
frequency threshold, the WSS is coherent at different plate radial positions and can be 
described as a function of the angular velocity ( go)  calculated by equation [ 3 ] .
In line with literature findings (260) it was verified that WSS waveforms derived 
from AVF areas generally protected from IH development, PUL_A and PUL_V, 
elicited HUVEC morphological adaptations that led to cells elongating and aligning 
with the flow direction. Furthermore, these waveforms caused an organized cytoskeletal 
remodeling where F-actin stress fibers were preferentially orientated in the flow
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direction. In addition, the beneficial effect of pulsatile WSS stimuli was confirmed by 
the upregulation of KLF2, a transcription factor known to induce quiescence in ECs. On 
the contrary, HUVECs exposed to reciprocating WSS waveforms derived from AVF 
areas exposed to IH development, R E C A  and RECB,  have shown no elongation nor 
alignment and a lack of cytoskeletal organization compared to HUVECs maintained in 
static culture. These reciprocating waveforms also failed to induce KLF2 mRNA 
expression but sustained the expression of genes involved in cytoskeleton 
reorganization.
To investigate the potential role of WSS in sustaining inflammation and promoting 
monocyte recruitment, the production of cytokines known to be involved in IH 
proliferative phase and vessel inflammation was evaluated (156, 415). Milliplex 
analysis showed an increased MCP-1 and IL- 8  average production of HUVECs exposed 
to REC_A and REC_B WSS compared to the production induced by PUL_A and 
PUL_V waveforms or by static condition. The time course of cytokine production 
showed that MCP-1 medium content was significantly higher in the Ti period of 
REC_B flow exposure compared to PUL_V or a static condition and IL- 8  resulted in 
significant up-regulation in REC_A and REC B using T4 medium compared to PUL_V 
or a static control (figure 58). These results demonstrate that AVF specific WSS 
waveforms modulate HUVEC chemoattractant signaling.
To further explore the paracrine proliferative potential elicited by flow, human 
SMCs were incubated with medium conditioned by HUVECs exposed to different WSS 
waveforms. Thus the increase in SMC proliferation was quantified after 24 hours 
incubation with HUVECs EM collected during different periods of HUVEC exposure to 
PUL_V, REC_A and REC_B flow experiments or static. The results have shown that 
mediums collected during the T2 and T4 periods of exposure to REC A and REC_B
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elicited a limited but statistically significant increase in SMC proliferation. These 
results are only partially consistent with the cytokine production time course (figure 60) 
since medium conditioned by static cultures induced a generally higher proliferation 
despite lower contents of MCP-1 and IL-8.
Finally, despite their probable role in IH development (114, 426), neither CK la 
nor CCR2 mRNA levels were up-regulated by reciprocating WSS. In conclusion, in- 
vitro HUVECs exposed to reciprocating/disturbed WSS of AVF high-risk stenosis areas 
showed an activation state and a pro-inflammatory signaling that is coherent with 
neointimal growth. This results leads to acceptance of the initial working hypothesis, 
that reciprocating WSS waveforms are a determinant of intimal hyperplasia 
development influencing AVF maturation and outcome.
9.B) Discussion
To provide adequate renal replacement therapy to the increasing number of end- 
stage renal disease patients is an open challenge. The lack of kidney donors causes an 
increase of demand for dialysis. However to perform efficient and effective dialysis 
treatment it is necessary to create a vascular access (VA) that provides an adequate 
blood flow to the filtration system with low complication rates.
Despite the fact that VA surgical placement has been performed for many years, 
the associated complications are the main cause of hospitalization among hemodialysis 
patients (9). Even the autologous arteriovenous fistulas (AVFs), considered the best VA 
modality choice, have high failure rates due to stenosis induced by neointimal formation 
(100). In this context, the aim of this work was to assess the influence of mechanical 
stress, and in particular the Wall Shear Stress (WSS) that may develop in the AVF 
geometry after creation, on endothelial cell monolayers in in-vitro culture.
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For many years it has been known that WSS has profound effects on EC 
phenotype (75). AVF creation introduces hemodynamics changes that go far beyond the 
normal physiological range (78). Very high frequency fluctuations and very high 
velocities create unique hemodynamics that vessel remodeling should accommodate to 
reestablish WSS and pressure to physiological values. The specific WSS patterns can 
interfere with the restoration of a functional endothelium after AVF creation and 
prevent AVF maturation.
CFD methods are currently widely used to study hemodynamics in realistic 
vasculature geometries. There is an increasing body of evidence that challenges 
traditional paradigms to evaluate WSS effects on the endothelium. The analysis of 
multidirectional WSS in locating atherosclerosis seems more accurate than considering 
just the OSI value. Furthermore, a study focused on internal carotid artery aneurysms 
revealed strong flow instabilities and periodic vortex shedding at 100 Hz frequency 
(434). In a recently published study of our group, it has been shown that high frequency 
oscillations developed in patient-specific AVF geometries and that new hemodynamic 
index such as the transverse WSS or transWSS (460) provides more information than 
OSI regarding localization of AVF areas most exposed to IH development (435). The 
magnitude of WSS waveforms frequency components has recently emerged as a 
determinant in controlling EC state (446). In this context, the CPD developed in this 
study provides a valuable tool to investigate the effect of a wide variety of realistic WSS 
waveforms. However, new designs in cell shearing devices are necessary to investigate 
the effects of planar multidirectional stimulation. Furthermore, a limitation of CPD use 
emerged during the experimental activity concerning the device engine heat production. 
For high velocity rotation (necessary to obtain WSS higher than 30 dyn/cm ), an 
increase of temperature within the cell incubator above 37°C was measured. This is
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caused by the insulation of the incubator environment that prevents heat exchange. To 
solve this issue it would be necessary to develop a refrigerating system, which could 
affect the ease of the experimental procedure and the compactness of the device that 
were required by the project.
The biological determinations performed on HUVEC monolayers exposed to 
different flows, have led to acceptance of the working hypothesis, identifying WSS as 
central to AVF maturation and failure. This study corroborates the idea that disturbed 
WSS in the AVF has the potential to trigger IH.
In recent years many pharmacological and surgical treatments have been 
proposed to ameliorate AVF outcomes. However, the results have been disappointing, 
since none of the proposed methods induced an increase in AVF usability and patency. 
Statin treatment is a meaningful example of promising pharmacological approaches to 
protect EC function that has failed in preventing AVF failure, despite the promising 
results obtained in a murine model. These vasoprotective molecules are widely used in 
clinical practice due their effect on the endogenous cholesterol metabolism and anti­
inflammatory properties. These molecules are also known to induce KLF2 and eNOS 
expression in ECs and to exert a protective function on the endothelium (436). Recent 
studies however, showed that statins might have a negative effect on EC structure (437) 
by preventing stress fibers and focal adhesion formation. Furthermore statins induce the 
over-expression of adhesion molecule expression in ECs (438). In this context, Florescu 
and Birch suggested that statins anti-inflammatory effects are likely to be insufficient in 
AVF remodeling due the ESRD context (439). Recently it has been showed that statins 
beneficial effects are amplified by combination with laminar unidirectional WSS (147, 
438, 440). On the contrary, reciprocating WSS reduces EC sensitivity to statin treatment 
(440, 441). The precise role of reciprocating WSS in impairing statins protective effects
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in ECs remains to be elucidated (441), but it indicates once more the importance of 
hemodynamics in vascular disease.
Since no treatments are currently available to reduce native vascular accesses 
stenosis and failure and despite the complete mechanism of intimal hyperplasia growth 
is not established yet, the hemodynamics that develop in a newly created AVF has a 
role in vessel tone regulation and inflammation, thus it is a potential target to ameliorate 
AVF outcome.
In line with these observations, computer-assisted pre-surgical planning emerges 
as the main available method to prevent or reduce disturbed hemodynamics that 
develops in AVF. The shape of a side-to-end anastomosis is commonly established with 
an angle between the artery and the vein. Our group has shown that reduced AVF angles 
minimize areas exposed to reciprocating shear stress (79) and clinically encouraging 
results were also obtained using a narrow-angle anastomosis technique in AVF creation 
(442). Further studies must be performed to determine the best clinical and surgical 
procedures to ensure functional vascular access in hemodialysis patients.
9.C) Future perspective
Since the definition of the role of WSS in vascular pathologies is still an open 
question, many groups around the world are currently producing data in this field.
The most recent findings have led to definition of major areas that should be 
developed in order for knowledge to advance and to provide clinical solutions for the 
many vascular dysfunctions where WSS is potentially involved.
The first area concerns the development of new tools to stimulate cell culture 
with conditions as close as possible to physiological conditions. Since in in-vivo 
investigations it is difficult to assess the exact mechanical forces that act on living
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tissues, in vitro studies remain fundamental to develop concepts that then have to be 
tested in animal models or clinical tests. As previously reported, new emerging 
evidence directs theories of WSS effects to turn toward the study of multidirectional 
WSS (443). To investigate the effects of this complex hemodynamic condition a new 
cell shearing device has been developed by Wang and colleagues (444, 445). The 
system is based on a plate, seeded with cells, that can rotate in a uniform flow field 
generated by a parallel flow chamber. This device has significant potential and the 
results may define once for all the relative importance of magnitude and direction in 
atherosclerosis development but also in other vascular dysfunctions such as AVF 
failure.
Another feature of WSS waveforms that has shown to be important in 
establishing endothelial phenotype is the WSS profile frequency components. As 
previously reported (446), by changing the magnitude of higher frequency components 
it is possible to dramatically change the effect of WSS stimulation. In this field of 
research, our system has the potential to provide useful information on the effects of 
changing WSS frequency and magnitude, despite the limitations previously described.
Beyond the tools necessary to investigate the effect of WSS on endothelium, 
new biological focus is emerging from different areas of research such as cancer 
therapy, transplant and molecular biology. As reported in Chapter 1, TGF-P seems to be 
central in the events that elicit cell proliferation and migration, as well as in matrix 
deposition, leading to IH development.
A recently addressed downstream signal of TGF-p in endothelium is based on 
the induction of the matricellular proteins that belong to the CCN family, via AP-1 
(447-449). CCN1 and CCN2 have been shown to be pro-fibrotic and to promote 
angiogenesis (449-451). On the contrary CCN3 seems to be protective and to prevent
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IH formation possibly via the downregulation of NF-kB activity (453). In a CCN3-ko 
mice model IH development was dramatically increased. Furthermore CCN3 has been 
shown to reduce EC VCAM expression and to prevent monocyte adhesion (454, 455).
CCN family member activation relies on the TGF-(3 signalling pathways, thus on 
binding to the different TGF-P receptors and WSS has been shown to regulate this 
binding, thus the role of WSS in modulating CCN has been addressed. The results 
showed that CCN3 can be induced by laminar WSS (455) but no data are available of 
the role of WSS features in inducing this molecule. In this context the CPD system has 
potential to investigate the role of AVF-specific WSS stimuli on TGF-p receptors and 
the downstream activation of SMAD pathways and CCN.
Another recently emerging field where the effects of WSS stimuli remain poorly 
understood is microRNA (miRNA) regulation and function (456). miRNA has been 
shown to participate in the transcriptional and post-transcriptional modification of 
mRNA. Different flow-induced miRNAs are involved in inflammation as well as in the 
protection of vessel tissues (110, 457-459). However no data are available on the effects 
of realistic WSS waveforms on miRNA transcription and activation and the possible 
downstream regulation caused by flow onset or long term exposure. Since miRNAs 
have been shown to participate in most intimate cell functions, the comprehension of 
these mechanisms could provide new therapeutic strategies in order to improve AVF 
outcomes.
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Appendix A
To evaluate the influence o f the mesh used to discretize the flu id  volume in the CFD 
simulation o f the Cone-and-Plate device, we performed a mesh sensitivity test using 
three different meshes. A coarse (69K  elements), medium (138K elements) and fine  
mesh (27OK elements) were constructed and used in flow simulations as describe in 
Chapter 3. Here we reported the results o f  the test.
A l) Mesh sensitivity test
As shown in figure A l, in the plate region of interest, no major differences using 
the three meshes were found in calculating the effective WSS delivered at plate level for 
PUL_A waveform. However, the used meshes return different WSS value at the outer 
border of the plate (r=6.75 cm, figure A2), and in particular coarser meshes return 
higher values of WSS. Similar results were obtained in REC_A simulation (figures A3 
and A4). Furthermore no appreciable differences were found in terms of WSS peak 
magnitude and mean value, as shown in the table of the figures A2 and A4.
According to these results, since no differences emerged respect to 270K mesh, 
the 138K mesh has been used to simulate the WSS waveforms of the present studies, as 
described in Chapter 3.
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Fig.Al: The graphs represent the result obtained by simulating PUL A WSS profile with the 
three different meshes, at different radial positions (r = 2.475 cm and r = 6.453 cm), compared 
to results obtained using Sucosky formula [3] at the same radius.
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Fig.A2: The graphs represent the result obtained by simulating PUL A WSS profile with the 
three different meshes, at the outer border of the fluid domain (r = 6.75 cm), compared to results 
obtained using Sucosky formula [3] at the same radius. The table shows the WSS peak and 
mean values obtained in the different conditions.
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Fig.A3: The graphs represent the result obtained by simulating REC A WSS profile with the 
three different meshes, at different radial positions (r = 2.475 cm and r = 6.453 cm), compared 
to results obtained using Sucosky formula [3] at the same radius.
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Fig.A4: The graphs represent the result obtained by simulating REC_A WSS profile with the 
three different meshes, at the outer border of the fluid domain (r = 6.75 cm), compared to results 
obtained using Sucosky formula [3] at the same radius. The table shows the WSS peak and 
mean values obtained in the different conditions.
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Appendix B
To evaluate the cytoskeleton reorganization and the cell shape o f HUVECs exposed to 
different flows, two open-source software have been used. The orientation o f F-actin 
stress fibers was evaluated using an ImageJ plug-in, OrientationJ, developed by the 
EPFL (Lousanne, CH). Furthermore, Cell Profiler, developed by the Broad Institute 
(Cambridge, USA) has been used to measure cells elongation and alignment. Herein 
are reported the detailed methods used to obtain the results presented in the Chapter 4.
B l)  O rientationJ
The software acquires the immunofluorescence image of HUVECs monolayer 
stained for F-actin (red) and nuclei (blue). The image is split into its RGB colour 
components. The red channel image is then transformed into a 32bit image in order to 
be processed by the software. In the images below (figure Bl.A  and Bl.B) are reported 
the software settings and an example of the results.
B2) Cell Profiler
The software acquires the immunofluorescence images of HUVECs monolayer 
stained for tight junction protein ZO-1 (green) and nuclei (blue). The image is then 
processed according to a "pipeline" defined by the user within the software interface. A 
cascade of modules that perform different activities composes each pipeline. Two 
pipelines were defined (figures B2.A and B2.B), one for elongated cells and one for the 
cobblestone shape cells. Basically the software acquires the image and processes it in 
order to ameliorate the signal. After image processing, a dedicate module performs the 
automatic recognition of nuclei according the user specification. From the recognized
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nuclei, the software recognizes the surrounding cell body according the method defined 
by the user. The main difference between the two pipelines is the method used to 
identify cell body. Elongated cells were recognized by " Watershed-gradient" filter 
while cobblestone cells were recognized by "Propagation" filter. However, both the 
pipelines have a module to manually correct the eventual errors made the automatic 
recognition modules.
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Fig.Bl.A: OrientationJ settings used to analyze immunofluorescence images.
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Fig.B2.A: Pipeline used to identified elongated cells and an example of result.
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Fig.B2.B: Pipeline used to identified cobblestone cells and an example of result
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